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 The electron transfer initiated cyclization (ETIC) has been shown to be an efficient 
method for the generation of cyclic amido acetals.  The tetrahydrofuranyloxy methyl ether was 
shown to be a stable nucleophilic hemiacetal surrogate allowing for the incorporation of a 
formaldehyde equivalent in the ETIC reaction.   
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 The ETIC reaction was employed in the stereoselective synthesis of amido trioxadecalin 
systems relevant to the synthesis of the mycalamides, onnamides and theopederins.  The 
stereoselectivity resulting from these cyclizations was controlled by the substituents of the 
tetrahydropyran ring and the conformational bias of the developing trioxadecalin system.  The 
epimerization of the N-acylaminal center of the amido trioxadecalin system was possible under 
mildly acidic conditions. 
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 An efficient and stereoselective synthetic route has been developed that intends to 
employ the ETIC reaction to selectively generate the N-acylaminal of mycalamide B.  A linear 
approach to the generation of the right half of mycalamide B has been applied allowing for 
expedient access to the dimethyl tetrahydropyran core.  The synthetic sequence employs an 
asymmetric Leighton allylation, selective boron mediated aldol, 1,3-syn-reduction, and selective 
epoxidation and syn-vinylation to establish the stereochemistry of the right hand fragment of 
mycalamide B. 
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 The stereoselective synthesis of the N7-C24 fragment of psymberin was developed.  The 
synthesis is highlighted by the de novo generation of the C25-C17 pentasubstituted arene that 
allows for the expedient generation of multigram quantities of this intermediate.  The 
stereochemistry of this fragment was established by an asymmetric Brown crotylation and 
Leighton allylation, selective Mukaiyama aldol addition, 1,3-syn-reduction, and a selective 
Lewis acid catalyzed TMSCN displacement of an acyl lactol.   
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1.   The Development of the Electron Transfer Initiated Cyclization for Application in 
the Synthesis of Amido Trioxadecalin Systems 
 
1.1  Introduction 
 
I. General 
 
 Nature continually provides synthetic challenges in the form of complex, biologically 
active natural products.  The challenges presented by these compounds demand the continual 
development of new synthetic methods and the creative application of established chemistry.  
The isolation of the family of natural products represented by mycalamides A,1 B2 and D,3 
onnamides A-F4-7 and theopederins A-F8,9, K and L10 has generated unique challenges for the 
synthetic chemist.  These compounds have a common core structure, shown in Figure 1, and all 
have displayed potent biological activity.  The scarce availability of these compounds from 
natural sources has inhibited the thorough examination of their therapeutic potential.  
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Figure 1: The Core Structure of the Mycalamide, Onnamides, and Theopederins 
  
 The complex structure and biological activity of the mycalamides, onnamides, and 
theopederins has generated a considerable amount of synthetic study that has resulted in 
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 significant advances in organic chemistry.  The amido trioxadecalin system, in particular the B 
ring including the N-acylaminal functional group, has been particularly difficult to synthesize.  
Two methods have been developed to generate this sensitive functional groups, but are either 
limited by efficiency or selectivity.  The synthetic efforts devoted to these and related 
compounds will be discussed in detail in Chapter 2.   
 A novel approach to the generation of the B ring of the mycalamides, onnamides and 
theopederins is through the use of photosensitized electron transfer (PET).  Recently, Floreancig 
and coworkers21 reported the development of an electron transfer initiated cyclization (ETIC) 
reaction that allows for the generation of acetal and N-acylaminal functional groups under 
essentially neutral conditions.  The following describes the basic principles of radical cations in 
the context of the ETIC reaction and discusses our development (Chapter 1) and application of 
the ETIC reaction for the synthesis of amido trioxadecalin systems (Chapter 2). 
 
II. The Radical Cation 
 
 Radical cations are singly electron deficient intermediates that can undergo a variety of 
transformations.11  These intermediates are commonly generated from neutral molecules by 
single electron oxidations utilizing chemical, anodic or photoinduced electron transfer (PET) 
conditions.  Non-oxidative methods have been reported, such as the combination of a radical 
with a cation and the protonation of a radical species, but are employed with less frequency.12  
Common reaction pathways available to radical cations include bond cleavage (1), radical based 
processes (2) and reactions initiated by nucleophiles (3, Figure 2).11
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Figure 2: Reaction Pathways of Radical Cations 
 
  PET oxidation is a powerful method for the generation of radical cations.  This type of 
oxidation can occur through two possible reaction pathways.  The first pathway utilizes the 
ability of electronically excited acceptors molecules (A*) to serve as strong single electron 
oxidants (1, Figure 3) to generate a radical cation/radical anion pair.  The second pathway relies 
on the ability of electronically excited donor molecules (D*) to function as strong single electron 
donors (2, Figure 3) to generate the radical cation/radical anion pair.  A common and facile 
reaction pathway of radical cation/radical anion pairs is return electron transfer regenerating the 
neutral ground state species.  The impact of this nonproductive, but nondestructive, pathway can 
be minimized with the proper choice of solvent, acceptor and cosensitizer.12 
 
D + A hν D + A* D + A
D + A hν D* + A
1.
2. D + A  
Figure 3: Photoinduced Electron Transfer Oxidation 
 
 The electron deficient nature of radical cations decreases the electron density and 
weakens the bonds around the periphery of molecule.  The benzylic bonds of arene radical 
cations are weakened to the greatest extent when the benzylic C-C σ-bond is orthogonal to the 
arene (Figure 4).12   The weakened benzylic bonds can result in fragmentation generating a 
radical and a cationic species.11  This type of bond cleavage is known as mesolytic cleavage.13  
3 
 Mesolytic cleavage has been shown to be a relevant reaction pathway when radical cations are 
generated in solution.12  Benzylic carbon-hydrogen, carbon-carbon, and carbon-silicon bonds of 
aryl radical cations have been shown to undergo mesolytic cleavage generating the aryl radical 
and the corresponding cation.14   
 
 
Figure 4: Orbital Alignment Required for Mesolytic Cleavage 
 
III. Carbon-Carbon σ-Bond Activation 
 
 Cyclic voltammetry studies by Kochi and coworkers15 of alkyl arenes established that 
arene radical cations have lifetimes less than ~100 µs.   The cyclic voltammogram of tert-butyl 
benzene in acetonitrile has been shown to be reversible, consistent with an oxidative process to 
generate a radical cation and a reductive process to regenerate a neutral species.  Additionally, 
the tert-butyl benzene radical cation displayed a longer lifetime than the radical cations of other 
alkyl benzenes, such as toluene and ethyl benzene, that did not display reversible cyclic 
voltammograms.  The shorter lifetimes and nonreversible cyclic voltammograms of the alkyl 
benzene radical cations were attributed to the presence of benzylic C-H bonds in these 
compounds.  Mesolytic cleavage of the benzylic C-H bonds in aryl radical cations has been 
shown to limit the lifetimes of these species.  This study indicated that for simple aliphatic arene 
radical cations carbon-hydrogen bond activation is favored over carbon-carbon bond 
acitivation.15 
4 
  Arnold and coworkers have demonstrated that with the appropriate alkyl substitution 
carbon-carbon bond cleavage can efficiently compete with carbon-hydrogen bond cleavage in 
arene radical cations.  They demonstrated that when methyl 2,2-diphenylethyl ether (1) was 
irradiated in acetonitrile and methanol (3:1) at 10 °C in the presence of 1,4-dicyanobenzene 
fragmentation occurred to generate diphenylmethane (2) and dimethoxymethane (3) as the only 
products (Figure 5).16   
 
O
CH3CN, CH3OH
hv, A, 10 oC
O O+
1 2A = 1,4-dicyanobenzene 3  
Figure 5: Carbon-Carbon Bond Cleavage in Arene Radical Cations 
 
 The mechanism proposed by Arnold and coworkers17 for the carbon-carbon bond 
cleavage of arene radical cations is shown in Figure 6.  Photoexcitation of the of the acceptor (A) 
to generate a strong single electron oxidant is the initial step of the reaction mechanism (1, 
Figure 6).17 The excitation wavelength of the photosensitizer, 1,4-dicyanobenzene, extends 
beyond the absorption cutoff of the Pyrex filter (280 nm), while aryl alkanes are not 
electronically excited when a Pyrex filter is employed during irradiation.17   
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Figure 6: Mechanism for Photosensitized Carbon-Carbon Bond Cleavage 
 
 The second step of the mechanism is single electron transfer from the arene to the 
electronically excited acceptor (2, Figure 6).  Single electron transfer between the singly excited 
1,4-dicyanobenzene and arylalkanes has been shown to occur at a diffusion-controlled rate.  The 
resulting radical cation/radical anion pair can undergo return electron transfer to regenerate the 
neutral species (3, Figure 6) or mesolytic cleavage can occur to generate the aryl radical and an 
α-alkoxy cation (4, Figure 6).17   
 The thermodynamic propensity for a radical cation carbon-carbon bond to undergo 
mesolytic cleavage can be evaluated by examining the bond dissociation energy of the radical 
cation (BDE(RC)) (Figure 7).  The BDE(RC) can be approximated from the bond dissociation 
energy of the substrate (BDE(S)), the oxidation potential of the substrate (Epa(S)) and the 
oxidation potential of the radical precursor to the electrophilic fragment (Epa(E)), as shown in 
Figure 7.17  Mesolytic cleavage of the radical cation occurs to generate the carbocation of the 
radical fragment with the lower oxidation potential, as described by the relationship in Figure 
7.16  In the case of the homobenzylic ether (1, Figure 5) the oxidation potential of the α-alkoxy 
radical is approximately 0.6 V lower than that of the biphenyl radical.18  
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Figure 7: Bond Dissociation Energy of an Alkylaryl Radical Cation 
 
 The cation fragment generated from mesolytic cleavage can then undergo nucleophilic 
attack from the solvent to generate an ether (5, Figure 6).  Single electron transfer between the 
biphenyl methyl radical (generated from mesolytic cleavage of the radical cation) and the radical 
anion of the acceptor regenerates the ground state acceptor (6, Figure 6) and protonation of the 
resulting biphenyl methyl anion provides biphenyl methane (7, Figure 6).17 
 
IV. The Electron Transfer Initiated Cyclization (ETIC) 
 
 Recently Floreancig and coworkers19 reported the synthesis of furanosides and 
pyranosides from the single electron oxidation of homobenzylic ethers (Figure 8).  The radical 
cation of the homobenzylic ether is generated by photoinduced electron transfer resulting in the 
weakening of the benzylic carbon-carbon σ-bond.  Subsequent mesolytic cleavage generates a 
benzyl radical and an α-alkoxy carbocation.  Nucleophilic attack by the pendent nucleophile 
(alcohol or ether) onto the cationic intermediate completes the reaction. 
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 OC8H17
O
OC8H17
Nuc
OC8H17
Nuc-1 e-n n
n
Nuc = alcohol or ether  
Figure 8: A General ETIC Reaction 
 
 The ETIC reactions are conducted in dichloroethane (DCE, solvent) by irradiating a 
substrate with a medium pressure mercury lamp through a Pyrex filter in the presence of either 
stoichiometric or catalytic N-methylquinolinium hexafluorophosphate (NMQ, photosensitizer), 
tert-butyl benzene or toluene (cosensitizer), sodium thiosulfate (Na2S2O4, reducing agent) and 
sodium acetate (NaOAc) (insoluble base).  The cationic photosensitizer (NMQ) was employed in 
these reactions to minimize return electron transfer.19  The ETIC reaction can be conducted 
under anaerobic or aerobic conditions.  Aerobic conditions are generally preferred since catalytic 
amounts of NMQ can be employed.  In the aerobic ETIC reaction oxygen serves as the 
stoichiometric oxidant by regenerating NMQ, 4, from the N-methylquinoline radical, 5, 
generated during the single electron oxidation of the cosensitizer (Figure 9).21
 
N
N
O2
O2-
single electron oxidation4
5
N
*
hv cosensitizer radical cation
 
Figure 9: Aerobic Oxidation Mechanism of the ETIC Reaction 
 
 The mechanism of the ETIC reaction begins when NMQ is irradiated (318 nm) and 
promoted to its singly excited state.  A single electron transfer occurs between toluene 
8 
 (cosensitizer) and the photoexcited NMQ generating the radical cation of toluene and the N-
methylquinoline radical.  The lack of coulombic attraction between the radical cation and the N-
methylquinoline radical allows for rapid diffusion limiting return electron transfer.  A reversible 
electron transfer from the homobenzylic ether to the radical cation of toluene generates the 
substrate radical cation (Figure 10).  At this point cyclization can occur through an associative 
SN2-like pathway that leads to stereochemical inversion at the electrophilic center or a 
dissociative SN1-like pathway can occur resulting in a planar cationic intermediate and a racemic 
mixture.19 
 
Ph
OR
OH Ph
OR
OH
OR
OH+
associative
cyclization
cyclization
ORO
ORO
recombination dissociation
- 1 e-
+ 1 e-
 
Figure 10: Mechanism of the ETIC Reaction 
 
 The extent to which the ETIC reaction proceeds through an associative or dissociative 
pathway is highly substrate dependent.  Substrates possessing good nucleophiles with unhindered 
transition states were shown to proceed through an associative mechanism, while substrates 
containing weaker or bulky nucleophiles or that generated steric repulsion in the transition state 
proceeded through the dissociative pathway.19  However, as the catalog of ETIC reactions 
increases the dissociative pathway appears to be the more common mechanistic pathway.   
 When cyclization is slow the oxidatively generated radical cation can undergo 
fragmentation to generate the cation and radical fragments (Figure 10).  In the absence of 
9 
 nucleophilic attack the radical and cation fragments can recombine to regenerate the radical 
cation species.  This dissociation/recombination mechanism can result in a loss of stereochemical 
identity at the homobenzylic position.  Evidence for this process was obtained by taking a 
diastereomerically pure substrate to partial conversion and isolating a diastereomeric mixture in 
the recovered starting material.19  
  The ETIC reaction has also shown to be efficient for the generation of cyclic N-
acylaminals (Figure 11).  Unlike their homobenzylic ether counterparts, the homobenzylic 
amides have been shown to only react through a dissociative pathway generating an N-
acyliminium ion as the reactive intermediate.21  These highly reactive intermediates undergo 
facile nucleophilic addition of mild, pendent nucleophiles to generate cyclic N-acylaminals.  As 
shown by the carbamate (Figure 11), these reactions tolerate inductively withdrawing 
substituents in the β-position which have been shown to increase the bond dissociation energy of 
the radical cation by increasing the oxidation potential of the amidoalkyl radial.  In these systems 
oxidation likely occurs at the amide or carbamate since the oxidation potential of tertiary amides 
and carbamates is approximatiely 0.5 V lower than monoalkyl arenes.21
 
OHBn
HN
O
C5H11
hv, NMQPF6, O2, NaOAc, Na2S2O3
toluene, DCE
ON
H
C5H11
O
BocN
O
Bn
OTHP hv, NMQPF6, O2, NaOAc, Na2S2O3
toluene, DCE O
O
N
Boc
71%
88%      >19:1 dr
 
Figure 11: Cyclic Acylaminal Formation with the ETIC reaction 
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  The ETIC reaction is a useful method for generating acetals and N-acyl aminals and 
provides a powerful new method for synthetic organic chemists.  The advantages of this process 
are centered on the use of a benzyl group as the precursor to reactive functionality.  The benzyl 
group is relatively inert to most reaction conditions, which allows for its early incorporation into 
a synthetic sequence.  Additionally, the single electron oxidation of the benzyl moieties and  
subsequent fragmentation to generate the oxocarbenium and N-acyliminium ions occurs under 
essentially neutral conditions allowing for the incorporation of sensitive functionality into the 
ETIC substrates.  Also the highly reactive electrophiles generated in these reactions allows for 
the use of a wide range of mild, pendent nucleophiles.   
 
V. Project Goals and Objectives 
 
 The ability to expand the scope of the ETIC reaction to include the generation of cyclic 
amido acetals and ultimately the amido trioxadecalin ring system of the mycalamides, 
onnamides, and theopederins was examined.  The following section describes the generation of a 
cyclic amido acetal model compound relevant for the synthesis of compounds containing amido 
trioxadecalin ring systems. This study also resulted in the development of a stable nucleophile 
that can serve as the functional equivalent of a formaldehyde hemiacetal. 
 
11 
 1.2  Results and Discussion 
 
 The ETIC reaction provides a powerful method for the generation of acyliminium ions 
from homobenzylic amides and carbamates under mild reaction conditions.  The nucleophilic 
addition of pendent nucleophiles, such as alcohols or ethers, to oxidatively generated 
acyliminium ions has resulted in the generation of cyclic N-acylaminals under essentially neutral 
conditions.21  While this method was successful for the generation of a variety of N-acylaminals, 
there was no precedent for the generation of cyclic amido acetals, such as 1, a ring system 
prevalent in the mycalamide, theopederins and onnamides (Figure 12). 
 
O
O
N
H
C5H11
O
formaldehyde
equivalent
HN C5H11
O
O
1 2
R
 
Figure 12: Retrosynthetic Evaluation of Cyclic Amido Acetals 
 
 
 This study was designed to extend the scope of the ETIC reaction to include the synthesis 
of cyclic amido acetal 1 by employing a nucleophile that would serve as a formaldehyde 
hemiacetal surrogate, shown in Figure 12.   To this end homobenzylic amides 3-5 (Figure 13) 
were evaluated based on their ability to donate a formaldehyde equivalent in the ETIC reaction.  
The synthesis and reactivity of these substrates are described in the following section.  A 
majority of this chapter has been published as a communication and a full paper.24,25 
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Figure 13: ETIC Substrates Containing Potential Formaldehyde Donor Nucleophiles 
 
I. Synthesis and Evaluation of the Hemiacetal Nucleophile 
 
 The successful application of alcohol nucleophiles in the ETIC reaction prompted us to 
examine the use of a hemiacetal nucleophile in these reactions.  The use of a hemiacetal 
nucleophile would expand the scope of the ETIC to include the generation of cyclic amido 
acetals.  As a result of the highly unstable nature of the hemiacetal that precludes its efficient 
isolation, this functional group will be generated in situ. The in situ generation of ETIC substrate 
3 (Figure 13) from alcohol 11 (Scheme 1) has been examined under ETIC reaction conditions 
modified to promote hemiacetal formation.   
Alcohol 11 was synthesized in a 7 step sequence starting from phenylacetaldehyde.  The 
addition of allylmagnesium bromide to phenylacetaldehyde generated alcohol 6 in an 88% yield 
(Scheme 1).  Ozonolysis of 6 followed by reduction with NaBH4 resulted in diol 7 in a 78% 
yield.  Selective protection of the primary alcohol of diol 7 proceeded smoothly in the presence 
of tert-butyldimethylsilyl chloride (TBSCl) and imidazole at reduced temperatures to provide 
silyl ether 8 in a 93% yield.  Mesylation of the secondary alcohol of 8 followed by nucleophilic 
mesylate displacement with sodium azide generated azide 9 in a 68% yield over 2 steps.  
Reduction of azide 9 proceeded smoothly to the corresponding amine under Staudinger 
conditions. The crude reaction mixture was treated with triethylamine and hexanoyl chloride to 
13 
 generate amide 10 in an 88% yield.  TBAF deprotection of 10 resulted in the desired alcohol 11 
in 93% yield.   
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Reagents: (a) allylmagnesium bromide, THF, -78 °C to rt, 88%; (b) O3, CH2Cl2 , -78 °C, then NaBH4, MeOH, rt, 78%; 
(c) TBSCl, imidazole, CH2Cl2, -42 °C, 93%; (d) MsCl, NEt3, CH2Cl2, 0 °C; (e) NaN3, Bu4NI, DMF, 40 °C, 69% over 2 
steps; (f) PPh3, THF, rt, then H2O, then Et3N and hexanoyl chloride, 88%; (g) TBAF, THF, 93%.
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Scheme 1: Synthesis of Homobenzylic Amide 
  
 Alcohol 11 was subjected to modified ETIC conditions that included formaldehyde and 
cesium carbonate (to facilitate hemiacetal formation), NMQ (sensitizer), sodium thiosulfate 
(peroxide reducing agent), toluene (aromatic cosensitizer) and 1,2-dichloroethane (DCE, 
solvent).  Air (O2 serves as terminal oxidant) was bubbled through the reaction mixture while it 
was irradiated with a medium pressure mercury lamp through a Pyrex filter (Scheme 2).  The 
irradiation of the reaction mixture lasted for 6 hours and resulted in complete degradation of 
starting material with no isolable products.  The lack of cyclization was attributed to the 
prohibitively short lifetime of the hemiacetal under the modified ETIC conditions. 
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Scheme 2: Evaluation of In Situ Hemiactal Formation in the ETIC Reaction 
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 II. Synthesis of Formaldehyde Hemiacetal Surrogates 
 
 In addition to the in situ hemiacetal generation, we were interested in examining more 
stable functional groups that could serve as formaldehyde hemiacetal surrogates.  The 
trimethylsilylethoxymethyl (SEM) ether protecting group was an attractive option because it 
could be generated in one step from commercially available starting material and the electron 
rich silyl functional group was expected to promote the desired fragmentation.   SEM ether 4 was 
generated in a single step in 92% yield by treating alcohol 11 with commercially available 
trimethylsilylethyloxymethyl chloride (SEM-Cl) in the presence of diisopropylethylamine 
(DIPEA) at 45 °C (Scheme 3).   
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Reagents: (a) SEM-Cl, DIPEA, CH2Cl2, 45 °C, 92%.  
Scheme 3: Synthesis of SEM Ether ETIC Substrate 
 
 Our previous success employing THP ethers as nucleophiles in the EITC reaction led us 
to examine the tetrahydrofuranyloxymethyl (TFM) ether (5, Scheme 4) as a formaldehyde 
hemiacetal surrogate.   TFM ether 5 was generated from alcohol 11 by a three step sequence that 
required the development of the benzyloxybutoxymethyl (BBM) ether protecting group.  BBM 
ether 12 was generated in a 93% yield by treating alcohol 11 with benzyloxybutoxymethyl 
chloride (BBM-Cl) in the presence of DIPEA at 45 °C.  BBM-Cl was generated in quantitative 
yield by bubbling anhydrous HCl through a solution of commercially available 
15 
 benzyloxybutanol and formaldehyde in CH2Cl2 at 0 °C.  Cleavage of the benzyl ether followed 
by oxidative etherification employing conditions developed by Suarez and coworkers22 generated 
the TFM ether 5 in an 85% yield over 2 steps.  
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H2, EtOH; (d) PhI(OAc)2, I2, hv, cyclohexane, 85% over 2 steps.
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Scheme 4: Synthesis of ETIC Cyclization Substrates 
 
 The generation of the TFM ether under the Suarez oxidative etherification conditions was 
rationalized by invoking a radical based mechanism, as shown in Figure 14.  Suarez and 
coworkers have proposed the in situ generation of acyl hypoiodite (2AcOI) from the reaction of 
(diacetoxyiodo)benzene (PhI(OAc)2) and molecular iodine.  The oxygen-iodine bond, generated 
from the reaction of the acyl hypoiodite with the primary alcohol of 13, undergoes homolytic 
cleavage when irradiated with a medium pressure mercury lamp through a Pyrex filter.  The 
resulting alkoxy radical abstracts the α-alkoxy proton generating the lower energy α-alkoxy 
radical.  Single electron oxidation of the α-alkoxy radical generates an oxocarbenium ion and 
subsequent addition of the pendent alcohol completes the formation of the TFM ether. 
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Figure 14: Suarez Oxidative Cyclization to Generate the TFM Ether.   
 
III. Formaldehyde Hemiacetal Surrogates in the ETIC Reaction 
 
 Subjecting SEM ether 4 to standard ETIC conditions (NMQ (cat.), hυ, O2, NaOAc, 
Na2S2O3, 1,2-dichloroethane and toluene) resulted in the isolation of N-acyl hemiaminal 14 in a 
67% yield (Figure 15).  N-Acyl hemiaminal 14 was isolated by standard chromatography and 
was found to be surprisingly stable.  The stability of the N-acyl hemiaminal was attributed to 
intermolecular hydrogen bonding interactions between the N-acyl hemiaminal hydroxyl 
functional group and the amide carbonyl and the amide proton with the proximal acetal oxygen 
(Figure 15).  The stability of similar N-acyl hemiaminals has been attributed to this type of 
hydrogen bonding interactions.23 
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Figure 15: ETIC Reaction of the SEM Ether Substrate 
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  The generation of N-acyl hemiaminal 14 was explained by examining the fate of the 
intermediate oxonium ion generated from the ETIC reaction (Figure 16).  Single electron 
oxidation followed by mesolytic cleavage resulted in the generation of an N-acyliminium 
ion/benzyl radical pair.  Nucleophilic addition by the distal oxygen of the acetal generates an 
oxonium species that can react through two separate reaction pathways.  If R+ loss is faster than 
the ring opening process the cyclic amido acetal is generated.  If the loss of R+ is slow, then the 
regeneration of the acyliminium ion is the dominant pathway allowing for the addition of H2O 
into the N-acyl iminium ion generating the N-acyl hemiaminal.  This mechanism is supported by 
the facile addition of H2O to the oxidatively generated N-acyliminium ion of 4 (Figure 15), 
which is inconsistent with the extremely slow addition of H2O observed with other cation 
ion/radical pairs generated during previous ETIC reactions.  This would suggest that the addition 
of H2O must occur into a more reactive free N-acyliminium ion generated from the ring opening 
of the oxonium ion (no longer a cation/radial pair).  According to the mechanism described in 
Figure 16, increasing the rate of the R+ group loss following oxonium ion formation would allow 
for the generation of the desired cyclic amido acetal. 
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Figure 16: Fates of the Oxonium Ion Generated in the ETIC Reaction 
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  The success of tetrahydropyranyl ethers as nucleophiles in previously reported ETIC 
reactions prompted our investigation of the TFM ether 5.  The increased ability of the 
tetrahydrofuranyl moiety to stabilize a cation was expected to increase the rate of fragmentation 
of the oxonium ion generated during the ETIC reaction favoring the formation of the cyclic 
amido acetal.  Additionally, 4 Å molecular sieves were added to the ETIC reaction conditions to 
minimize the concentration of alternative nucleophiles.  When 5 was subjected to the standard 
ETIC conditions in the presence of 4 Å molecular sieves the cyclic amido acetal 1 was generated 
in a 79% yield (Figure 17).  The efficient generation of the cyclic amido acetal supported our 
proposed mechanism (Figure 16) and indicated that the TFM ether can be used as a stable 
nucleophilic hemiacetal surrogate.  The role of the 4 Å molecular sieves is consistent with that of 
a desiccant, although the possibility for surface catalysis cannot be ruled out.   
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Figure 17: ETIC Cyclization of TFM Ether 
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 1.3  Conclusions 
  
 The scope of the ETIC reaction has been extended to include the generation of cyclic 
amido acetals.  This study demonstrated that the in situ generated hemiacetal functionality does 
not serve as an efficient nucleophile in the ETIC reaction.  Also the SEM ether was shown to 
function as competent nucleophile in the ETIC reaction; however the slow decomposition the 
resulting oxonium ion intermediate limited its utility for the generation of the cyclic amido 
acetal.  The generation of the desired cyclic amido acetal was made possible by the development 
of the tetrahydrofuranyloxymethyl (TFM) ether group.  The stability of the tetrahydrofuranyl 
cation allowed for the fast decomposition of the oxonium ion intermediate resulting in the 
generation of the desired cyclic amido acetal.  The development of the TFM ether also provides a 
formaldehyde hemiacetal surrogate that could be useful in a variety of other applications.   
20 
 1.4  Experimentals 
 
General Experimental: 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded on 
Bruker Avance 300 spectrometers at 300 MHz and 75 MHz, respectively.  The chemical shifts 
are given in parts per million (ppm) on the delta (δ) scale.  The solvent peak or the internal 
standard tetramethylsilane were used as reference values.  For 1H NMR: CDCl3 = 7.27 ppm, 
TMS = 0.00.  For 13C NMR: CDCl3 = 77.23, TMS = 0.00.  For proton data: s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets, dt = doublet of triplets, ddt 
= doublet of doublets of triplets; br = broad; m = multiplet; app t  = apparent triple; app q = 
apparent quartet; app p = apparent pentet. 
High resolution and low resolution mass spectra were recorded on a VG 7070 spectrometer.  
Infrared (IR) spectra were collected on a Mattson Gygnus 100 spectrometer. 
Analytical thin layer chromatography (TLC) was performed on E. Merck pre-coated (25 nm) 
silica gel 60F-254 plates.  Visualization was done under UV (245 nm).  Flash column 
chromatography was preformed using ICN SiliTech 32-63 60 Å silica gel.  Reagent grade ethyl 
acetate and hexanes (commercial mixture) were purchased from EM Science and used as is for 
chromatography.  Reagent grade methylene chloride (CH2Cl2), dichloroethane (C2H4Cl2), 
acetonitrile (CH3CN), benzene and toluene were distilled from CaH2.  Diethyl ether (Et2O) and 
tetrahydrofuran (THF) were distilled from sodium benzophenone ketal prior to use.  Anhydrous 
N,N-dimethylformamide (DMF), methanol (MeOH), dimethylformamide (DMF), methanol 
(MeOH), dimethyl sulfoxide (DMSO) were purchased from Aldrich and used as is.  All reactions 
were conducted under nitrogen atmosphere, unless otherwise specified. 
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Phenylpent-4-en-2-ol, 6:20  To phenylacetaldehyde (4.87 g, 40.58 mmol) in 
THF (100 mL) at -78 °C was added allylmagnesium bromide (1M in THF, 
60.0 mL, 60.00 mmol).  The reaction mixture was stirred for 1 h at -78 °C then allowed to warm 
to room temperature and stirred for 2 hours.  Saturated aqueous NH4Cl (10 mL) was added and 
the resulting mixture was stirred for 10 minutes then extracted with EtOAc (3 x 10 mL).  The 
organic layers were combined, washed with brine (2 x 10 mL), dried with Na2SO4, filtered and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(10% EtOAc in hexanes) to provide the desired product (5.81 g, 88%):  1H NMR (300 MHz, 
CDCl3) δ 7.34-7.21 (m, 5H), δ 5.94-5.82 (m, 1H), δ 5.20-5.12 (m, 2 H), δ 3.93-3.84 (m, 1H), δ 
3.80 (dd, J = 13.6, 5.0 Hz, 1H), δ 2.70 (dd, J = 13.5, 7.9 Hz, 1H), δ 2.39-30 (m, 1H), δ 2.45-2.17 
(m, 1 H), δ 1.67 (bs, 1H).   
 
4-Phenylbutane-1,3-diol, 7:  Ozone was bubbled through a solution of 6 
(7.00 g, 43.1 mmol) in CH2Cl2 (50 mL) at -78 °C until the reaction mixture 
sustained a dark blue color.  Methanol (50 mL) was added to the solution at -78 °C followed by 
the slow addition of NaBH4 (6.53 g, 172 mmol).  The reaction was stirred at -78 °C for 1 hour 
then slowly warmed to room temperature and stirred for 4 hours.  The reaction was concentrated 
under reduced pressure and extracted with EtOAc (3 x 10 mL).  The organic layers were 
combined, washed with water (2 x 10 mL) and brine (2 x 10 mL), dried with Na2SO4, filtered, 
and concentrated under reduced pressure.  The resulting oil was purified by flash 
chromatography (40% EtOAc in hexanes) to provide the desired product (5.21 g, 78%):  1H 
NMR (300 MHz, CDCl3) δ 7.30-7.22 (m, 5H), 4.12-4.08 (m, 1H), 3.89-3.82 (m, 2H), 2.83-2.77 
OH
OH
OH
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 (m, 2H), 2.28 (bs, 2H), 1.80-1.75 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 137.9, 129.4, 128.6, 
126.6, 73.1, 61.7, 44.3, 37.7; IR (neat) 3349, 3026, 2938, 1052 cm-1; HRMS (EI) calcd. for 
C10H14O2 (M+) 166.0993, found 166.0996. 
 
4-(tert-Butyldimethylsilanyloxy)-1-phenylbutan-2-ol, 8:  To a solution of 
7 (1.72 g, 10.2 mmol) in CH2Cl2 (50 mL) at room temperature was added 
imidazole (1.51 g, 22.4 mmol).  The solution was stirred for 10 minutes then cooled to -42 °C.  
TBSCl (1.64 g, 11.2 mmol) was added to the reaction mixture which was stirred for two hours at 
-42 °C.  Saturated aqueous NH4Cl (10 mL) was added and the reaction mixture was warmed to 
room temperature.  The reaction mixture was extracted with CH2Cl2 (2 x 10 mL).  The organic 
layers were combined, washed with brine (10 mL), dried with MgSO4, filtered, and concentrated 
under reduced pressure.  The resulting oil was purified by flash chromatography (30% EtOAc in 
hexanes) to provided the desired product (2.63 g, 93%):  1H NMR (300 MHz, CDCl3) δ 7.32-
7.18 (m, 5H), 4.11-4.03 (m, 1H), 3.92-3.85 (m, 1H), 3.82-3.74 (m, 1H), 3.32 (bs, 1H), 2.85 (dd, J 
= 13.5, 7.0 Hz, 1H), 2.73 (dd, J = 13.5, 6.2 Hz, 1H), 1.72-1.60 (m, 2H), 0.90 (s, 9H), 0.07 (s, 
6H);  13C NMR (75 MHz, CDCl3) δ 138.8, 129.5, 128.4, 126.3, 72.8, 62.5, 44.0, 36.9, 25.8, 18.1, 
-5.5; IR (neat) 3450, 2953, 2857 cm-1; HRMS (EI) calcd. for C16H28O2Si (M+) 280.1858, found 
280.1815. 
 
3-Azido-4-phenylbutoxy-tert-butyldimethylsilane, 9: To a solution of 8 
(9.36 g, 33.2 mmol) in DMF (100 mL) was added triethylamine (13.4 g, 
0.132 mol) and the solution was cooled to 0 °C.  Methanesulfonyl chloride (5.70 g, 49.8 mmol) 
was added drop wise and the reaction mixture was stirred for 3.5 hours at 0 °C.  Brine (10 mL) 
OH
OTBS
N3
OTBS
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 was added and the reaction was allowed to warm to rt.  The reaction mixture was extracted with 
hexanes (2 x 10 mL).  The organic layers were combined, washed with H2O (20 mL), dried with 
MgSO4, filtered and concentrated under reduced pressure. The resulting oil was dissolved in 
DMF (60 mL) and NaN3 (10.3g, 0.158 mol) and tetrabutylammonium iodide (0.031 g, 0.080 
mmol) were added.  The solution was stirred at 55 °C for 14 hours.  The reaction was allowed to 
cool to rt, H2O (10 mL) was added and the reaction mixture was extracted with hexanes (2 x 10 
mL).  The organic layers were combined, dried with MgSO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (5% EtOAc in 
hexanes) to provide the desired product (6.93 g, 68%):  1H NMR (300 MHz, CDCl3) δ 7.34-7.21 
(m, 5H), 3.77-3.71 (m, 1H), 3.74-3.71 (m, 2H), 2.85 (dd, J = 13.8, 6.0 Hz, 1H), 2.84 (dd, J = 
13.8, 7.8 Hz, 1H), 1.78-1.76 (m, 1H), 1.67-1.62 (m, 1H), 0.89 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H);  
13C NMR (75 MHz, CDCl3)  δ 139.5, 129.3, 128.5, 126.7, 60.8, 59.5, 41.1, 37.0, 25.9, 18.1, -5.4; 
IR (neat)  2955, 2930, 2857, 2100, 1812, 1742 cm-1;  HRMS (EI) calcd. for C16H27N3OSi (M-
C4H9) 248.1201, found 248.1207. 
 
Hexanoic acid 1-benzyl-3-tert-butyldimethylsilanyloxypropyl amide, 
10:  To a solution of 9 (1.20 g, 3.93 mmol) in THF (20 mL) was added 
triphenylphosphine (1.24 g, 4.72 mmol), and the reaction mixture was stirred for 6 hours at rt.  
To the reaction mixture was added H2O (4 mL).  The reaction mixture was stirred for 8 hours at 
room temperature.  To the reaction mixture was added triethylamine (1.19 g, 11.8 mmol) 
followed by hexanoyl chloride (1.05 g, 7.86 mmol).  The reaction mixture was stirred for 6 hours 
at room temperature.  The reaction mixture was extracted with EtOAc (2 x 10 mL).  The organic 
layers were combined, washed with brine (10 mL), dried with Na2SO4, filtered, and concentrated 
HN
OTBS
C5H11
O
24 
 under reduced pressure.  The resulting oil was purified by flash chromatography (50% EtOAc in 
hexanes) to provide the desired product (1.31 g, 88%):  1H NMR (300 MHz, CDCl3) δ 7.31-7.19 
(m, 5H), 6.17 (d, J = 7.5 Hz, 1H), 4.34-4.23 (m, 1H), 3.83 (ddd, J = 10.5, 8.7, 4.5 Hz, 1H), 3.72-
3.64 (m, 1H), 3.00 (dd, J = 13.5, 5.5 Hz, 1H), 2.74 (dd, J = 13.5, 8.2 Hz, 1H), 2.11 ( t, J = 7.2 
Hz, 2H), 1.81-1.70 (m, 1H), 1.67-1.51 (m, 3H), 1.35-1.24 (m, 4H), 0.92 (s, 9 H), 0.89 (t, J = 7.1 
Hz, 3H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 172.6, 138.4, 129.4, 128.3, 
126.3, 60.6, 49.3, 40.0, 37.1, 34.8, 33.9, 31.2, 25.9, 24.4, 22.4, 13.9, -5.4; IR (neat) 3287, 2930, 
2858, 1711, 1643, 1097 cm-1; HRMS (EI) calcd. for C21H36NO2Si (M-CH3) 362.2515, found 
362.2521. 
 
Hexanoic acid 1-benzyl-3-hydroxypropylamide, 11:  To a solution of 10 
(549 mg, 1.45 mmol) in THF (13 mL) at 0 °C was added 
tetrabutylammonium fluoride (TBAF) (1.14 g, 4.35 mmol).  The reaction mixture was warmed to 
room temperature and stirred for 2 hours.  H2O (10 mL) was added the reaction mixture was 
extracted with EtOAc (2 x 10 mL).  The organic layers were combined, washed with brine (10 
mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil 
was purified by flash chromatography (50% EtOAc in hexanes) to provide the desired product 
(343 mg, 89%):  1H NMR (300 MHz, CDCl3)  δ  7.30-7.13 (m, 5H), 5.52 (d, J = 8.4 Hz, 1H), 
4.43-4.34 (m, 1H), 3.71 (bs, 1H), 3.61-3.64 (m, 2H), 2.87 (dd, J = 14.0, 6.0 Hz, 1H), 2.73 (dd, J 
= 14.0, 7.8 Hz, 1H), 2.13-2.06 (m, 2H), 1.92-1.84 (m, 1H), 1.48 (p, J = 7.2, 2H), 1.36-1.27 (m, 
1H), 1.24-1.07 (m, 4H), 0.82 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 174.5, 137.5, 
129.1, 128.6, 126.7, 58.4, 46.8, 41.2, 37.8, 36.6, 31.2, 25.4, 22.3, 13.9; IR (neat) 3280, 2929, 
1647, 1621, 1544, 1054 cm-1; HRMS (EI) calcd. for C16H25NO2 (M+) 263.1885, found 263.1886. 
HN
OH
C5H11
O
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Hexanoic acid 1-benzyl-3-(2-trimethylsilanylethoxymethoxy)-
propyl amide, 4:  To a solution of 11 (0.10 g, 0.38 mmol) in CH2Cl2 
(2 mL) at room temperature was added N,N-diisopropylethylamine (DIPEA) (2 mL) followed by 
2-(trimethylsilyl)ethoxymethyl chloride (0.13 g, 0.76 mmol).  The reaction mixture was heated to 
45 °C for 8 hours.  The reaction mixture was cooled to room temperature and H2O (5 mL) was 
added.  The reaction mixture was extracted with CH2Cl2 (2 x 5 mL).  The organic layers were 
combined, washed with 10% aqueous acid (5 mL) and brine (5 mL), dried with Na2SO4, filtered, 
and concentrated under reduced pressure.  The resulting oil was purified by flash 
chromatography (50% EtOAc in hexanes) to provide the desired product (0.14 g, 92%):  1H 
NMR (300 MHz, CDCl3) δ 7.29-7.16 (m, 5H), 5.79 (d, J = 8.2 Hz, 1H), 4.63 (s, 2H), 4.35-4.23 
(m, 1H), 3.71-3.55 (m, 4H), 2.89 (dd, J = 13.6, 6.0 Hz, 1H), 2.79 (dd, J = 13.6, 8.1 Hz, 1H), 2.10 
(t, J = 8.1 Hz, 2H), 1.88-1.77 (m, 1H), 1.65-1.50 (m, 3H), 1.33-1.17 (m, 4H), 0.92 (t, J = 8.5 Hz, 
2H), 0.87 (t, J = 6.8 Hz, 3H), 0.01 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 172.4, 137.9, 129.3, 
128.3, 126.3, 94.9, 65.2, 48.4, 40.3, 36.9, 32.9, 25.3, 22.3, 21.0, 18.0, 13.8, -1.5; IR (neat) 3282, 
2954, 1639, 1549, 1060 cm-1; HRMS (EI) calcd. for C22H39NO3Si (M+) 393.2699, found 
393.2706. 
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4-Chloromethoxybutoxymethylbenzene: To a solution of 4-
benzyloxybutanol (1.22 g, 6.78 mmol) in CH2Cl2 (50 mL) was added 
paraformaldehyde (0.200 g, 6.78 mmol) and the suspension was cooled to 0 °C.  HCl gas was 
bubbled through the reaction mixture until the paraformaldehyde was consumed (approximately 
1 hour).  The reaction mixture was place under HCl atmosphere and stirred for an additional 4 
Cl O
O
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 hours at 0 °C.  Nitrogen was bubbled through the solution to remove the HCl, the solution was 
dried with Na2SO4, filtered, concentrated under reduced pressure providing the desired product 
in quantitative yield.  The product was used without purification: crude 1H NMR (300 MHz, 
C6D6) δ 7.28-7.15 (m, 5H), 5.07 (s, 2H), 4.35 (s, 2H), 3.43-3.38 (m, 2H), 3.32-3.25 (m, 2H), 
1.63-1.55 (m, 4H). 
 
Hexanoic acid 1-benzyl-3-(4-benzyloxybutoxymethoxy)-propyl amide, 
12: To a solution of 5 (0.20 g, 0.77 mmol) in CH2Cl2 (2 mL) at room 
 DIPEA (2 mL) followed by 4-chloromethoxybutoxymethylbenzene (0.30 
g, 1.2 mmol).  The reaction mixture was heated to 45 °C for 8 hours.  The reaction mixture was 
cooled to room temperature and H
temperature was added
2O (5 mL) was added.  The reaction mixture was extracted 
with CH2Cl2 (2 x 5 mL).  The organic layers were combined, washed with 10% aqueous acid (10 
mL) and brine (10 mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  
The resulting oil was purified by flash chromatography (50% EtOAc in hexanes) to provide the 
desired product (0.32 g, 93%):  1H NMR (300 MHz, CDCl3) δ 7.36-7.17 (m, 10H), 5.65 (d, J = 
8.2 Hz, 1H), 4.64 (s, 2H), 4.50 (s, 2H), 4.29 (br, 1H), 3.69-3.47 (m, 6H), 2.90 (dd, J = 13.6, 5.9 
Hz, 1H), 2.77 (dd, J = 13.6, 7.3 Hz, 1H), 2.15-2.10 (m, 2H), 1.89-1.79 (m, 1H), 1.72-1.52 (m, 
7H), 1.32-1.18 (m, 4H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 172.8, 138.9, 
138.3, 129.8, 128.7, 128.6, 127.9, 127.8, 126.7, 95.8, 73.2, 70.4, 68.1, 65.4, 48.8, 40.8, 37.3, 
33.4, 31.7, 26.8, 26.8, 25.7, 22.7, 17.2; IR (neat) 3290, 2928, 1641, 1547, 1113 cm-1; HRMS (EI) 
calcd. for C21H34NO4 (M-C7H7) 364.2488, found 364.2495. 
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 Hexanoic acid 1-benzyl-3-(4-hydroxy-butoxymethoxy)-propyl-amide, 
13: To a solution of 12 (0.22 g, 0.49 mmol) in ethanol at room 
temperature was added Pd/C (44 mg, 20 wt%).  The reaction mixture was placed under hydrogen 
atmosphere and stirred at room temperature for 8 hours.  The reaction mixture was filtered 
through a pad of celite, concentrated under reduced pressure and purified by flash 
chromatography (20% hexanes in EtOAc) to provide the desired product (0.17 g, 98% yield):  1H 
NMR (300 MHz, CDCl3) δ 7.31-7.17 (m, 5H), 5.67 (d, J = 8.0 Hz, 1H), 4.66 (s, 2H), 4.38-4.26 
(m, 1H), 3.69-3.51 (m, 6H), 2.91 (dd, J = 13.7, 6.2 Hz, 1H), 2.79 (dd, J = 13.7, 7.1 Hz, 1H), 2.26 
(bs, 1H), 2.11 (t, J = 6.7 Hz, 2H), 1.91-1.82 (m, 1H), 1.71-1.49 (m, 7H), 1.34-1.17 (m, 4H), 0.86 
(t, J = 6.7 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 172.7, 137.9, 129.5, 138.4, 126.4, 95.5, 68.0, 
65.2, 62.5, 48.3, 40.7, 36.9, 33.4, 31.4, 29.8, 26.4, 25.4, 33.4, 13.9; IR (neat) 3289, 2930, 1643, 
1549, 1046 cm-1; HRMS (EI) calcd. for C21H36NO4 (M+H) 366.2644, found 366.2632. 
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Hexanoic acid 1-benzyl-3-(tetrahydro-furan-2-yloxymethoxy)-
propyl-amide, 5:  To a solution of 13 (0.17 g, 0.48 mmol) in 
cyclohexane was added iodobenzene diacetate (0.34 g, 1.1 mmol) and iodine (96 mg, 0.76 
mmol).  The reaction mixture was irradiated for 2 hours.  The reaction mixture was extracted 
with EtOAc, washed with saturated aqueous Na2S2O3 (10 mL) and brine (10 mL), dried with 
Na2SO4, filtered, concentrated under reduced pressure and purified by flash chromatography 
(50% EtOAc in hexanes) to provide the desired product as a mixture of diastereomers (0.10 g, 
59%):  1H NMR (300 MHz, CDCl3) δ 7.30-7.17 (m, 5H), 5.80 (d, J = 7.9 Hz, 1H), 5.36-5.32 (m, 
1H), 4.90-4.85 (m, 1H), 4.64-4.58 (m, 1H), 4.32-4.24 (m, 1H), 3.96-3.81 (m, 1H), 3.79-3.71 (m, 
1H), 3.70-3.62 (m, 1H), 3.56-3.48 (m, 1H), 2.96-2.86 (m, 1H), 2.81-2.74 (m, 1H), 2.13-2.00 (m, 
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 2H), 1.99-1.75 (m, 5H), 1.67-1.52 (m, 3H), 1.34-1.15 (m, 4H), 0.88 (t, J = 6.7 Hz, 3H); 13C 
NMR (300 MHz, CDCl3) δ 172.6, 138.1, 129.4, 129.1, 126.3, 101.5, 92.7, 67.3, 65.7, 48.8, 48.4, 
40.4, 36.9, 32.7, 31.4, 25.4, 23.5, 23.2, 13.9; IR (neat) 3289, 2929, 1614, 1544 cm-1; HRMS (EI) 
calcd. for C19H28NO4 (M-C2H5) 334.2018, found 334.2036. 
 
Hexanoic acid 1-hydroxy-3-(2-trimethylsilanyl-ethoxymethoxy)-
propyl-amide, 14:  To a solution of 5 (0.11 g, 0.28 mmol) in 
dichloroethane (6 mL) at room temperature was added N-methylquinolinium 
hexafluorophosphate (NMQ) (4.0 mg, 0.01 mmol), NaOAc (0.22 g, 200 wt.%), Na2S2O3 (0.22 g, 
200 wt.%) and toluene (1 mL).  Air was gently bubbled through the suspension and the solution 
was irradiated for 4 hours.  The reaction mixture was filtered through a small plug of silica, and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(80% EtOAc in hexanes) to provide 15 (60 mg, 65%):  1H NMR (300 MHz, CD2Cl2) δ 6.85 (br, 
1H), 5.44-5.38 (m, 1H), 4.65 (s, 2H), 3.94 (d, J = 3.2 Hz, 1H), 3.82-3.75 (m, 1H), 3.67-3.54 (m, 
3H), 2.14 (t, J = 7.3 Hz, 2H), 1.92-1.84 (m, 2H), 1.63-1.53 (m, 2H), 1.36-1.24 (m, 4H), 0.96-0.87 
(m, 5H), 0.02 (s, 9H); 13C NMR (75 MHz, CD2Cl2) δ 175.1, 95.3, 73.8, 65.6, 63.9, 37.1, 34.7, 
31.7, 25.4, 22.7, 18.4, 14.0, -1.4; IR (neat) 3299, 2955, 1654, 1538, 1249, 1060 cm-1; LRMS 
(EI): m/z 320, 302, 262, 246, 232, 202, 188, 172. 
C5H11 NH
O
O
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Hexanoic acid 1,3-dioxan-4-ylamide, 1:  To a solution of 5 (90 mg, 0.25 
mmol) in dichloroethane (6 mL) at room temperature was added  NMQ (3.5 
mg, 0.01 mmol), NaOAc (0.18 g, 200 wt.%), Na2S2O3 (0.18 g, 200 wt.%), 4 Å molecular sieves 
(0.18 g, 200 wt.%) and toluene (1 mL).  Air was gently bubbled through the suspension while it 
O O
H
NC5H11
O
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 was irradiated for 4 hours.  The reaction mixture was filtered through a small plug of silica, and 
concentrated under reduced pressure.  The resulting oil was purified by column flash 
chromatography (50% EtOAc in hexanes) to provide the desired product (39 mg, 79%):  1H 
NMR (300 MHz, CD2Cl2) δ 5.92 (br, 1H), 5.43 (td, J = 10.0, 2.8 Hz, 1H), 5.05 (d, J = 6.5 Hz, 
1H), 4.83 (d, J = 6.5 Hz, 1H), 4.15 (app dd, J = 11.6, 4.9 Hz, 1H), 3.79 (td, J = 11.7, 2.8 Hz, 1H), 
2.22 (t, J = 7.3 Hz, 2H), 1.91-1.78 (m, 1H), 1.75-1.60 (m, 3H), 1.35-1.26 (m, 4H), 0.90 (t, J = 6,9 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 172.7, 92.8, 77.2, 65.9, 36.7, 32.1, 31.3, 25.0, 22.4, 13.9; 
IR (neat) 3325, 2927, 1661, 1540, 1015 cm-1; HRMS (EI) calcd. for C10H19NO3 (M+) 201.1365, 
found 201.1361. 
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 2.   Efforts Toward the Total Synthesis of Mycalamide B 
 
2.1  Introduction 
 
 The mycalamides A-D,1-4 onnamides A-F,5-8 theopederins A-L9-11 and 
psymberin/iriciniastatin A12,13 are members of a class of natural products structurally related to 
pederin14 (Figure 18).  Most of these compounds have been shown to exhibit potent biological 
activity; however their limited availability from natural sources has hindered the thorough 
examination of their therapeutic potential.  The interesting structure, biological activity and 
scarce availability of these compounds has generated a considerable amount of interest among 
the synthetic community.  Matsumoto,15-18 Meinwald,19-22 Kishi,23,24 Kocienski,25-38 Roush,39-42 
Nakata,43-46 Ihara,47,48 Hoffman,49 Trost,50 Rawal,51 and De Brabander52 have reported synthetic 
studies directed toward the generation of these compounds. 
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Figure 18: Pederin and Mycalamide A and B 
 
 The structure of pederin14 was reported in 1965 from the dermestid beetle, Psiderus 
fusipes.  Pederin’s structure was considered to be unique until 1988 when Blunt and coworkers1 
reported mycalamide A (isolated from a New Zealand sponge of the genus Mycale) and Furusaki 
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 and coworkers5 reported onnamide A (isolated from Okinawan sponge of the genus Theonella).  
The remaining members of the pederin family were isolated in virtually all parts of the world 
from a variety of marine sponges belonging to the class Demospongiae.  The highly diverse 
nature of the source organisms for the pederin family of natural products has led to the 
speculation that these compounds may have a common bacterial origin.53
 
I. Isolation and Structural Determination of Mycalamide A and B 
 
 Mycalamide A1 was isolated in 1988 and mycalamide B2 in 1990 by Blunt and coworkers 
from a marine sponge of the genus Mycale native to the Otago Harbour of New Zealand (Figure 
19).  Reverse phase, gel permeation and silica gel chromatography techniques were utilized in 
the isolation of these compounds.  The purification of extract resulting from 200 g of mycale 
sponge generated approximately 3.7 mg of mycalamide A, which was reported to be nearly twice 
as abundant as mycalamide B.1,2
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Figure 19: Structure of Mycalamide A and B 
 
 The structure of mycalamide A was determined using mass spectrometry and NMR and 
IR spectroscopy.1  HRMS-EI provided a weak molecular ion peak (503.2722 daltons) 
corresponding to the molecular formula C24H41NO10.  The presence of 4 exchangeable protons 
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 was identified through CIMS using ND3 as the reagent gas.  1H NMR indicated the presence of a 
secondary amide with a one proton doublet (δ 7.49 (d, J = 9.8 Hz, 1 H)) that slowly disappeared 
upon treatment with D2O.  The presence of the amide was confirmed by the 13C NMR (δ 171.5) 
and IR (1700 cm-1) spectrum.  The 13C NMR spectrum also indicated the presence of a 1,1′-
disubstituted olefin (δ 110.4, 145.4).1 
 The pederic acid fragment of mycalamide A was further examined by HETCOR, COSY, 
long-range HETCOR and nOe experiments.  The connectivity was established by long-range 
HETCOR (Figure 20).  A comparison of the 1H NMR spectra of the left hand fragments of 
mycalamide A and pederin suggested these fragments were nearly identical providing a 
benchmark for the assignment of the stereochemistry.1  nOe analysis indicated the dominant 
conformation of the pederic acid fragment is a chair-like conformation that places the C6-OCH3 
in the axial position, consistent with the anomeric effect.2
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Figure 20: Long-Range HETCOR Analysis of the Pederic Acid Fragment of Mycalamide A 
 
 The conformation and connectivity of the amido trioxadecalin fragment of mycalamide A 
was determined by a series of nOe experiments.1  The nOe data were consistent with a cis-fused 
trioxadecalin system with both rings residing in a chair conformation.2  The defining nOe 
enhancements are shown in Figure 21.  Mycalamide B was isolated as a less polar component in 
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 the purification of mycalamide A.  Similar analyses were employed to determine the structure of 
mycalamide B.2
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Figure 21: Pertinent nOe Enhancements of the Amido Trioxadecalin Fragment  
 
II. Biological Activity 
 
 Mycalamides A and B possess potent biological activity with the potential for use in three 
separate therapeutic areas.  These compounds have been shown to be inhibitors of tumor cell 
proliferation54 and potent immunosuppressive agents.55  They have also displayed moderate 
antiviral activity.56   
 Burres and Clement54 demonstrated that mycalamides A and B inhibit the proliferation of 
murine leukemia P388 cell replication at IC50 values of 5.2 nM and 1.3 nM, respectively.  
Nanomolar range inhibition was also observed with the human promyelocytic (HL-60) leukemia, 
and human lung (A549) and colon (HT-29) carcinoma cells.  Additionally, mycalamides A and B 
performed well against the P388 in vivo leukemia model showing a 40% (10 µg/kg) and 50% 
(2.5 µg/kg) increase in lifespan, respectively.  Increases in lifespan were observed with other in 
vivo models, such as, M5076 ovarian carcinoma and B16 melanoma.  Mycalamide A was also 
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 shown to inhibit the growth of solid tumor models (Lewis Lung, M5076, and Burkitt’s 
Lymphoma).54
 Mycalamide A was also shown to efficiently block the activation of CD4+T cells with an 
IC50 of 1 pM. When concentrations approached 10 pM T cell proliferation is abrogated.  The 
immunosuppressive activity of mycalamide A is 40 fold and 1000 fold more potent than the 
clinical immunosuppressive agents FK506 and cyclosporine, respectively.55  The antiviral 
activity of mycalamides A and B was observed by Perry and coworkers when these compounds 
were exposed to Hav-NRK cell cultures.  Mycalamide A induced a positive morphological 
change at 20 µM, while the same response was generated by mycalamide B at 2 µM.56
 The biological activity of mycalamides A and B appears to result from their ability to 
inhibit protein biosynthesis.  The incorporation of radiolabeled leucine in P388 cells following 
treatment with mycalamide A and B showed a significant decrease in protein synthesis with 
complete inhibition at 2 µM for mycalamide A and 0.2 µM for mycalamide B.54  In Hav-NRK 
cells protein synthesis was inhibited by 50% at concentrations of 12 µM and 3 µM for 
mycalamides A and B, respectively.56  Moreover, it was determined that mycalamides A and B 
preferentially inhibited the biosynthesis of p21 protein,56 which participates in temporarily 
arresting cell replication in response to the detection of DNA damage.57  In a recent study 
competitive binding experiments suggest that pederin and related compounds inhibit protein 
biosynthesis by selectively binding to the 60S large ribosomal subunit.58
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 III. Structure Activity Relationships of Mycalamides A and B 
 
 An examination of the effects of structure on the biological activity of mycalamides A 
and B has indicated that the C10 N-acylaminal, C7 hydroxy and C6 methoxy functional groups are 
required for potent biological activity (Figure 22).59-62  Derivatives of the C10 N-acylaminal, 
including N-methylation and C10 stereochemical inversion, resulted in a >1000 fold and 100 fold 
loss in activity, respectively.  Significant reductions (50–1000 fold) in biological activity were 
also observed when derivatives of the C6 methoxy and/or C7 hydroxy groups were generated.  
Other functional groups such as the exocyclic olefin, the C12 alkoxy and the C17 and C18 
positions of the side chain where shown to tolerate synthetic manipulation, exhibiting only 
moderate changes in biological activity.59-62
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Figure 22: Relevant Functionality for Biological Activity 
 
IV. Previous Syntheses 
 
 The limited availability from natural sources, structural complexity and interesting 
biological activity of mycalamides A and B has resulted in a considerable amount of synthetic 
interest in these compounds.  Total syntheses have been reported by Kish,23 Roush,42 
Kocienski,36 Nakata44 and Rawal51 and formal or partial syntheses have been Ihara,47 Hoffman,49 
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 Mienwald19 and Trost.50  Despite the numerous synthetic efforts devoted toward these 
compounds only two general methods have been developed for the generation of the C10 N-
acylaminal (Figure 23).   
 The first approach, developed by Hong and Kishi,23 utilizes an N-acylation of the 
nucleophilic amino trioxadecalin system by a pederic acid derivative to complete the formation 
of the N-acylaminal functional group (Figure 23).  While the nucleophilicity of the amino 
trioxadecalin system allows for facile coupling to the pederic acid fragment, the instability of the 
hemiaminal functional group resulted in rapid epimerization generating a diastereomeric mixture 
at the C10 N-acylaminal center.23  Recently, the utility of this approach was significantly 
increased by Rawal and coworkers51 when they reported N-acylation conditions that allowed for 
the selective generation of the C10 N-acylaminal of mycalamide A from the coupling of the 
amino trioxadecalin and pederic acid fragments.  
 Roush and coworkers40 reported an alternative approach that employs a Curtius reaction 
to generate the C10 N-acylaminal (Figure 23).  While this method allows for the stereoselective 
synthesis of the N-acylaminal functional group, the low reactivity of the resulting carbamate 
precluded its coupling to pederic acid derivatives.  The following is a detailed account of the 
synthetic approaches utilized by Kishi, Roush and Rawal in their syntheses of mycalamides A 
and B. 
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Figure 23: Synthetic Approaches toward the N-Acylaminal 
 
 The first total synthesis of mycalamides A and B was published by Hong and Kishi23 in 
1990, two years after the isolation of mycalamide A was reported.  Mycalamides A and B were 
generated in 29 and 35 linear steps, respectively, from glycoside 1 (Scheme 5), which was 
derived in 6 steps from commercially available α-D-glucopyranoside.  The requisite 
stereochemistry at the C12, C13 and C15 centers was inherent to glycoside 1.  The remaining C11 
and C17 stereocenters were established by an anomeric propargylation and an asymmetric 
dihydroxylation, respectively.  A three step sequence generated the B ring as a hemiacetal that 
was subsequently converted to the azido trioxadecalin system (7, Scheme 5) as an inseparable 
mixture of diastereomers.  The azido trioxadecalin system 7 served as the precursor to 
mycalamide A.  Subsequent protecting group manipulation of the C15 side chain generated the 
precursor to mycalamide B (8, Scheme 5) as a separable mixture of diastereomers.  
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Scheme 5: Kishi’s Generation of the Azido Trioxadecalin System 
 
 Azide reduction generated the amino trioxadecalin systems (11 and 12, Scheme 6) that 
were shown to be configurationally unstable to acidic, basic and neutral conditions.23  The amino 
trioxadecalin systems (11 and 12) readily coupled with pederic acid derivative 15 yielding 
separable mixtures of α-13 (38% yield) and β-13 (40% yield) or α-14 (59% yield) and β-14 (26% 
yield), with the α-diastereomer possessing the natural configuration.  Both β-13 and β-14 were 
shown to undergo an epimerization at the C10 N-acylaminal center to generate the corresponding 
natural α-configuration under basic conditions (t-BuOK/THF/reflux). The alkaline treatment of 
β-13 resulted in almost complete epimerization to the natural diastereomer and β-14 epimerized 
to a 1:1 mixture of natural (α-14) and unnatural (β-14) diastereomers.  Deprotection of α-13 and 
α-14 generated mycalamide A and B, respectively.   
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Scheme 6: Kishi’s Completion of Mycalamides A and B 
 
 Kishi has since published a total synthesis of onnamide A, wherein the synthesis of the 
mycalamide core was considerably improved.  However, epimerization of the amino 
trioxadecalin system continued to be a problem.24
 Rawal’s synthesis of the amino trioxadecalin fragment of mycalamide A began with the 
desymmetrization of D-tartrate generating aldehyde 17 in good yield (Scheme 7).51  The tartrate 
stereocenters were utilized to effectively control the remaining stereochemistry of the amino 
trioxadecalin ring through a prenylation and a lewis acid promoted lactol allylation.  The dioxane 
ring was generated by the treatment with formaldehyde under acidic conditions and subsequent 
lactol acylation generated 21 in good yield.  An asymmetric dihydroxylation of the olefin of 21 
established the side chain stereochemistry with moderate selectivity (22, Scheme 7) and the 
Lewis acid mediated TMSCN displacement of the acyllactol 22 generated the azide precursor to 
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 the amine functional group.  Reduction of the azide resulted in the generation of the amino 
trioxadecalin coupling partner, 23.   
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Scheme 7: Rawal’s Synthesis of the Amino Trioxadecalin System of Mycalamide A 
 
 A highlight of the Rawal synthesis of mycalamide A was the enhanced selectivity 
reported in the coupling of the amino trioxadecalin fragment 23 with pederic acid derivative 24 
(Figure 24).51    Rawal reported the generation of the precursor to C10-epi-mycalamide A, 25, as a 
single diastereomer in 61% yield when PyAOP was employed in the presence of DIPEA to 
generate the activated ester of 24 prior to coupling with 23.  Under conditions that employed 
DCC and DMAP the coupling proceeded in a 56% yield with 5:1 diastereoselectivity in favor of 
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 the natural diastereomer, 26.  Methyl ester hydrolysis of the coupling product completed the 
synthesis of mycalamide A.  The selectivity observed by Rawal and coworkers is a marked 
improvement over the conditions reported by Kishi and significantly increases the utility of this 
method.   
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Figure 24: Rawal’s Coupling to Synthesize Mycalamide A 
 
 In 2000, Roush and coworkers41,42 reported the total synthesis of mycalamide A and 7-
epi-mycalamide A wherein they describe the stereoselective formation of the C10 N-acylaminal 
by a Curtius reaction (Scheme 8).41  The synthesis began with alcohol 27 generated from the 
asymmetric prenylboration of D-glyceraldehyde 3-pentylidene ketal and relies heavily on reagent 
control to establish the remaining stereochemistry of the B and C rings.  The C10 N-acylaminal 
was generated from the configurationally stable trioxadecalin carboxylic acid 34 by a Curtius 
reaction that proceeded with retention of configuration to provide the amido trioxadecalin 
precursor to mycalamide A (35, Scheme 8).   
 
46 
 OMe OTrocO
O
O
OH
OH
O
n,o p,q,r
O
O
OH
O
O
OMe OH
O
O
OMe OH
O
O
O
OMe OH O
O
O
OHC
OMe O O
O
O
a,b,c d,e f,g
h,i, j k,l,m
Reagents: (a) MeI, NaH; (b) O3, Ph3P, 82% over two steps; (c) Ipc2BAll, 89%, >98:2; (d) BuLi then BOC-ON; (e) IBr
then NaOH, 77% and 25:1; (f) NaOAc, DMF, H2O; (g) triphosgene and pyridine, 64% over 2 steps; (h) Troc-Cl, pyridine; 
(i) HOAc-H2O; (j) KIO4, 65% over 3 steps; (k) E-γ -(trimethylsilyl)allylboronate, 93% with >98:2; (l) DMDO, then MeOH-
HOAc; (m) SAE, 77%; (n) Zn, HOAc; (o) TBDPS-Cl, imidazole, 73% over 2 steps; (p) P2O5, methylal; (q) TBAF; (r)
Jones, 76% over 3 steps; (s) (PhO)2(O)N3, NEt3, TMS(CH2)2OH, 64%.
Troc
s
27 28 29
30 31 32
33 34 35
O
OH
TBDPSO
OH
OMe
O
O
O
O
HO2C
O O
OMe
O
O
O
O
HN
O O
OMe
O
O
O
Teoc B
C
 
Scheme 8: Roush’s Approach to Mycalamide A 
 
 To complete the synthesis Roush and coworkers42 attempted to couple the carbamate 35 
with a pederic acid derivatives 36 but were unsuccessful (Scheme 9).  The lack of reactivity was 
attributed to the steric congestion surrounding the C6-ketal and C10-N-acylaminal functional 
groups.  To complete the synthesis carbamate 35 was acylated with benzyloxyacetyl chloride.  
The resulting N-acylaminal was subjected to a titanium mediated aldol addition into aldehyde 37 
that generated 38 as a mixture of diastereomers favoring the unnatural stereochemistry at the C7-
stereocenter.  Further elaborations of aldol adduct 38 allowed for the completion of the total 
synthesis of mycalamide A. 
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Scheme 9: Roush’s Completion of Mycalamide A 
 
 Mycalamides A and B, in particular the N-acylaminal functional group, have proven to be 
a formidable synthetic challenge.  The coupling approach developed by Kishi, including the 
advances reported by Rawal, is an effective method for the synthesis of the requisite functional 
groups with an adequate level of selectivity.  The method developed by Roush is highly selective 
for the generation of the desired N-acylaminal functional group, but is limited by the reactivity of 
subsequent intermediates.  These methods focus largely on the generation C-N amide bond of the 
N-acylaminal to complete the synthesis of the amido trioxadecalin system.  An alternative 
approach to this functional group would increase the available synthetic options providing an 
enhanced opportunity to increase the selectivity and efficiency of the synthetic approaches to 
mycalamides A and B. 
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 V. Project Goals and Retrosynthesis  
 
 The generation of the amido trioxadecalin system through the nucleophilic addition of a 
pendent formaldehyde hemiacetal equivalent into an N-acyliminium ion provides a novel 
approach to the synthesis of mycalamides A and B (Figure 25).  This approach allows for the 
generation of the N-acylaminal late in the synthetic sequence, allowing for the inherent chirality 
of the C ring to control the resulting stereochemistry of the C10 N-acylaminal (TS-40).  The 
sensitivity of the substrate and product of this transformation require that the generation of the 
acyliminium ion occur under mild conditions.   
 As described in Chapter 1, cyclic amido acetals were efficiently generated by the ETIC 
reaction under essentially neutral conditions making it an ideal choice for this application.  
Homobenzylic amide 41 will serve as the ETIC precursor to the acyliminium ion.  The cleavage 
of the C-N amide bond of 41 (Figure 26) was chosen as the next disconnection generating amine 
42 and a pederic acid derivative (not shown).  Based on the coupling described by Kishi23 and 
Rawal,51 the nucleophilic amine 42 will readily couple to the pederic acid fragment.  Amine 42 is 
expected to arise from pyran 43 though a sequence that includes acetal and imine formation 
followed by nucleophile addition into the imine to install the benzyl functionality.  Pyran 43 
could be generated from a selective epoxidation and syn-vinylation of dihydropyran 44.   
Dihydropyran 44 was expected to arise from the syn-reduction, cyclization and dehydration of 
45.  An asymmetric allyation and selective boron-mediated methyl ketone aldol addition are 
expected to generate 45 from ketoaldehyde 46 that can be easily generated in multi-gram 
quantities. 
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Figure 25: Retrosynthetic Analysis of Mycalamide B 
 
 Prior to initiating the synthesis of mycalamide B, studies were conducted that extended 
the scope of the ETIC reaction to include the synthesis of the amido trioxadecalin system.  In 
addition to exploring the scope and limitations of the ETIC reaction, the synthesis of these model 
systems also allowed for the evaluation of synthetic methods for use in the later stages of the 
synthesis of mycalamide B.  The following is an account of the ETIC model studies directed 
toward the generation of the amido trioxadecalin system followed by a description of our 
progress toward the total synthesis of mycalamide B. 
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 2.2  Results and Discussion 
  
 Model systems 47 and 48 are structurally similar to the ETIC substrates required to 
generate mycalamides A and B (Figure 26).  These compounds have provided the opportunity to 
evaluate the efficiency and selectivity of the ETIC reaction for the generation of the amido 
trioxadecalin system.  Additionally, they have provided valuable information that will allow the 
ETIC reaction to be employed in the total synthesis of mycalamide B.  Portions of this chapter 
have been published as a communication and a full paper.87, 88 
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I. Synthesis of ETIC Substrates: Model Systems for Mycalamide B 
 
 The model ETIC substrate 47 was generated in 12 linear steps from tri-O-methyl-D-
glucal (Scheme 10).63  The diastereoselective glycal epoxidation64 of 49 with dimethyl 
dioxirane65-67 generated the highly sensitive epoxide 50 that was carried on without purification.  
Opening of the epoxide by treatment with trivinylalane (51) and subsequent vinyl addition into 
the oxocarbenium ion generated 52 as a single diastereomer.  The epoxidation/syn-vinylation 
protocol was developed by Rainier and coworkers68 for the synthesis of C-glycosides.   
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Scheme 10: Epoxidation and Trivinylalane Addition of Tri-O-Methyl D-Glucal 
 
 The hydroxyl group of 52 was protected under standard conditions (TBSOTf, 2,6-
lutidine) providing silyl ether 53 in a 77% yield (Scheme 11).  Oxidative cleavage of the olefin in 
53 by treatment with ozone followed by triphenylphosphine generated a highly unstable 
aldehyde that was carried on without purification.  Condensation of the aldehyde with Ellman’s 
(R)-tert-butanesulfinamide69 in the presence of Ti(OiPr)4 provided 54 in a 71% yield from 53.  
The addition of benzyl magnesium chloride into 54 followed by acid cleavage of the resulting 
sulfinamide and subsequent carbamate formation provided the homobenzylic carbamate 55 in a 
68% yield over three steps.  The Grignard addition proceeded selectively to generate a single 
diastereomer,70 however the identity of this stereocenter is inconsequential to the outcome of the 
ETIC reaction and thus was not rigorously defined.  The silyl ether of 55 was removed by 
treatment with TBAF generating 56 in a 76% yield.   The acetal of 57 was generated by 
treatment with 3-butenyloxymethylchloride71 in the presence of DIPEA to provide 57 in a 97% 
yield.  Hydroboration of 57 generated 58 in a 93% yield and oxidative etherification under 
Suarez’s conditions72 (described in Chapter 1) provide the ETIC cyclization substrate 47 in a 
64% yield.   
 
52 
 O
O
O
O
O
HN
Ph
Boc
O
O
O
O
O
O
HN
Ph
Boc
O
HO
O
O
O
O
O
HN
Ph
Boc
OO
Reagents: (a) TBSOTf, 2,6-lutidine, CH2Cl2, 77%; (b) O3, CH2Cl2, -78 oC then PPh3; (c) (R)-tert-butanesulfinamide, Ti(OiPr)4, 
THF, 71%, over 2 steps; (d) BnMgCl, CH2Cl2, -78 oC; (e) 4M HCl in MeOH; (f) (Boc)2O, NEt3, CH2Cl2, reflux 68%, over 3 steps;
(g) TBAF, THF, 76%; (h) 3-butenyloxymethylchloride, DIPEA, CH2Cl2, 40 oC,  97%; (i) BH3•THF, THF, 0 oC then NaOOH, 
93%;  (j) PhI(OAc)2, I2, hν, cyclohexane, 64%;
g i
j
57
58 47
O
O
O
O
HO
HN
Ph
Boc
h
56
O
O
O
O
TBSO
O
O
O
O
TBSO
N
S
O
O
O
O
O
TBSO
HN
Ph
Boc
53 54
55
a b,c
O
d,e,f
O
O
O
HO
52
 
Scheme 11: Synthesis of D-Glucal ETIC Model System 
 
 The synthesis of the ethyl pyran ETIC model system 48 (Figure 26) commenced with a 
Friedel Crafts-like acylation of bis-trimethylsilylacetylene by isobutyryl chloride in the presence 
of aluminum chloride generating 59 (Scheme 12) in a 92% yield.73  Treatment of 59 with 1,4-
diazabicyclo[2.2.2]octane (DABCO) in methanol resulted in desilylation followed by the 
Michael addition of methanol generating 60 in 75% yield.74  The formation of silyl enol ether 61 
was accomplished in 75% yield by treating 60 with TMSOTf and Et3N in diethyl ether.  
Treatment of 61 with BF3•OEt2 in the presence of propionaldehyde promoted a hetero-Diels 
Alder reaction75 that generated 62 in an 81% yield.  The Luche76 reduction of 62 followed by 
methylation of the resulting alcohol generated 63 in a 67% yield over 2 steps.  Optimal yields 
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 were observed when the alcohol resulting from the Luche reduction was carried into the 
methylation without purification.   
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Scheme 12: Generation of the Dihydropyran Precursor to the ETIC Ethyl Pyran Model 
 
 Further synthetic elaboration of dihydropyran 63 proceeded in a similar fashion to the 
generation of the D-glucal based ETIC substrate, described previously.  The diastereoselective 
epoxidation64 of 63 with dimethyldioxirane65-67 followed by treatment with trivinylalane, as per 
the Rainier68 protocol, generated 64 in an 80% yield as a single diastereomer (Scheme 13).  The 
benzyloxybutoxymethyl ether was installed by treating 64 with BBMCl (Chapter 1, pg 16) in the 
presence of DIPEA generating 65 in a 76% yield.  Olefin cleavage of 65 under oxidatitive 
conditions (O3, -78 °C, then PPh3) followed by condensation with Ellman’s (R)-tert-
butanesulfinamide69 generated 66 in a 67% yield as an inseparable mixture of diastereomers.  
The installation of the benzyl group was accomplished by treating 66 with benzylmagnesium 
chloride.  The resulting sulfinamide was taken crude into acidic cleavage and subsequent 
acylation of the resulting amine generated amide 67 in a 73% yield over three steps.  The 
benzylmagnesium chloride addition into 68 proceeded selectively generating approximately a 1:1 
separable mixture of diastereomers.70  The diastereomers were separated and advanced through 
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 the synthetic sequence separately exhibiting identical reactivity.  The stereochemistry of the 
diastereomers was not determined because their identity did not have a significant impact on this 
study.  However, the potential for the resolution of diastereomers at this stage in the synthetic 
sequence could be potentially useful for the synthesis of the mycalamides and related 
compounds.   Treatment of 67 with palladium on carbon under an atmosphere of H2 resulted in 
the removal of the benzyl ether generating 68 in an 80% yield.  Oxidative etherification under 
conditions developed by Suarez72 resulted in the generation of ETIC substrate 48 in an 89% 
yield.   
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Scheme 13: Completion of the Ethyl Pyran ETIC Substrate 
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 II. Generation of the Amido Trioxadecalin System by the ETIC Reaction 
 
 Subjecting 47 to the ETIC conditions developed for the generation of cyclic amido 
acetals (cat. NMQ, hv, air, toluene, NaOAc, Na2S2O3, 4 Å molecular sieves, DCE) resulted in the 
formation of the amido trioxadecalin system in a 94% yield as a 10:1 mixture of separable 
diastereomers at the N-acylaminal center (Figure 27).  The diastereomeric mixture was separated 
by column chromatography and the stereochemistry and conformations of amido trioxadecalin 
systems 69 and 70 were determined through the analysis of 1H NMR and nOeSY spectrum.   
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Figure 27: ETIC Reaction of the D-Glucal Based Model System 
 
 The analysis of the 1H-1H coupling constants and nOe enhancements observed in the 
NMR spectrum of the amido trioxadecalin systems 69 and 70 revealed an interesting 
conformational preference inherent in this system (Figure 28).  The small 1H-1H vicinal coupling 
constants (~1-2 Hz) observed for the protons around the tetrahydropyran ring (shown in blue) of 
the major diastereomer (69, Scheme 28) are indicative of an equatorial-equatorial relationship 
and suggested that the amido trioxadecalin system resides in the conformation that places the 
majority of the substituents attached to the pyran ring in an axial orientation.  The predominantly 
axial or “inverted” conformation of 68 was confirmed by observing the nOe enhancements 
(shown by the red double headed arrows) that were present for the axial protons of the N-
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 acylaminal ring and an enhancement between the axial proton of the tetrahydropyran ring and the 
α-methoxy proton of the ring substituent during a nOeSY analysis.   
 The larger 1H-1H vicinal coupling constants (~10 Hz) observed for the protons of the 
pyran ring (shown in blue) of the minor diastereomer (70, Scheme 28) are indicative of an axial-
axial relationship suggesting a conformation where the majority of the tetrahydropyranyl 
substituents are oriented in an equatorial position, or “normal” conformation.  The conformation 
of 70 was confirmed by observing nOe enhancements between the axial protons across the 
tetrahydropyran and N-acylaminal rings, shown in Figure 28.  The stereochemistry of amido 
trioxadecalin 70 is that which is required for the generation of mycalamide B. 
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Figure 28: Conformation of the Amido Trioxadecalin Products of the ETIC Reaction 
 
 The product distribution and the unexpected stereochemistry and conformation of the 
“inverted” amido trioxadecalin ring system (69, Figure 28) resulting from the ETIC reaction can 
be rationalized by invoking a mechanism that accounts for the energetic preferences of the 
developing ring systems, shown in Figure 29.  We proposed the acyliminium ion generated 
during ETIC reaction exists in a conformational equilibrium between a conformer that places a 
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 majority of the tetrahydropyran substituents in an axial orientation (71) and a conformer that 
places these substituents in the equatorial orientation (72).  The proposed conformational lability 
of the N-acyliminium ion is supported by the 1H-1H vicinal coupling constants of the protons 
attached to the tetrahydropyran ring of 47 that exhibit a ~4 Hz coupling constant, indicative of a 
1:1 mixture of conformers (Figure 29).  While significant structural differences exist between the 
homobenzylic amide 47 and the N-acyliminium ion (71 and 72), the conformational lability of 47 
indicates that the methoxy and methylmethoxy substituents of the tetrahydropyran are not 
sufficient conformational locks to restrict the N-acyliminium ion to a single ring conformation.  
The conformationally labile N-acyliminium ion provides access to two cyclization pathways that 
lead to the generation of the observed amido trioxadecalin systems, 69 and 70.   
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Figure 29: Mechanism of Amido Trioxadecalin Formation 
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 Our previous studies concerning the ETIC generation of cyclic amido acetals suggest that 
the oxonium ions (73 and 74) are higher in energy than the acyliminium ions (71 and 72) 
suggesting these cyclizations proceeded through late transitions states (Figure 29).  By this 
reasoning the relative energies of the transition states 73 and 74 should reflect the relative 
energies of the products, 69 and 70.  Therefore, the preferential formation of 69 indicated that 
transition state 73 is lower in energy than transition state 74.  The energetic difference between 
transition states 73 and 74 can be attributed to the conformational preference of the developing 
trioxadecalin ring system and the steric and electronic interactions of the substituents on the 
tetrahydropyran ring system.  Fuchs and coworkers77 calculated that the core trioxadecalin 
system favors conformation 75 (observed in transition state 73) (Figure 30) by 4.3 kcal/mol over 
conformation 76 (observed in transition state 74).  This energy difference was attributed to the 
presence of two COCC gauche interactions (shown in red) present when the trioxadecalin ring 
system resides in conformation 76.   
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Figure 30: Conformations of the Amido Trioxadecalin System 
  
  To gain further insight into the relative energies of transition states 73 and 74 the relative 
energies of the cyclization products 69 and 70 were evaluated.  Calculations (MM3) of the 
relative energies of the cyclization products (69 and 70, Figure 29) have indicated that amido 
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 trioxadecalin ring system 69 is 4.4 kcal/mol lower in energy than 70 (Figure 29).89,90  These 
calculations are consistent with the outcome of the cyclization and the postulate that these 
reactions proceed through a late transition state.  Even though the evaluation of the relative 
energies of the products resulting from the cyclization overestimates the observed selectivity, it 
provides a useful method to predict the outcome of these reactions.   
 Interestingly, a similar calculation performed on the ethyl pyran ETIC model system, that 
includes the geminal dimethyl functionality in the 4 position of the pyran, predicted a reversal in 
selectivity.  This calculation indicated that the “normal” ETIC cyclization product (77, Figure 
31) is favored by 3.0 kcal/mol over the “inverted” cyclization product (78).  The predicted 
reversal in selectivity can be attributed to the incorporation of geminal dimethyl functionality 
into the tetrahydropyran of amidotrioxadecalin systems 77 and 78.  The energetic benefit 
obtained from the minimization of the gauche interactions of the tetrahydropyran substituents (as 
seen with the previous model system) is eliminated by the incorporation of the geminal dimethyl 
functionality at the 4 position of the tetrahydropyran. 
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Figure 31: Relative Energies of a Mycalamide-Like Amido Trioxadecalin System 
 
 To further enhance our understanding of these systems, 48 was subjected to the modified 
ETIC conditions (cat. NMQ, hυ, air, toluene, NaOAc, Na2S2O3, 4 Å molecular sieves, in DCE) 
resulting in the generation of the amido trioxadecalin systems 77 and 78 in a 94% yield as a 1.6:1 
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 mixture of separable diastereomers, respectively (Figure 32).  The amido trioxadecalin ring 
system 77 generated from the ETIC reaction resides in the expected conformation possessing the 
stereochemistry required for the synthesis of mycalamide B.  The stereochemistry and 
conformation of the amido trioxadecalin systems 77 and 78 were confirmed by the appropriate 
NMR analysis, as was described for the previous system.   
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Figure 32: Cyclization of the Ethyl Pyran ETIC Model 
 
 During our evaluation of amido trioxadecalin systems 77 and 78 we observed the 
epimerization of the acylaminal under mildly acidic conditions.  Subjecting 78 to catalytic 
amounts of para-toluenesulfonic acid in trifluorethanol at room temperate for 4 hours resulted in 
the epimerization of the N-acylaminal center generating a 1.6:1 mixture of diastereomer in favor 
of 77 (Figure 33).  No degradation of the amido trioxadecalin system was observed even during 
extended exposure (24 hours) to these reaction conditions.  Amido trioxadecalin system 77 was 
also observed to undergo an identical epimerization under these conditions.   The epimerization 
conditions described here are considerably milder than those utilized by Kishi (KOtBu, THF, 
reflux) during the total synthesis of mycalamides A and B. 
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Figure 33: Epimerization of the Amido Trioxadecalin System 
 
III. Synthetic Efforts Toward Mycalamide B 
 
 Once the scope of the ETIC reactions had been expanded to include the synthesis of 
amido trioxadecalin systems, we initiated a research effort aimed at developing an efficient and 
flexible total synthesis of mycalamide B.  Subjecting 7978 to the (R,R)-pseudoephedrine derived 
allylating agent (80, Scheme 14), described by Leighton and coworkers,79 resulted in the 
generation of alcohol 81 in a 94% yield with a 91% ee, as determined by GC (ChiraldexTM G-TA 
column).  No products resulting from the ketone allylation of 79 were observed during this 
process.  The methylation of 81 under nonanionic conditions (MeOTf, 2,6-di-tert-butylpyridine) 
generated 82 in an 88% yield.  Nonanionic methylation conditions were employed to avoid a 
facile retro-aldol reaction that occurs upon generation of the alkoxy anion.  Treatment of methyl 
ketone 82 with diethylboron triflate in the presence of DIPEA generated the diethylboron enolate 
that underwent a smooth addition into aldehyde 83 generating the aldol adduct 84 in an 83% 
yield as a 3:1 mixture of inseparable diastereomers.  The 1,5-anti-diastereomer was generated as 
the major product from the aldol addition (85, Scheme 14) and was the result of asymmetric 
induction originating from the β-alkoxy substituent of 82.  The 1,5-asymmetric control resulting 
from β-alkoxy boron enolates was first observed by Masamune81 and has been subsequently 
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 explored by Patterson82 and Evans.83  The 3:1 inseparable mixture of diastereomers persisted 
through the synthetic sequence until separation was possible following the methylation of 
dihydropyran 92 (Figure 34, pg 65).  
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Scheme 14: Asymmetric Allylation and Boron-Mediated Aldol Reactions 
 
  The β-hydroxyketone 84 was selectively reduced by lithium borohydride with 
diethylboron methoxide as a chelating agent,84 generating diols 85 and 86 in a 98% yield as a 
10:1 separable mixture of diastereomers favoring the 1,3-syn diol 85 (Scheme 15).  The identities 
of the diols were confirmed by the 13C NMR acetonide analysis developed by Rychnovsky and 
coworkers.85   Diols 85 and 86 were separated and individually treated with catalytic para-
toluenesulfonic acid in dimethoxypropane generating acetonides 87 and 88 in excellent yield.  
The carbon shifts observed for the syn and anti acetonides (87 and 88 respectively) were 
consistent with the values reported by Rychchnovsky85 for syn and anti acetonides (Scheme 15).   
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 Reagents: (a) Et2BOMe, THF, -78 oC then LiBH4, 98%, 10:1 dr; (b) pTsOH (cat.), dimethoxypropane, >90%.
OMe O OH
OTBS
84
OMe
OTBS
87
OMe
OTBS
88
OOOO
100.1 ppm
24.5 ppm24.9 ppm
98.3 ppm
19.9 ppm30.1 ppm
OMe
OTBS
85
OHOH OMe
OTBS
86
OHOH
+
a
b b
O
R
B
O
OTBSEt
Et
+
H-
 Syn-Reduction
 
Scheme 15: Syn-Reduction of the β-Hydroxyketone 
 
 Oxidative olefin cleavage of 85 resulted in the generation of lactol 89 in a 98% yield 
containing minor impurities (Scheme 16).  The highly sensitive lactol could not withstand a 
lengthy chromatographic purification and was flushed through a plug of silica to remove the 
triphenylphosphine and triphenylphosphine oxide.  Dehydration of 89 to generate dihydropyran 
92 occurred through a one pot protocol beginning with the bisacylation of the lactol and side 
chain alcohol functional groups by treatment with trifluoroacetic anhydride in the presence of 
DIPEA (90, Scheme 16).  Heating the reaction mixture resulted in the elimination of the more 
reactive acyl lactol functional group generating the monoacylated dihydropyran 91.  To our 
surprise the remaining trifluoroacetate ester was resistant to hydrolysis and could be isolated by 
silica gel chromatography (91, Scheme 16).  The addition of methanol directly to the reaction 
mixture and subsequent heating (gentle reflux for 8 hours) resulted in the complete removal of 
the trifluoroacetate ester generating dihydropyran 92 in a 99% yield.  
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Scheme 16: Generation of the Dihydropyran Precursor to Mycalamide B 
 
 The propagation of the 3:1 mixture of diastereomers generated during the boron-mediated 
aldol addition (Scheme 14, pg 63) resulted in the formation of dihydropyran 92 as a 3:1 mixture 
of inseparable diastereomers 92a and 92b (Figure 34).  Treatment of the mixture of 92a and 92b 
with nonanionic methylation conditions (MeOTf and 2,6-di-tert-butylpyridine) resulted in the 
generation of dihydropyrans 93 and 94 in a 96% yield as a 3:1 mixture of separable 
constitutional isomers.  Dihydropyran 93 was generated from 92a by methylation of the 
secondary alcohol, while the formation of 94 from 92b can be explained by a reaction sequence 
that includes the methylation of the secondary alcohol followed by a Ferrier86 rearrangement 
brought upon by the conformational lability of 92b. 
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Figure 34: Methylation of the Dihydropyran Precursor to Mycalamide B 
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  The 4,6-anti-relationship of the substituents attached to dihydropyran 92b generates a 
conformational equilibrium between the ring conformations A and B (Figure 35).  This is 
supported by the 1H NMR of 92 (diastereomeric mixture) where the minor diastereomer (92b) of 
the mixture is shown to exist in approximately a 1.5:1 mixture of conformational isomers.    
Conformation B places the methoxy functionality in the axial orientation providing the required 
orbital alignment of the π-orbitals of the olefin and the antibonding σ-orbital of the methoxy 
group to allow for Lewis acid catalyzed oxocarbenium ion formation (95, Figure 35).  
Subsequent addition of methanol or its functional equivalent into the oxocarbenium ion resulted 
in the formation of 94 as a single diastereomer.  The 1H NMR of the major diastereomer (92a, 
Figure 34) of this mixture exhibited no such conformational equilibrium.  Dihydropyran 93 
(Scheme 17) was advanced through the synthetic sequence as a single diastereomer.   
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Figure 35: Mechanism of the Ferrier Degradation 
 
 The required 1,2-syn relationship of the pyran was, once again, established by employing 
the Rainier68 protocol (Scheme 17).  The selective DMDO65-67 epoxidation of 93 followed by 
treatment with trivinylalane resulted in the generation 96 in an 85% yield as a single 
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 diastereomer.  Subjecting 96 to BBMCl (Chapter 1, pg 16) in the presence of DIPEA generated 
97 in an 80% yield.  Oxidative cleavage of 97 followed by condensation of the resulting 
aldehyde with Ellman’s (R)-tert-butanesulfinamide69 generated 98 in a 62% yield.  At this point 
the completion of the synthesis of mycalamide B has been delayed until the appropriate pederic 
acid derivative can be generated (an ongoing project in our laboratory).  98 provided a stable 
intermediate to stockpile material until the synthesis can resume.  
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Scheme 17: Generation of a Stable Intermediate in the Synthesis of Mycalamide B 
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2.3  Conclusions 
 
 We have demonstrated that the amido trioxadecalin ring system, prevalent in mycalamide 
B and related compounds, can be efficiently and stereoselectively generated by the ETIC 
reaction.  We have also established that these reactions likely proceed through a late transition 
state whereby the relative energies of the potential products can be used to predict the outcome 
of the cyclization.  It was also observation that the amidotrioxadecalin system epimerizes under 
mildly acidic conditions. 
 The synthesis of mycalamide B is currently being pursued through an efficient and 
selective synthetic sequence.  An asymmetric Leighton allylation was employed to generate the 
initial stereocenter of this sequence from which all others were generated.  The generation of the 
1,5-anti-stereochemical relationship was established with moderate selectivity through a boron-
mediated aldol addition that led to a β-hydroxyketone.  The 1,3-syn-diol relationship was 
generated by the chelate controlled reduction of the β-hydroxyketone.  Oxidative olefin cleavage, 
dehydration and methylation resulted in the generation of the 4,6-syn-dihydropyan.  The 
remaining stereochemistry was established by an epoxidation and trivinylalane ring 
opening/addition.  Once the appropriate pederic acid derivative can be generated the synthesis of 
mycalamide B will be completed. 
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2.4  Experimentals 
General Procedures: 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded on 
Bruker Avance 300 spectrometers at 300 MHz and 75 MHz, respectively.  The chemical shifts 
are given in parts per million (ppm) on the delta (δ) scale.  The solvent peak or the internal 
standard tetramethylsilane were used as reference values.  For 1H NMR: CDCl3 = 7.27 ppm, 
TMS = 0.00.  For 13C NMR: CDCl3 = 77.0, TMS = 0.00.  For proton data: s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets, dt = doublet of triplets, ddt 
= doublet of doublets of triplets; br = broad; m = multiplet; app t = apparent triple; app q = 
apparent quartet; app p = apparent pentet. 
High resolution and low resolution mass spectra were recorded on a VG 7070 spectrometer.  
Infrared (IR) spectra were collected on a Mattson Gygnus 100 spectrometer. 
Analytical thin layer chromatography (TLC) was performed on E. Merck pre-coated (25 nm) 
silica gel 60F-254 plates.  Visualization was done under UV (245 nm).  Flash column 
chromatography was preformed using ICN SiliTech 32-63 60Ǻ silica gel.  Reagent grade ethyl 
acetate and hexanes (commercial mixture) were purchased from EM Science and used as is for 
chromatography.  Reagent grade methylene chloride (CH2Cl2), dichloroethane (C2H4Cl2), 
acetonitrile (CH3CN), benzene and toluene were distilled from CaH2.  Diethyl ether (Et2O) and 
tetrahydrofuran (THF) were distilled from sodium benzophenone ketal prior to use.  Anhydrous 
N,N-dimethylformamide (DMF), methanol (MeOH), dimethylformamide (DMF), methanol 
(MeOH), dimethyl sulfoxide (DMSO) were purchased from Aldrich and used as is.  All reactions 
were conducted under nitrogen atmosphere, unless otherwise specified. 
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4,5-Dimethoxy-6-methoxymethyl-2-vinyltetrahydropyran-3-ol (52):  
Preparation of 0.10 M trivinylalane:  To a suspension of AlCl3 (4.44 g, 33.3 
mmol) in CH2Cl2 (233 mL) at room temperature was added 
vinylmagnesium bromide (1 M in THF, 100 mL, 100 mmol) drop wise, over a period of 1 hour.  
The solution was cooled when necessary to prevent reflux and stirred at room temperature for 4 
hours. 
O
O
O
O
HO
Synthesis of 4,5-dimethoxy-6-methoxymethyl-2-vinyltetrahydropyran-3-ol (52):  To a solution of 
49 (3.00 g, 16.0 mmol) in CH2Cl2 (10 mL) cooled to 0 °C was added dimethyldioxirane (0.2 M, 
76.8 mL, 17.2 mmol) and the solution was stirred for 30 minutes.  The reaction mixture was 
concentrated under reduced pressure, dissolved in CH2Cl2 (60 mL), and added drop wise over a 
period of 1 hour to a solution of trivinylalane (0.010 M, 333 mL) cooled to -72 °C.  The reaction 
mixture was allowed to slowly warm to room temperature and stir for 8 hours.  The reaction was 
carefully quenched with H2O, 10% aqueous HCl was added until the aluminum salts were 
dissolved, and the solution was extracted with ether.  The organic layers were combined, washed 
with 10% HCl (2 x 10 mL) and brine, dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (60% EtOAc) to 
provide the desired product (2.52 g, 62 %):  1H NMR (500 MHz, CDCl3) δ 6.05 (ddd, J = 16.2, 
10.8, 5.4 Hz, 1H), 5.42 (ddd, J = 17.5, 1.7, 1.7 Hz, 1H), 5.37 (ddd, J = 10.7, 1.7, 1.7 Hz, 1H), 
4.46 (ddd, J = 5.1, 1.6, 1.6 Hz, 1H), 3.83 (app dt, J = 7.8, 4.1 Hz, 1H), 3.71 (dd, J = 7.6, 5.0 Hz, 
1H), 3.60 (dd, J = 10.0, 4.7 Hz, 1H), 3.59 (dd,  J = 10.4, 3.7 Hz, 1H), 3.59 (s, 3H), 3.50 (s, 3H), 
3.44 (s, 3H), 3.34 (app t, J = 7.2 Hz, 1H), 3.28 (app t, J = 7.2 Hz, 1H), 2.28 (bs, 1H); 13C (125 
MHz, CDCl3) 132.7, 119.2, 82.0, 78.8, 73.9, 72.8, 71.0, 70.5, 59.9, 59.4, 59.2; IR (neat) 3450, 
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 2930, 1081 cm-1; [α]25D +98.87° (c 3.20, CHCl3); HRMS (EI) calcd. for C11H20O5 (M+) 
232.1311, found 232.1303. 
tert-Butyl-(4,5-dimethoxy-6-methoxymethyl-2-vinyltetrahydropyran-3-
yloxy)dimethylsilane (53):  To a solution of 52 (0.40 g, 1.6 mmol) in 
CH2Cl2 (1.6 mL) was added 2,6-lutidine (0.35 g, 3.2 mmol).  The solution 
was cooled to 0 °C and TBSOTf (0.64 g, 3.4 mmol) was added dropwise.  The reaction mixture 
was allowed to warm to room temperate and was stirred for 30 minutes.  The reaction was 
quenched with saturated aqueous NH4Cl (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The 
organic layers were combined, washed with brine (2 x 10 mL), dried Na2SO4, filtered, and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(5% EtOAc in hexanes) to provide the desired product (0.43 g, 77%):  1H NMR (300 MHz, 
CDCl3) δ 6.08 (ddd, J = 17.6, 11.0, 3.4 Hz, 1H), 5.45-5.36 (m, 2H), 4.39-4.36 (m, 1H), 3.77-3.72 
(m, 1H), 3.63-3.53 (m, 3H), 3.58 (s, 3H), 3.53 (s, 3H), 3.40 (s, 3H), 3.17 (app t, J = 9.0 Hz, 1H), 
3.10 (app t, J = 9.0 Hz, 1H), 0.89 (s, 9H), 0.11 (s, 3H), 0.05 (s, 3H); 13C (75 MHz, CDCl3) δ 
131.9, 119.1, 85.2, 80.3, 76.3, 72.7, 71.6, 71.5, 61.2, 60.4, 59.2, 25.7, 17.9, -4.7, -4.9; IR (neat) 
2931, 2894, 1114, 1093 cm-1; [αD]25D +81.5° (c 3.2, CHCl3); HRMS (ES) calcd. for 
C17H34KO5Si (M + K) 385.1813, found 385.1800. 
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2-Methylpropane-2-sulfinic acid 3-(tert-butyldimethylsilanyloxy)-4,5-
dimethoxy-6-methoxymethyltetrahydropyran-2-ylmethyleneamide 
(54):  A solution of 53 (0.387 g, 1.12 mmol) in CH2Cl2 was cooled to -78 
°C and ozone was gently bubbled through the solution until it sustained a 
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O
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 deep purple color.  Triphenylphosphine (0.587 g, 2.24 mmol) was added at -78 °C and the 
reaction mixture was warmed to room temperature and stirred for 2 hours.  The reaction mixture 
was concentrated under reduced pressure, dissolved in THF (4 mL) and at room temperature 
Ti(OiPr)4 (1.59 g, 5.60 mmol) was added followed by the addition of (Rs)-tert-butanesulfinamide 
(0.245 g, 2.00 mmol).  The reaction mixture was stirred for 4 hours at room temperature.  The 
reaction mixture was poured into an equal volume of brine, filtered through a pad of Celite and 
extracted with EtOAc (3 x 10 mL).  The organic layers were combined, washed with brine (10 
mL), dried with Na2SO4, filtered, concentrated under reduced pressure and purified by flash 
chromatography (20% EtOAc in hexanes) to provide the desired product (0.396 g, 71 %):  1H 
NMR (300 MHz, CDCl3) δ 8.34 (d, J = 2.3 Hz, 1H), 4.60 (dd, J = 6.7, 2.3 Hz, 1H), 3.95 (m, 2H), 
3.62-3.55 (m, 2H), 3.57 (s, 3H), 3.53 (s, 3H), 3.41 (s, 3H), 3.42 (app t, J = 9.2 Hz, 1H), 3.09 (app 
t, J = 9.4 Hz, 1H), 1.12 (s, 9H), 0.91 (s, 9H), 0.14 (s, 3H), 0.12 (s, 3H); 13C (75 MHz, CDCl3) δ 
166.3, 85.6, 80.0, 76.6, 73.8, 72.8, 71.1, 61.2, 60.4, 59.1, 57.1, 25.8, 22.4, 18.0, -4.7, -4.9; IR 
(neat) 2929, 1712, 1095 cm-1; [α]25D +28.27° (c 0.53, CHCl3);  HRMS (EI) calcd. for 
C19H38NO6SSi (M - CH3) 436.2189 found 436.2170. 
1-3-(tert-Butyldimethylsilanyloxy)-4,5-dimethoxy-6-
methoxymethyltetrahydropyran-2-yl-2-phenylethylcarbamic acid 
tert-butyl ester (55):  To a solution of 54 (0.380 g, 0.811 mmol) in 
 was treated with benzylmagnesium chloride (1 M in diethylether, 1.63 
mL, 1.63 mmol) and the reaction mixture was stirred at -78 °C for 1 hour.  The reaction was 
quenched with saturated aqueous NH
CH2Cl2 cooled to -78 °C
4Cl (5 mL), warmed to room temperature and extracted 
with CH2Cl2 (2 x 10 mL).  The organic layers were combined, washed with brine (10 mL), dried 
with Na2SO4, filtered and concentrated under reduced pressure.  The resulting oil was dissolved 
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 in methanol (5 mL) and aqueous HCl (4 M, 2.00 mL, 8.16 mmol) was added.  The reaction 
mixture was stirred for 1 hour at room temperature.  The reaction was quenched with saturated 
aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 x 10 mL).  The organic layers were 
combined, washed with brine (10 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was dissolved in CH2Cl2 (3 mL), triethylamine (2 mL) and 
di-tert-butyl dicarbonate (0.712 g, 3.26 mmol) were added and the solution was heated to 43°C 
for 8 hours.  The reaction was cooled to room temperature, extracted with CH2Cl2 (3 x 5 mL), 
washed with 5 % aqueous HCl (5 mL) and brine (5 mL), dried with Na2SO4, filtered, and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(50% EtOAc in hexanes) to provide the desired product (0.270 g, 68 %):  1H NMR (300 MHz, 
CDCl3) δ 7.30-7.17 (m, 5 H), 4.66 (br, 1 H), 4.17 (br, 1 H), 3.83 (dd, J = 7.6, 5.1 Hz, 1 H), 3.74 
(app t, J = 5.5 Hz, 1 H), 3.75-3.63 (m, 1H), 3.54 (s, 3 H), 3.54-3.48 (m, 2 H), 3.48 (s, 3 H), 3.40 
(s, 3H), 3.30 (d, J = 5.5 Hz, 1 H), 3.25 (d, J = 5.5, 1 H), 3.23-3.17 (m, 1 H), 2.52 (br, 1 H), 1.32 
(s, 9 H), 0.93 (s, 9 H), 0.14 (s, 3 H), 0.09 (s, 3 H); 13C (75 MHz, CDCl3) δ 155.1, 138.4, 129.6, 
128.2, 126.1, 84.0, 79.7,  77.6, 76.5, 73.2, 72.4, 71.5, 60.2, 59.4, 59.1, 51.8, 34.1, 28.3, 26.0, 
18.0, -4.4, -4.6; IR (neat) 2930, 1710, 1109, 1030 cm-1; [α]25D +36.49° (c 0.57, CHCl3); HRMS 
(EI) calcd. for C24H40N06Si (M - C4H9O) 466.2625, found 466.2261. 
 
1-(3-Hydroxy-4,5-dimethoxy-6-methoxymethyltetrahydropyran-2-
yl)-2-phenylethylcarbamic acid tert-butyl ester (56):  To a solution 
of 55 (230 mg, 0.431 mmol) in THF (5 mL) was added TBAF (340 mg, 
1.29 mmol).  The reaction mixture was stirred for 1 hour at room 
temperature, quenched with H2O (10 mL) and extracted with EtOAc (3 x 10 mL).  The organic 
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 layers were combined, washed with brine (10 mL), dried with Na2SO4, filtered, and concentrated 
under reduced pressure.  The resulting oil was purified by flash chromatography (80% EtOAc in 
hexanes) to provide the desired product (140 mg, 76 %):  1H NMR (300 MHz, CDCl3) δ 7.32-
7.18 (m, 5H), 4.82 (br, 1H), 4.12 (br, 1H), 4.03-3.94 (m, 1H), 3.84 (br, 1H), 3.72 (m, 1H), 3.66 
(dd, J = 10.3, 6.9 Hz, 1H), 3.51-3.47 (m, 2H), 3.47 (s, 3H), 3.41 (s, 3H), 3.40 (s, 3H), 3.28 (app t, 
J = 3.4 Hz, 1H), 2.98 (d, J = 6.6, 2H), 1.61 (bs, 1H), 1.40 (s, 9H); 13C (75 MHz, CDCl3) δ 155.8, 
138.3, 129.3, 128.1, 126.1, 79.0, 78.5, 76.6, 74.0, 70.2, 69.2, 68.5, 58.8, 58.2, 58.0, 53.8, 37.3, 
28.2; IR (neat) 3360, 2930, 1712, 1114 cm-1; [α]25D +7.41° (c 0.27, CHCl3); HRMS (EI) calcd. 
for C18H26NO6 (M-C4H9O) 352.1760 found 352.1768. 
 
1-(3-But-3-enyloxymethoxy-4,5-dimethoxy-6-
methoxymethyltetrahydropyran-2-yl)-2-phenylethylcarbamic 
acid tert-butyl ester (57):  To a solution of 56 (428 mg, 1.01 mmol) 
in CH2Cl2 (5 mL) and DIPEA (3 mL) was added 4-
chloromethoxybut-1-ene (608 mg, 5.05 mmol) and the reaction mixture was heated to 40 °C and 
stirred for 8 hours.  The solution was cooled to room temperature, saturated aqueous NH4Cl (5 
mL) was added and the reaction mixture was extracted with CH2Cl2 (2 x 5 mL).  The organic 
layers were combined, washed with 5% aqueous HCl (5 ml), dried with Na2SO4, filtered, and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(50% EtOAc in hexanes) to provide the desired product (497 mg, 97%):  1H NMR (300 MHz, 
CDCl3) δ 7.29-7.18 (m, 5H), 5.87-5.74 (m, 1H), 5.12-5.02 (m, 2H), 4.93 (d, J = 7.3 Hz, 1H), 
4.79 (d, J = 6.8 Hz, 1H), 4.69 (d,  J = 6.9 Hz, 1H), 4.07 (br, 1H), 3.89-3.79 (m, 2H), 3.73 (br, 
1H), 3.70-3.55 (m, 3H), 3.52-3.45 (m, 2H), 3.46 (s, 3H), 3.45 (s, 3H), 3.39 (s, 3H), 3.15 (app t, 1 
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 H), 3.04 (dd,  J = 13.6, 6.4 Hz, 1H), 2.86 (br, 1H), 2.32 (m, 2H), 1.34 (s, 9H);  13C (75 MHz, 
CDCl3) δ 155.3, 138.3, 135.1, 129.6, 128.3, 126.2, 116.6, 95.9, 78.1, 75.9, 73.5, 71.4, 70.7, 67.7, 
65.6, 60.0, 59.1, 58.8, 58.7, 52.0, 34.1, 32.8, 28.3; IR (neat) 2930, 1720, 1172 cm-1; [α]25D 
+18.7° (c 3.2, CHCl3);  HRMS (EI) calcd. for C27H44NO8 (M+H) 510.3067, found 510.3079. 
 
1,3-(4-Hydroxybutoxymethoxy)-4,5-dimethoxy-6-
methoxymethyltetrahydropyran-2-yl-2-phenylethylcarbamic 
acid tert-butyl ester (58)  To a solution of 57 (481 mg, 0.944 
mmol) in THF (30 mL) cooled to -10° C was added BH3•THF 
(4.72 mL, 1 M, 4.72 mmol) and the reaction mixture was stirred for 4 hours at -10 °C.  The 
excess borane was quenched with H2O followed by the addition of NaOH/HOOH solution (20% 
NaOH/30% HOOH, 1:1 by volume) (5 mL) and the reaction mixture was stirred for 2 hours at 
room temperature.  Saturated aqueous NaS2O3 (10 mL) was added and the reaction mixture was 
stirred for 1 hour at room temperature.  The reaction mixture was extracted with EtOAc (3 x 10 
ml).  The organic layers were combined, washed with brine (10 mL), dried with NaSO4, filtered, 
and concentrated under reduced pressure. The resulting oil was purified by flash chromatography 
(50% EtOAc in hexanes) to provide the desired product (461 mg, 93%): 1H NMR (300 MHz, 
CDCl3) δ 7.27-7.17 (m, 5H), 4.95 (br, 1H), 4.80 (d, J = 6.9 Hz, 1H), 4.69 (d, J = 6.9 Hz, 1H), 
4.05 (br, 1H), 3.84 (br, 1H), 3.81 (dd, J = 5.6, 3.6 Hz, 1H), 3.73 (br, 1H), 3.66-3.37 (m, 7H), 3.46 
(s, 3H), 3.45 (s, 3H), 3.39 (s, 3H), 3.19 (br, 1H), 3.04 (dd, J = 13.6, 6.5 Hz, 1H), 2.85 (br, 1H), 
1.96 (br, 1H), 1.69-1.63 (m, 4H), 1.36 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 155.4, 138.3, 129.6, 
128.2, 126.2, 95.7, 78.0, 77.4, 75.8, 73.5, 73.5, 71.3, 70.5, 68.4, 62.5, 59.1, 58.9, 58.7, 52.0, 37.3, 
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 29.6, 28.3, 26.2; IR (neat) 3452, 2932, 1707, 1107 cm-1; [α]25D +14.2° (c 2.4, CHCl3);  HRMS 
(EI) calcd. for C20H38NO9 (M-C7H7) 436.2547, found 436.2553. 
 
1-(4,5-Dimethoxy-6-methoxymethyl)-3-(tetrahydrofuran-2-
ymethoxy)-tetrahydropyran-2-yl-2-phenylethylcarbamic acid 
tert-butyl ester (47)  To a solution of 58 (47 mg, 0.09 mmol) in 
cyclohexane (10 mL) was added iodobenzene diacetate (63 mg, 0.20 mmol) and iodine (18 mg, 
0.14 mmol) at room temperature.  The reaction mixture was irradiated for 2 hours.  The reaction 
mixture was extracted with EtOAc (10 mL), washed with saturated aqueous NaSO
ylox
4 (5 mL) and 
brine (5 ml), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting 
oil was purified by flash chromatography (50% EtOAc in hexanes) to provide the desired 
product (30 mg, 64%) as an inseperable mixture of diastereomers: 1H NMR (300 MHz, CDCl3) δ 
7.31-7.15 (m, 5H), 5.41 (m, 0.6H), 5.37 (m, 0.4H), 4.98 (d, J = 6.8 Hz, 0.4H), 4.97 (d, J = 6.8 
Hz, 0.6H), 4.91 (br, 1H), 4.77 (d, J = 6.8 Hz, 0.4H), 4.65 (d, J = 6.8, 0.6H), 4.10-4.02 (m, 1H), 
3.87-3.70 (m, 5H), 3.55-3.40 (m, 4H), 3.44 (s, 3H), 3.43 (s, 3H), 3.37 (s, 3H), 3.20 (br, 1H), 3.06 
(d, J = 10.7, 5.0 Hz, 1H), 2.83 (br, 1H), 2.02-1.70 (m, 4H), 1.34 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 155.30, 155.23, 138.4, 138.3, 129.6, 128.2, 126.0, 100.9, 92.5, 91.3, 81.4 81.1, 79.0, 
78.6, 75.1, 73.3, 73.3, 71.3, 71.2, 70.5, 67.1, 59.0, 58.9, 58.7, 51.7, 38.5, 38.2, 32.2, 32.1, 28.2, 
23.2, 23.1; IR (neat) 2930, 1709, 1668, 1105 cm-1; [α]25D + 28.0° (c 0.99, CHCl3).  
 
4-Methyl-1-trimethylsilanylpentyn-3-one (59):  To a stirred solution of 
bis(trimethylsilyl)acetylene (3.50 g, 20.5 mmol) and isobutyryl chloride 
(2.00 g, 18.8 mmol) in CH2Cl2 (45 mL) at 0 °C was slowly added AlCl3 (3.00g, 22.5 mmol).  
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 The reaction mixture was stirred for 2 hours at 0 °C, warmed to rt and stirred for an additional 2 
hours.  The resulting black solution was poured into a mixture of ice (50 g) and 10% aqueous 
HCl (50 mL) and biphasic mixture was extracted with CH2Cl2 (3 x 10 mL).  The organic layers 
were combined, washed with brine (2 x 10 mL), dried with Na2SO4, filtered, and concentrated 
under reduced pressure.  The resulting oil was purified by flash chromatography (5% EtOAc in 
hexanes) to provide the desired product (2.92 g, 92%).  The crude product can used without 
purification: 1H NMR (300 MHz, CDCl3) δ 2.72 (sept, J = 7.0 Hz, 1H), 1.26 (d, J = 7.0, 6H), 
0.32 (s, 9H);  13C NMR (75 MHz, CDCl3) δ 191.9, 100.9, 98.6, 42.7, 17.7, -0.9; IR (neat) 2969, 
1678, 1252, 1067, 847 cm-1; HRMS (EI) m/z calcd. for C9H16OSi (M+) 168.0970 found 
168.09665. 
 
1-Methoxy-4-methylpent-1-en-3-one (60):  To a stirred solution of 59 (2.21 
g, 13.1 mmol) in methanol at rt was slowly added 1,4-
diazabicyclo[2.2.2]octane (DABCO) (2.91 g, 25.9 mmol).  The solution was stirred at rt for 20 
minutes, concentrated under reduced pressure, taken up in EtOAc (20 mL), washed with brine (2 
x 10 mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting 
oil was purified by flash chromatography (10% EtOAc in hexanes) to provide the desired 
product (1.22 g, 75%):  1H NMR (300 MHz, CDCl3) δ 7.62 (d, J = 12.5, 1H), 5.63 (d, J = 12.5, 
1H), 3.72 (s, 3H), 2.69 (sept, J = 6.8, 1H), 1.11 (d, J = 6.8, 6H); 13C NMR (75 MHz, CDCl3) δ 
202.5, 162.5, 103.3, 57.5, 39.5, 18.6; IR (neat) 2969, 1686, 1620, 1595, 1244, 1205, 1054 cm-1;  
HRMS (EI) m/z calculated for C7H12O2 (M+) 128.0837 found 128.0836. 
MeO
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 1-(2-Methoxy-vinyl)-2-methylpropenyloxytrimethylsilane(61):  A stirred 
solution of 60 (4.05 g, 31.6 mmol) in diethyl ether (60 mL) and triethylamine 
(6.40 g, 63.2 mmol) cooled to -10 °C was added dropwise trimethylsilylmethyl triflate 
(TMSOTf) (7.84 g, 33.18 mmol).  The reaction mixture was slowly warmed to 5 °C over 5 hrs.  
The reaction mixture was diluted with pentane (60 mL) and transferred to a separatory funnel.  
The lower layer was removed and the upper, organic layer was washed with saturated aqueous 
NaHCO3 (2 x 10 mL) and brine (2 x 10 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The product was distilled (38.0 – 41.0 °C, 0.2 torr) from the crude oil to 
provide the desired product (4.71 g, 75%):  1H NMR (300 MHz, C6D6) δ 6.94 (d, J = 12.2 Hz, 
1H), 5.79 (d, J = 12.2 Hz, 1H), 3.16 (s, 3H), 1.73 (s, 3H), 1.62 (s, 3H), 0.18 (s, 9H). 
MeO
OTMS
 
2-Ethyl-3,3-dimethyl-2,3-dihydro-pyran-4-one (62):  To a stirred solution of 61 
(4.57 g, 22.8 mmol) and propionaldehyde (1.59 g, 27.3 mmol) in CH2Cl2 (50 mL) 
cooled to -5 °C was added BF3•OEt2 (0.32 g, 2.28 mmol) and the reaction was stirred for 3 hours 
at -5 °C.  Triflouroacetic acid (2 mL) was added to the reaction mixture at -5 °C and the reaction 
mixture was warmed to rt and stirred for 4 hours.  H2O (5 mL) was added and the reaction was 
quenched via slow addition of solid NaHCO3.  The reaction mixture was stirred for 1 hour at rt 
and extracted with CH2Cl2 (2 x 10 mL).  The organic layers were combined, washed with brine 
(2 x 10 mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The 
resulting oil was purified by flash chromatography (20% Et2O in pentane) to provide the desired 
product (2.85 g, 81%):  1H NMR (300 MHz, CDCl3) δ 7.31 (d, J = 5.8 Hz, 1H), 5.33 (d, J = 5.8 
Hz, 1H), 3.90 (dd, J = 10.5, 2.6 Hz, 1H), 1.79-1.60 (m, 2H), 1.11 (s, 3H), 1.10 (t, J = 7.4 Hz, 
3H), 1.02 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 198.7, 161.6, 105.1, 88.3, 44.4, 21.3, 19.8, 17.9, 
O
O
78 
 10.7; IR (neat) 2971, 1673, 1602, 1276 cm-1; HRMS (EI) m/z calculated for C9H15O2 (M + H) 
155.1067, found 155.1072. 
 
2-Ethyl-4-methoxy-3,3-dimethyl-3,4-dihydro-2H-pyran (63):  To a stirred 
solution of 62 (3.48 g, 22.6 mmol) in 0.50 M CeCl3 in methanol (56.0 ml) cooled 
to -10 °C was slowly added NaBH4 (2.56 g, 48.6 mmol).  The reaction mixture was slowly 
warmed to rt and stirred for 1 hour.  Brine (50 ml) was added and the reaction mixture was 
repeatedly extracted with diethyl ether (5 x 30 ml).  The resulting organic layers were combined, 
washed with brine (2 x 20 mL), dried with Na2SO4, filtered, and concentrated under reduced 
pressure.  The resulting oil was taken up in DMF (20 ml) and cooled to 0 °C.  NaH (2.71 g, 67.7 
mmol) was added and the reaction mixture was stirred for 30 min. at 0 °C then warmed to rt and 
stirred for an additional 30 min.  The reaction mixture was cooled to 0 °C, methyl iodide (4.81 g, 
67.7 mmol) was added and the reaction was slowly warmed to rt and stirred for 8 hours.  The 
excess NaH was quenched by slow addition of H2O and the reaction mixture was extracted with 
pentane (3 x 20 mL).  The resulting organic layers were combined, washed with brine (10 mL), 
dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil was 
purified by flash chromatography (10% Et2O in pentane) providing the desired product (2.61 g, 
67%): 1H NMR (300 MHz, CDCl3) δ 6.35 (dd, J = 6.2, 1.0 Hz, 1H), 4.79 (dd, J = 6.2, 1.8 Hz, 
1H), 3.45-3.36 (m, 2H), 3.36 (s, 3H), 1.62-1.54 (m, 2H), 1.0 (t, J = 7.4, 3H), 0.96 (s, 3H), 0.86 
(s, 3H); 13C (75 MHz, CDCl3) δ 114.3, 100.1, 84.6, 80.8, 57.3, 35.6, 23.6, 21.0, 13.8, 11.1; IR 
(neat) 2964, 1647, 1239, 1103 cm-1; HRMS (EI) m/z calcd. for C10H17O2 (M - H) 169.1220, 
found 169.1229. 
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 6-Ethyl-4-methoxy-5,5-dimethyl-2-vinyltetrahydropyran-3-ol (64):  
Preparation of 0.10 M trivinylalane:  To a suspension of AlCl3 (4.44 g, 33.3 
mmol) in CH2Cl2 (233 mL) at rt was added vinylmagnesium bromide (1 M in 
THF, 100 mL, 100 mmol) drop wise, over a period of 1 hour.  The solution was cooled when 
necessary to prevent reflux and stirred at rt for 4 hours. 
O
O
HO
Synthesis of 64:  To a stirred solution of 63 (2.20 g, 12.9 mmol) in CH2Cl2 (15 mL) cooled to 0 
°C was added dimethyldioxirane (71.0 mL, 0.2 M) dropwise and the reaction mixture was stirred 
at 0 °C for 30 minutes.  The reaction mixture was concentrated under reduced pressure and taken 
up in CH2Cl2 (80 mL).  The resulting solution was added dropwise over a period of 1 hour to a 
0.10 M solution trivinylalane (333 mL) cooled to -72 °C.  The resulting reaction mixture was 
allowed to slowly warm to rt and stir for 6 hours.  H2O (10 mL) was slowly added to quench the 
excess trivinylalane.  10% aqueous HCl (100 mL) was added to the reaction mixture and the 
solution was stirred for 30 min.  The organic phase was collected and the resulting aqueous 
phase was extracted with CH2Cl2 (20 mL).  The organic layers were combined, washed with 
10% aqueous HCl (2 x 30 mL) and brine (2 x 30 mL), dried with Na2SO4, filtered, and 
concentrated under reduced pressure.  The resulting yellow oil was purified by flash 
chromatography (20% EtOAc in hexanes) to provide the desired product (2.21 g, 80%): 1H NMR 
(300 MHz, CDCl3)  δ 6.14 (ddd, J = 16.2, 11.3, 5.3 Hz, 1H), 5.84-5.38 (m, 2H), 4.56-4.54 (m, 
1H), 3.92-3.87 (m, 1H), 3.75 (s, 3H), 3.27 (dd, J = 9.8, 0.7 Hz, 1H), 2.78 (d, J = 10.0 Hz, 1H), 
2.34 (bs, 1H), 1.49-1.43 (m, 1H), 1.33-1.25 (m, 1H), 0.97 (t, J = 7.3 Hz, 3H), 0.92 (s, 3H), 0.87 
(s, 3H): 13C NMR (75 MHz, CDCl3) δ 132.7, 119.0, 87.7, 78.6, 75.6, 69.9, 62.6, 41.6, 23.5, 21.8, 
13.9, 11.5; IR (neat) 3444, 2964, 2877, 1469, 1106, 1038, 926 cm-1; HRMS (EI) m/z calcd. for 
C12H22O3 (M+) 214.1564, found 214.1568.  
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5-(4-Benzyloxybutoxymethoxy)-2-ethyl-4-methoxy-3,3-
dimethyl-6-vinyltetrahydropyran  (65):  To a stirred solution 
of 64 (2.01 g, 9.39 mmol) in CH2Cl2 (7 mL) at rt was added 
DIPEA (3 mL) followed by BBMCl (Chapter 1, pg 27) (2.90 g, 11.2 mmol) and the reaction 
mixture was heated to 35 °C for 8 hours.  The reaction mixture was cooled to rt, saturated 
aqueous ammonium chloride (5 mL) was added, the reaction mixture was stirred for 30 minutes 
and extracted with CH2Cl2 (2 x 20 mL).  The organic layers were combined, washed with 10% 
aqueous HCl (2 x 20 mL) and brine (2 x 20 mL), dried with Na2SO4, filtered, and concentrated 
under reduced pressure.  The resulting orange oil was purified by flash chromatography (10% 
EtOAc in hexanes) to provide the desired product (2.91 g, 76%):  1H NMR (300 MHz, CDCl3) δ 
7.44-7.26 (m, 5H), 6.12 (ddd, J = 15.5, 10.9, 4.5 Hz, 1H), 5.48-5.36 (m, 2H), 4.76 (d, J = 6.7 Hz, 
1H), 4.73 (d, J = 6.7 Hz, 1H), 4.57-4.54 (m, 1H), 4.50 (s, 2H), 3.83 (dd, J = 10.1, 6.7 Hz, 1H), 
3.65-3.60 (m, 1H), 3.52 (s, 3H), 3.51-3.45 (m, 3H), 3.24 (dd, J = 8.9, 0.5 Hz, 1H), 2.81 (d, J = 
10.1 Hz, 1H), 1.72-1.62 (m, 4H), 1.52-1.38 (m, 1H), 1.36-1.23 (m, 1H),  0.98 (t, J = 7.3 Hz, 3H), 
0.90 (s, 3H), 0.86 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 138.6, 133.4, 128.3, 127.5, 127.4, 
118.5, 95.8, 85.9, 78.3, 76.7, 74.9, 72.8, 70.0, 67.8, 61.9, 41.7, 26.5, 26.4, 23.1, 21.9, 13.8, 11.5; 
IR (neat) 2934, 2875, 1107, 1038 cm-1; HRMS (ES) m/z calcd. for C24H38NaO5 (M + Na) 
429.2617, found 429.2591. 
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2-Methylpropane-2-sulfinic acid 3-(4-benzyloxybutoxymethoxy)-
6-ethyl-4-methoxy-5,5-dimethyltetrahydropyran-2-
ylmethyleneamide (66):  A stirred solution of (65) (0.80 g, 2.0 mmol) 
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 in CH2Cl2 (20 mL) cooled to -78 °C was subjected to ozone via gently bubbling for 20 minutes (until 
the reaction mixture sustained a pale blue color).  Triphenylphosphine (1.0 g, 3.9 mmol) was added 
to the reaction mixture at -78 °C which was then warmed to rt and stirred for 2 hours.  The reaction 
mixture was concentrated, the resulting residue was taken up in THF (8 mL) and Ti(OiPr)4 (2.8 g, 
9.9 mmol) was added followed by (R)-tert-butanesulfinamide (0.36 g, 3.0 mmol).  The reaction 
mixture was stirred at rt for 6 hours and poured in to an equal volume of brine.  EtOAc (30 mL) was 
added and the resulting emulsion was stirred for 30 minutes.  The emulsion was filtered through a 
pad of celite, the celite was washed with EtOAc (2 x 20 mL) and the organic phase was collected.  
The organic phase was washed with brine (2 x 20 mL), dried with Na2SO4, filtered, and concentrated 
under reduced pressure.  The resulting residue was purified by flash chromatography (20% EtOAc in 
hexanes) to provide the desired product as an inseparable mixture of diastereomers (0.67 g, 67%):  
1H NMR (300 MHz, CDCl3) δ 8.35 (dd, J = 9.9, 3.6 Hz, 1H), 7.39-7.26 (m, 5H), 4.85-4.73 (m, 3H), 
4.50 (s, 2H), 4.05-3.97 (m, 1H), 3.68-3.62 (m, 1H), 3.55-3.39 (m, 4H), 3.50 (s, 3H), 2.81 (dd, J = 
15.5, 10.2 Hz, 1H), 1.75-1.63 (m, 4H), 1.52-1.40 (m, 1H), 1.35-1.25 (m, 1H), 1.27 (s, 5H), 1.22 (s, 
4H), 1.01-0.93 (m, 3H), 0.90 (s, 3H), 0.87 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 167.1, 166.8, 
138.6, 128.3, 127.6, 127.5, 96.1, 96.0, 86.5, 80.8, 80.7, 76.1, 76.0, 72.8, 70.0, 68.3, 68.2, 62.1, 62.0, 
57.1, 57.0, 41.7, 26.5, 26.4, 26.4, 23.1, 22.9, 22.6, 22.4, 22.2, 22.1, 13.6, 11.5, 11.4; IR (neat) 2961, 
2874, 1363, 1103 cm-1; HRMS (ES) m/z calcd. for C27H45NO6NaS 534.2865, found 534.2823. 
 
N-1-3-(4-Benzyloxybutoxymethoxy)-6-ethyl-4-methoxy-5,5-
dim  O
O
Bn
HN
O
OO
BnO
ethyltetrahydropyran-2-yl-2-phenylethylacetamide  (67): 
To a stirred solution of (66) (0.85 g, 1.7 mmol) in CH2Cl2 (15 mL) 
at -78 °C was added benzylmagnesium chloride (1 M, 5.0 mL, 5.0 
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 mmol).  The reaction mixture was stirred at -78 °C for 5 minutes, warmed to 0 °C and stirred for 1.5 
hours.  Saturated aqueous NH4Cl (5 mL) was added and the reaction mixture was extracted with 
CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with brine (2 x 10 mL), dried with 
Na2SO4, filtered and concentrated under reduced pressure.  The resulting oil was taken up in 
methanol (5 mL), cooled to 0 °C, treated with HCl (4 M in dioxane) and stirred at 0 °C for 2 hours.  
Aqueous 10% sodium hydroxide (5 mL) was added and the reaction was warmed to rt and stirred for 
0.5 hours.  The reaction mixture was extracted with EtOAc (3 x 10 mL).  The organic layers were 
combined, washed with brine (2 x 10 mL) dried with Na2SO4, filtered, and concentrated under 
reduced pressure. The resulting oil was taken up in CH2Cl2 (4 mL), triethylamine (2 mL) was added 
and reaction mixture was cooled to -10 °C.  Acetyl chloride (0.26 g, 3.3 mmol) was slowly added.  
The reaction mixture was stirred at 0 °C for 0.5 hours, H2O (3 mL) was added and the reaction 
mixture was extracted with CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with 
10 % aqueous HCl (5 mL) and brine (2 x 5 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (50% EtOAc in hexanes) 
to provide the desired product (0.80 g, 72 %) as a separable mixture of diastereomers:  1H NMR (300 
MHz, CDCl3) δ 7.35-7.20 (m, 10H), 5.74 (d, J = 8.0 Hz, 1H), 4.78 (d, J = 6.6 Hz, 1H), 4.74 (d, J = 
6.6 Hz, 1H), 4.53-4.46 (m, 1H), 4.50 (s, 2H), 3.89 (dd, J = 6.8, 4.7 Hz, 1H), 3.75 (dd, J = 6.8, 4.7 
Hz, 1H), 3.65-3.57 (m, 2H), 3.53-3.46 (m, 2H), 3.43 (s, 3H), 3.24-3.11 (m, 2H), 3.01 (d, J = 7.0 Hz, 
1H), 2.86 (dd, J = 13.7, 6.2 Hz, 1H), 1.89 (s, 3H), 1.71-1.68 (m, 4H), 1.58-1.42 (m, 2H), 1.02 (s, 
3H), 0.91 (t, J = 7.3 Hz, 3H), 0.86 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 169.0, 138.5, 138.1, 129.8, 
128.3, 128.2, 127.6, 127.5, 126.2, 96.2, 85.1, 81.3, 75.5, 72.8, 70.0, 69.4, 68.4, 60.7, 49.6, 39.3, 38.9, 
26.5, 26.4, 25.1, 23.6, 21.2, 17.7, 11.6; IR (neat) 3285, 2935, 2876, 1646, 1103 cm-1; HRMS (ES) 
m/z calcd. for C32H48NO6 (M + H) 542.3482, found 542.3469. 
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N-1-6-Ethyl-3-(4-hydroxybutoxymethoxy)-4-methoxy-5,5-
dimethyltetrahydropyran-2-yl-2-phenylethylacetamide (68):  
To a 
r
H2 atmosphere and stirred for 8 
thyl-3-tetrahydrofuran-2-
yloxymethoxytetrahydropyran-2-yl]-2-phenylethylacetamide (48):  To a 
stirred solution of (68) (0.10 g, 0.23 mmol) in cyclohexane was added 
O
O
stirred solution of a single diastereomer (67) (0.27 g, 0.50 
mmol) (both diastereomers react identically) in ethanol (5 mL) at rt 
bon (26 mg, 0.05 mmol) and the reaction mixture was placed under 
hours.  The reaction mixture was filtered through a plug of celite.  
The celite was washed with EtOAc (20 mL) and the organic phase was collected from the resulting 
biphasic mixture.  The aqueous phase was extracted with EtOAc (20 mL).  The organic phases were 
combined, washed with brine (2 x 20 ml), dried with Na
Bn
HN
was added 20% palladium on ca
2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (99 % EtOAc in hexanes) 
to provide the desired product (0.20, 89%):  1H NMR (300 MHz, CDCl3) δ 7.31-7.15 (m, 5H), 5.85 
(d, J = 7.7 Hz, 1H), 4.78 (d, J = 6.7 Hz, 1H), 4.73 (d, J = 6.7 Hz, 1H), 3.92-3.88 (m, 1H), 3.89 (dd, J 
= 6.2, 4.4 Hz, 1H), 3.71 (dd, J = 6.2, 4.4 Hz, 1H), 3.67-3.60 (m, 4H), 3.40 (s, 3H), 3.17-3.13 (m, 
2H), 2.98 (d, J = 6.5 Hz, 1H), 2.89 (dd, J = 13.7, 6.0 Hz, 1H), 1.91 (s, 3H), 1.72-1.67 (m, 4H), 1.57-
1.49 (m, 1H), 1.43-1.37 (m, 1H), 1.04 (s, 3H), 0.92 (t, J = 7.3 Hz, 3H), 0.86 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 169.2, 138.2, 129.8, 128.2, 126.3, 95.8, 84.8, 81.7, 75.2, 68.8, 68.6, 62.4, 60.5, 50.0, 
39.0, 29.6, 26.3, 25.5, 23.6, 21.1, 18.3, 11.7; IR (neat) 3420, 3280, 2936, 1652, 1107, 1033 cm-1; 
HRMS (ES) m/z calcd. for C25H41NO6 (M+) 451.2934, found 451.2956.  
 
N-1-6-Ethyl-4-methoxy-5,5-dime
OMe
OO
HO
O
O
HN
O
OMe
O
O
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 iodobenzene diacetate (0.16 g, 0.51 m
was stirred for 20 minu
mixture was extracted w
Na2S2O3 (2 x 10 mL) an
n DCE (6 mL) was added 
MQ (0.8 mg, .003 mmol), NaOAc (58 mg, 200 wt.%), Na2S2O3 (58 mg, 200 wt.%), molecular 
mol) and iodine (47 mg, 0.37 mmol) and the reaction mixture 
tes at rt.  The reaction mixture was irradiated for 2 hours and the reaction 
ith EtOAc (20 mL).  The organic phase was washed with saturated aqueous 
d brine (2 x 10 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (70 % EtOAc in hexanes) 
to provide the desired product (0.92 g, 89 %) as an inseparable mixture of diastereomers:  1H NMR 
(300 MHz, CDCl3) δ 7.30-7.17 (m, 5H), 5.84 (d, J = 8.0 Hz, 0.65H), 5.75 (d, J = 8.0 Hz, 0.35H), 
5.43-5.40 (m, 1H), 5.03 (d, J = 6.6 Hz, 0.35H), 4.96 (d, J = 6.6 Hz, 0.65H), 4.80 (d, J = 6.6 Hz, 
0.35H), 4.57 (d, J = 6.6 Hz, 0.65H), 4.52-4.40 (m, 1H), 3.94-3.86 (m, 3H), 3.83-3.71 (m, 1H), 3.46 
(s, 1.05H), 3.43 (s, 1.95H), 3.24-3.09 (m, 2H), 3.04-2.89 (m, 2H), 2.06-1.90 (m, 4H), 1.60-1.36 (m, 
2H), 1.04 (s, 1.95H), 1.00 (s, 1.05H), 0.95-0.86 (m, 3H), 0.93 (s, 1.05H), 0.86 (s, 1.95H); 13C NMR 
(75 MHz, CDCl3) δ 169.1, 138.3, 138.2, 129.9, 129.8, 128.1, 126.2, 101.2, 100.9, 92.8, 92.2, 85.2, 
84.9, 81.5, 81.1, 76.2, 75.4, 67.2, 60.7, 60.6, 49.8, 49.5, 39.5, 39.1, 38.8, 38.4, 32.3, 32.2, 25.3, 24.9, 
23.5, 23.5, 23.3, 23.2, 21.2, 21.1, 11.6; IR (neat) 3283, 2967, 1642, 1561, 1101 cm-1; HRMS (ES) 
calcd. for C25H39NO6 (M+) 449.2777, found 449.2797. 
 
7,8-Dimethoxy-6-methoxymethylhexahydropyrano-(3,2)-(1,3)dioxin-4-ylcarbamic acid tert-
butyl ester (69 and 70)    To a solution of 47 (29 mg, 0.05 mmol) i
N
sieves (58 mg, 200 wt.%) and toluene (1 mL).  The suspension was stirred at room temperature 
for 30 minutes. Air was gently bubbled through the suspension while it was irradiated for 2 
hours.  The reaction mixture was filtered through a small plug of silica and concentrated under 
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 reduced pressure.  The resulting oil was purified by flash chromatography (50% EtOAc in 
hexanes) to provide the desired product (18 mg, 94%) a 10:1 mixture of diastereomers:  
major diastereomer (69):  1H NMR (300 MHz, CDCl3) δ 5.97 (d, J = 9.7 
Hz, 1H), 5.12 (d, J = 6.7 Hz, 1H), 5.08 (dd, J = 9.7, 1.4 Hz, 1H), 4.84 (d, J = 
s
154.9, 91.6, 80.7, 80
H), 5.17  (d, J = 9.3 Hz, 1H), 5.10 (d, J = 7.0 Hz, 1H), 4.88 (d, J = 
 
81.1, 79.8, 79.0, 7
l-8-methoxy-7,7-dimethylhexahydropyrano-3,2-d-1,3-dioxin-4-yl acetamide (77 and 
8):  To a stirred solution of (48) (82 mg, 0.18 mmol) in DCE (6 mL) at rt was added was added 
O
O
O
O
O
O
HN O
O
6.7 Hz, 1H), 4.17 (dt, J = 7.8, 4.0 Hz, 1H), 3.92 (dd, J = 1.8, 1.8, 1H), 3.72 
(dd, J = 1.8, 1.8 Hz, 1H), 3.62-3.60 (m, 2H), 3.50 (dd, J = 3.8, 2.5 Hz, 1H), 
, 3H), 3.42 (s, 3H), 3.31-3.29 (m, 1H) 1.47 (s, 9H); 3.47 (s, 3H), 3.47 ( 13C (125 MHz, CDCl3) δ 
.5, 79.6, 76.8, 74.5, 73.5, 71.5, 65.5, 59.3, 58.4, 57.7, 28.3;  IR (neat) 2922, 
1724, 1500 cm-1; [α]25D +17.87° (c 0.62 CHCl3); HRMS (ES) calcd. for C16H29NO8Na (M + Na) 
386.1791, found 386.1828. 
minor diastereomer (70):  1HNMR (300 MHz, CDCl3) δ 5.44 (dd, J = 9.3, 
8.6 Hz, 1
O
O
O
O
O
O
HN O
O
7.0 Hz, 1H), 4.14 (dd, J = 9.6, 6.3 Hz, 1H), 3.87 (app t, J = 9.0 Hz, 1H), 3.76 
(dd, J = 9.6, 6.3 Hz, 1H), 3.70-3.64 (m, 1H),  3.64 (s, 3H), 3.75-3.50 (m, 2H), 
(s, 3H), 3.27-3.20 (m, 1H), 1.47 (s, 9H); 3.54 (s, 3H), 3.38 13C (75 MHz, CDCl3) δ 155. 86.9, 
8.7, 77.9, 73.5, 71.2, 70.9, 60.8, 60.7, 59.3, 30.0, 28.5; [α]25D +47.53° (c 0.65 
CHCl3). 
 
N-6-Ethy
7
NMQPF6 (5.7 mg, .02 mmol), NaOAc (0.16 g, 200 wt.%), Na2S2O3 (0.16 g, 200 wt.%), 4 Å 
molecular sieves (0.16 g, 200 wt.%) and toluene (1 mL).  The suspension was stirred at rt for 30 
minutes. Air was gently bubbled through the suspension while it was irradiated for 2 hours.  The 
86 
 reaction mixture was filtered through a small plug of silica and concentrated under reduced pressure.  
The resulting oil was purified by flash chromatography (50% EtOAc in hexanes) to provide the 
desired product (18 mg, 94%) a 1.6:1 mixture of diastereomers:  
major diastereomer; 1H NMR (300 MHz, CDCl3) δ 5.98 (d, J = 9.8 Hz, 1H), 5.80 
(app t, J = 9.8 Hz, 1H), 5.17 (d, J = 7.0 Hz, 1H)
O
, 4.86 (d, J = 7.0 Hz, 1H), 4.26 (dd, 
d
3H), 0.86 (t, J = 
75.1, 73.8, 70.9, 6
13
27.8, 23.3, 22.5, 2
o a solution of amido trioxadecalin (77 and 78) (5.0 mg, 0.02 mmol) (major or minor 
roethanol (3 mL) at rt was added a catalytic amount (small crystal) of p-
O
O
HN
O
J = 10.5, 6.8 Hz, 1H), 3.81 (dd, J = 10.0, 6.8 Hz, 1H), 3.6 (s, 3H), 3.46 (d, J = 10.5 
, J = 10.1, 1.7 Hz, 1H), 2.05 (s, 3H), 1.51-1.39 (m, 1H), 1.29-1.21 (m, 1H), 0.98 (s, 
7.3 Hz, 3H), 0.85 (s, 3H); 
Hz, 1H), 3.11 (d
13C NMR (75 MHz, CDCl3) δ 170.3, 86.8, 80.6, 79.6, 
1.8, 41.9, 23.2, 23.0, 21.6, 13.2, 11.0; IR (neat) 3299, 2965, 1673, 1546, 1109 cm-
1; HRMS (ES) calcd for C14H26NO5 (M+H) 288.1811, found 288.1806.   
minor diastereomer; 1HNMR (300 MHz, CDCl3) δ 6.79 (d, J= 9.1 Hz, 1H), 4.43 
(dd, J = 9.5, 2.1 Hz, 1H), 5.10 (d, J = 6.6 Hz, 1H), 4.86 (d, J = 6.6 Hz, 1H), 3.71 
OMe
O
O
O
HN
O
OMe
(app t, J = 1.8 Hz, 1H), 3.55 (app bs, 1H), 3.45 (dd, J = 12.1, 3.3 Hz, 1H), 3.39 (s, 
3H), 2.91 (app d, J = 2.0 Hz, 1H), 2.04 (s, 3H), 1.24 (s, 3H), 0.94 (s, 3H), 0.88 (t, 
J = 7.4 Hz, 3H); C NMR (75 MHz, CDCl3) δ 169.8, 91.6, 84.0, 83.6, 76.6, 73.0, 60.9, 59.3, 36.7, 
0.0, 10.8; IR (neat) 3299, 2965, 1673, 1546, 1109 cm-1; HRMS (EI) calcd for 
C H NO  (M+H) 288.1811, found 288.1805. 
 
Epimerization Study 
14 26 5
T
diastereomer) in trifluo
toluenesulfonic acid monohydrate.  The reaction mixture was stirred at rt for 4 hours and H2O (5 
mL) was added and the reaction mixture was extracted with EtOAc (2 x 5 mL).  The organic 
87 
 layers were combined, washed with brine (2 x 5 mL), dried with Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude NMR showed a 1.6:1 mixture of diastereomers 
identical to that observed in the reaction.   
 
4-Hydroxy-3,3-dimethylhept-6-en-2-one, 81:  To a solution of 8079 (24.0 g, 
89.6 mmol) in toluene (450 mL) at -15 °C was added 7978 (8.20 g, 72.0 mmol) 
e
mL) was added a
OOH
dropwise and th  reaction mixture was stirred at -15 °C for 24 hours.  10% aqueous HCl (200 
t -15 °C and the reaction mixture was warmed to rt and stirred for 10 minutes.  
The organic layer was collected and the aqueous layer was extracted with toluene (3 X 10 mL).  
The organic layers were combined, washed with 10% aqueous HCl (20 mL) and brine (20 mL), 
dried with Na2SO4, filtered and applied directly to a silica gel flash column packed in pentane.  
The toluene was eluted from the column with pentane and the product was eluted with 20% ether 
in pentane to provide the desired product (10.1 g, 90%, 94% ee)  The enantioselectivity was 
determined by GC with a chiral stationary phase.  The chira CG column emplyed was a 
ChiraldexTM G-TA column (Advanced Separation Technologies, Inc.) using a flow rate 0.5 
mL/min, method: 100 °C for 20 minutes, Tr (min.) (R) 21.361, (S) 23.013):  1H NMR (CDCl3, 
300 MHz): δ 5.94-5.80 (m, 1H), 5.18-5.11 (m, 2H), 3.77 (ddd, J = 10.3, 4.2, 2.4 Hz, 1H), 2.36 
(d, J = 10.3 Hz, H), 2.32-2.23 (m, 1H), 2.19 (s, 3H), 2.09-1.96 (m, 1H), 1.17 (s, 3H), 1.14 (s, 
3H); 13C NMR (CDCl3, 75 MHz) δ 214.5, 135.8, 117.9, 75.3, 51.6, 36.4, 26.3, 21.7, 19.4: IR 
(neat) 3462, 3076, 2977, 1701, 1641, 1469, 1356, 1129, 1070, 915 cm-1; HRMS(EI) m/z calcd for 
C9H17O2 (M + H) 157.122855, found 157.122995; [α]20D +12.0° (c 1.10, CHCl3).  
 
 
88 
 4-Methoxy-3,3-dimethyl-hept-6-en-2-one 82:  To a solution of 81 (6.50 g, 
1.6 mmol) in CH2Cl2 (20 mL) at 0 °C was added 2,6-di-tert-butyl pyridine 
o
(8.88 g, 54.1 mmo
lsilanyloxy-2-hydroxy-6-methoxy-5,5-
imethylnon-8-en-4-one 84: To a solution of 82 (4.00 g, 23.5 mmol) 
8 °C was add
by the dropwise additio
 
4
(11.9 g, 62.4 mm l) followed by the drop wise addition of methyl trifluoromethanesulfonate 
l).  The reaction mixture was stirred for 8 hours at rt, H2O (5 mL) was added 
and the reaction mixture was extracted with CH2Cl2 (3 x 10 mL).  The organic layers were 
combined, washed with NaHCO3 (2 x 10 ml) (caution: vigorous gas evolution), dried with 
Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil was purified by 
flash chromatography (CH2Cl2) to provide the desired product (7.01 g, 99%):  1H NMR (CDCl3, 
300 MHz) δ 5.96-5.82 (m, 1H), 5.15-5.08 (m, 1H), 5.06-5.03 (m, 1H), 3.43 (dd, J = 6.5, 5.5 Hz, 
1H), 3.39 (s, 3H), 2.21-2.15 (m, 2H), 2.17 (s, 3H), 1.16 (s, 3H), 1.09 (s, 3H); 13C NMR (CDCl3, 
75 MHz) δ 212.9, 136.0, 116.4, 86.0, 59.9, 52.4, 36.7, 26.5, 20.9, 20.2; IR (neat) 2977, 2827, 
1704, 1469, 1100 cm-1; [α]25D +11.60° (c 1.00, CHCl3). 
 
1-tert-Butyldimethy
d
in ether (23.5 mL) at -7 ed N,N-diisopropylethylamine (3.96 g, 30.6 mmol) followed 
n of freshly prepared diethylboron trifluoromethanesulfonate (5.38 g, 
24.7 mmol).  The reaction mixture was stirred at -78 °C for 1 hour and tert-
butyldimethylsilyloxyacetaldehyde 83 (4.92, 28.2 mmol) was added dropwise as 1 M solution in 
ether.  The reaction mixture was stirred at -78 °C for 14 hours and methanol (5 mL) was added. 
The reaction mixture was warmed to 0 °C and pH 7 buffer (30 mL) was added followed by 30% 
aqueous hydrogen peroxide (10 mL).  The reaction mixture was stirred at rt for 2 hours and 
extracted with EtOAc (3 x 30 mL).  The organic layers were combined, washed with brine (2 x 
OMe O
OTBS
OH
OMe O
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 10 mL) and saturated aqueous Na2SO3 (2 x 10 mL), dried with Na2SO4, filtered, and 
concentrated under reduced pressure.  The resulting oil was purified by flash chromatography 
(10% EtOAc in hexanes) to provide the desired product as a 3:1 inseparable mixture of 
diastereomers by 1H NMR (6.40 g, 80%): 1H NMR (CDCl3, 300 MHz) δ 5.94-5.75 (m, 1H), 
5.15-5.12 (m, 1H), 5.21-5.00 (m, 1H), 4.13-4.05 (m, 1H), 3.58 (m, 2H), 3.43 (app. t, J = 6.1 Hz, 
1H), 3.37 (s, 0.75H), 3.36 (s, 2.25H), 3.04 (br d, J = 3.5 Hz, 1H), 2.77-2.61 (m, 2H), 2.25-2.15 
(m, 2H), 1.16 (s, 3H), 1.08 (s, 3H), 0.90 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 
215.7, 136.4, 117.0, 86.5, 68.7, 66.6, 60.3, 52.9, 42.1, 36.0, 26.1, 21.5, 20.5, 18.6, -5.1; IR (neat) 
3492, 2929, 2857, 1699, 1471 cm-1; HRMS (ES) m/z calcd. for (M + Na) 367.2281, found 
367.2264; [α]25D -7.50° (c 1.04, CHCl3). 
 
tert-Butyldimethylsilanyloxy-6-methoxy-5,5-dimethyl-non-8-ene-
2,4-diol 85:  To a solution of 84 (6.40 g, 18.6 mmol) in THF (120 mL) 
ethy
stirred at -78 °C for 1 
at -78 °C was added di lboron methoxide (1.86 g, 18.6 mmol) and the reaction mixture was 
hour.  Lithium borohydride (1.20 g, 55.3 mmol) was added and the 
reaction mixture was stirred at -78 °C for 48 hours.  The reaction mixture was poured into ice 
cooled pH 7 buffer (50 mL) and 30% aqueous hydrogen peroxide was added.  The reaction 
mixture was stirred at rt for 12 hours and was extracted with EtOAc (4 x 10 mL).  The organic 
layers were combined, washed with brine (2 x 10 mL) and saturated aqueous Na2SO3 (2 x 10 
mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil 
was purified by flash chromatography (8% EtOAc in hexanes) to provide the desired product as 
a 10:1 separable mixture of diastereomers (6.30 g, 98%):  syn diastereomer, 85: 1NMR (CDCl3, 
500 MHz) δ 5.96-5.88 (m, 1H), 5.14-5.11 (m, 1H), 5.06-5.02 (m, 1H), 3.90-3.80 (m, 1H), 3.81 
OMe OH
OTBS
OH
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 (d, J = 6.5 Hz, 1H), 3.74 (br d, J = 6.3 Hz, 1H), 3.62 (dd, J = 5.9, 3.4 Hz, 1H), 3.54 (d, J = 3.4 
Hz, 1H), 3.50 (dd, J = 5.8, 3.7 Hz, 1H), 3.45 (s, 2.25H), 3.42 (s, 0.75H), 3.22-3.20 (m, 1H), 2.45-
3.32 (m, 1H), 2.31-2.18 (m, 1H), 1.74-1.70 (m, 1H), 1.44-1.36 (m, 1H), 0.95 (s, 2.25H), 0.93 (s, 
0.75H), 0.90 (s, 9H), 0.84 (s, 2.25H), 0.79 (s, 0.75H), 0.08 (s, 6H); 13C NMR (CDCl3, 125 MHz) 
δ 137.1, 136.6, 116.6, 116.2, 89.7, 88.3, 78.3, 77.5, 73.1, 73.0, 67.1, 67.0, 60.2, 59.8, 42.3, 41.4, 
35.3, 35.1, 34.1, 33.7, 25.9, 21.5, 20.5, 18.3, 17.0, -5.3; IR (neat) 3440, 2956, 2928, 1471, 1255, 
1095 cm-1;  HRMS (EI) m/z calcd. for C14H29O4Si (M – C4H9) 289.1835, found 289.1842; [α]25D 
-2.83° (c 0.92, CHCl3). 
anti diastereomer, 86: 1H NMR (CDCl3, 500 MHz) δ 5.99-5.85 (m, 1H), 5.10 (ddd, J = 17.1, 3.1, 
1.5 Hz, 1H), 5.04 (m, 1H), 3.97-3.91 (m, 1H), 3.86 (dd, J = 10.6, 2.2 Hz, 1H), 3.66 (dd, J = 9.9, 
4.2 Hz, 1H), 3.50 (dd, J = 9.9, 7.4 Hz, 1H), 3.43 (s, 3H), 3.21 (dd, J = 7.1, 3.8 Hz, 1H), 2.50-2.42 
(m, 1H), 3.32-2.18 (m, 1H), 1.60 (ddd, J = 13.9, 10.3, 8.0 Hz, 1H), 1.44 (ddd, J = 14.0, 10.3, 3.5 
Hz, 1H), 0.92 (s, 3H), 0.90 (s, 9H), 0.78 (s, 3H), 0.08 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 
137.4, 116.5, 89.9, 74.8, 69.8, 67.5, 60.0, 42.3, 35.7, 34.1, 26.1, 21.4, 18.5, 16.5, -5.0, -5.1. 
 
OMe OH
OTBS
OH pTsOH
Dimethoxypropane
OMe O
OTBS
O
 
 
Representative procedure for acetonide formation: To a solution of 85 (50 mg, 0.14 mmol) in 
2,2-dimethoxypropane (2 mL) was added catalytic amounts para-toluenesulfonic acid and the 
reaction mixture was stirred at rt for 8 hours.  Triethylamine (0.1 mL) was added, H2O (5 mL) 
and the reaction mixture was extracted with EtOAc (3 x 5 mL).  The organic layers were 
combined, washed with brine (2 x 5 mL), dried with Na2SO4, filtered, concentrated and purified 
by flash chromatography (10% EtOAc in hexanes) to provide the desired product with yields 
91 
 consistently greater than 90%.  The resulting acetonides are described below are described 
below. 
 
tert-Butyl-6,2-methoxy-1,1-dimethylpent-4-enyl-2,2-dimethyl-1,3-
ioxan-4-ylmethoxydimethylsilane 87:  1 H NMR (CDCl3, 500 MHz) 
2-5
= 11.9 Hz, 0.75H), 3.92
tyl-6,2-methoxy-1,1-dimethyl-pent-4-enyl-2,2-dimethyl-1,3-
ioxan-4-ylmethoxydimethylsilane 88:  1H NMR (CDCl3, 500 MHz) 
9
3.71 (dd, J = 9.8, 6.3 Hz, 
 
d
δ 5.99-5.90 (m, 1H), 5.1 .07 (dd, J = 16.9, 10.7 Hz, 1H), 5.02 (d, J = 10.0 Hz, 1H), 3.96 (bd, J 
-3.76 (m, 1H), 3.73 (bd, J = 11.6 Hz, 0.25H), 3.70-3.65 (m, 1H), 3.51-
3.47 (m, 1H), 3.40 (s, 2.25H), 3.39 (s, 0.75H), 3.28 (dd, J = 8.3, 2.7 Hz, 0.75H), 3.13-3.10 (m, 
0.25H), 2.4-2.28 (m, 1H), 2.23-2.11 (m, 1H), 1.50-1.45 (m, 1H), 1.46 (s, 2.25H), 1.41 (s, 0.75H), 
1.37 (s, 3H), 1.27-1.19 (m, 1H), 0.94 (s, 0.75H), 0.90 (s, 11.25H), 0.79 (s, 2.25H), 0.77 (s, 
0.75H), 0.07 (s, 3H), 0.07 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 137.6, 115.8, 98.3, 85.8, 83.9, 
72.7, 71.0, 70.3, 70.2, 67.2, 67.1, 60.4, 60.2, 41.7, 35.5, 35.3, 30.1, 28.2, 27.7, 25.9, 19.9, 18.9, 
18.8, 18.3, 18.2, 17.3, -5.2, -5.3. 
 
tert-Bu
OMe O
OTBS
O
OMe O
OTBS
O
d
δ 5.98-5.90 (m, 1H), 5.0  (d, J = 17.0 Hz, 1H), 5.01 (d, J = 10.0 Hz, 1H), 3.83-3.78 (m, 1H), 
1H), 3.63 (dd, J = 10.7, 6.3 Hz, 1H), 3.56 (dd, J = 10.7, 4.7 Hz, 1H), 
3.39 (s, 3H), 3.09 (dd, J = 8.6, 2.3 Hz, 1H), 2.36 (dd, J = 14.1, 5.7 Hz, 1H), 2.19-2.13 (m, 1H), 
1.80-1.74 (m, 1H), 1.45-1.39 (m, 1H), 1.32 (s, 3H), 1.32 (s, 3H), 0.94 (s, 3H), 0.90 (s, 9H), 0.77 
(s, 3H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 137.5, 115.9, 100.1, 85.8, 
70.1, 68.3, 66.3, 60.4, 41.5, 35.4, 29.4, 25.9, 24.9, 24.5, 18.7, 18.5, 18.3, -5.1, -5.3. 
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 6,3-tert-Butyldimethylsilanyloxy-2-hydroxypropyl-4-methoxy-5,5-
dimethyltetrahydropyran-2-ol 89:  Ozone was gently bub
O
bled through 
a solution of 85 (7.00 g, 20.2 mmol) in CH2Cl2 (100 mL) at -78 °C until the reaction mixture 
lor
mixture was warmed to 
 92:  To a solution of 89 (3.72 g, 10.7 
mmol) in CH2Cl2 (67 mL) at -78 °C was added diisopropylethylamine 
ol) followed
reaction mixture was
hour.  The reaction m
HO
OMe
OH
sustained a deep blue co .  Triphenylphosphine (6.86 g, 26.3 mmol) was added and the reaction 
rt and stirred for 3 hours.  The resulting solution was concentrated and 
purified by flash chromatography (40% EtOAc in hexanes) via a short column to separate excess 
triphenylphosphine and triphenylphosphine oxide from the product (6.40g, 91%).  The product 
was used in the next step with minor of impurities.  A lengthy chromatographic separation 
resulted in decreased yields. 
 
1-tert-Butyl-dimethyl-silanyloxy-3,4-methoxy-3,3-dimethyl-3,4-
dihydro-2H-pyran-2-ylpropan-2-ol
OTBS
O
OMe
OH
OTBS
(8.28 g, 64.0 mm  by trifluoroacetic anhydride (4.71 g, 22.4 mmol).  The resulting 
 stirred at -78 °C for 10 minutes, warmed to 0 °C and stirred at 0 °C for 1 
ixture was then heated to gentle reflux for 12 hours.  The reaction mixture 
was cooled to rt, methanol (20 mL) was added and the reaction mixture was heated to gentle 
reflux for 8 hours.  The reaction mixture was cooled to rt, diluted with brine (50 mL) and 
extracted with CH2Cl2 (3 x 20 mL).  The organic layers were combined, washed with brine (30 
mL), dried with Na2SO4, filtered, concentrated under reduced pressure and purified by flash 
chromatography (5 % EtOAc in hexanes ) to provide the desired product (3.50 g, 99%). 1H NMR 
(CDCl3, 300 MHz) δ 6.40 (d, J = 6.0 Hz, 0.25H), 6.32 (dd, J = 6.2, 1.4 Hz, 0.75H), 4.99 (dd, J = 
6.0, 5.2 Hz, 0.25H), 4.82 (dd, J = 6.2, 1.9 Hz, 0.75H), 3.91-3.81 (m, 1.25H), 3.73 (dd, J = 10.7, 
93 
 2.4 Hz, 0.75H), 3.61-3.50 (m, 2.25H), 3.45 (app t, 0.75H), 3.37 (s, 2.25H), 3.33 (s, 0.75H), 2.97 
(d, J = 5.2 Hz, 0.15H), 2.95 (d, J = 2.6, 0.10H), 2.89 (d, J = 2.8, 0.75H), 1.90-1.83 (m, 1H), 1.80-
1.65 (m, 1H), 0.96 (s, 3H), 0.89 (s, 9H), 0.86 (s, 2.25H), 0.82 (s, 0.75H), 0.07 (s, 6H); 13C NMR 
(CDCl3, 300 MHz) δ 144.9, 143.5, 100.8, 99.4, 82.2, 80.4, 78.1, 77.9, 71.3, 71.3, 66.3, 57.2, 
56.3, 36.3, 35.5, 31.9, 31.5, 29.7, 25.8, 23.4, 21.5, 18.9, 18.2, 13.7, -5.4; IR (neat) 3571, 2956, 
1649, 1100 cm-1; HRMS (ES) m/z calcd. for C17H34O4NaSi (M + Na) 353.2124, found 353.2149; 
[α]25D -66.9° (c 1.00, CHCl3). 
 
tert-Butyl-2-methoxy-3,4-methoxy-3,3-dimethyl-3,4-dihydro-2H-pyran-
2-ylpropo
O
xydimethylsilane 93:  To a solution of 92 (1.80g, 5.45 mmol) in 
CH2Cl2 (10.9 mL) at 0 °C was added 2,6-di-tert-butylpyridine (2.09 g, 10.9 mmol) followed by 
a
and stirred for 14 ho
OMe
OT SB
OMe
methyltrifluorometh nesulfonate (1.34 g, 8.18 mmol).  The reaction mixture was warmed to rt 
urs.  H2O (10 mL) was added and the reaction mixture was extracted with 
CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with saturated aqueous 
NaHCO3 (2 x 10 mL) and brine (10 mL), dried with Na2SO4, filtered, concentrated under 
reduced pressure and purified by flash chromatography (3 % EtOAc in hexanes) to provide the 
desired product (1.20 g, 85%) and the degradation product (0.35 g, 81%).  1H NMR (CDCl3, 300 
HMz) δ 6.32 (dd, J = Hz, 1H), 4.80 (dd, J = 6.2, 1.8 Hz, 1H), 3.74-3.63 (m, 3H), 3.45-3.43 (m, 
1H), 3.42-3.36 (m, 1H), 3.39 (s, 3H), 3.37 (s, 3H), 1.85-1.79 (m, 2H), 0.95 (s, 3H), 0.90 (s, 9H), 
0.88 (s, 3H), 0.07 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 144.4, 100.6, 81.0, 80.1, 79.8, 77.3, 
64.2, 57.6, 35.7, 29.8, 26.2, 23.9, 18.6, 14.0, -5.0; IR (neat) 2929, 2650, 1463, 1250, 1102 cm-1; 
HRMS (EI) m/z calcd. for C17H33O3Si (M – OMe) 313.2199, found 313.2195; [α]25D  -u27.46° (c 
0.63, CHCl3). 
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tert-Butyl-2-methoxy-3,6-methoxy-3,3-dimethyl-3,6-dihydro-2H-
O pyran-2-ylpropoxydimethylsilane 94:  1H NMR (CDCl3, 300 MHz) 
δ 5.72 (dd, J = 10.0, 1.0 Hz, 1H), 5.57 (dd, J= 10.0, 2.8 Hz, 1H), 4.79 
dd
10.7, 1.4 Hz, 1H), 3.5-3.8 
1H), 1.62 (ddd, J =  14.0, 
 of 0.10 M 
trivinylalane:2 To a suspension of AlCl3 (4.44 g, 33.3 mmol) in CH2Cl2 (233 mL) at rt was added 
e (
was cooled with an ic
concentrated, the resulting oil was dissolved in CH2Cl2 (30 
MeO
(d, J = 2.8 Hz, 1H), 3.77 ( , J = 11.1, 3.2 Hz, 1H),3.69 (dd, J = 11.1, 4.7 Hz, 1H), 3.61 (dd, J = 
(m, 1H), 3.42 (s, 3H), 3.41 (s, 3H), 1.80 (ddd, J = 14.0, 9.1, 1.7 Hz, 
10.9, 4.1 Hz, 1H), 0.91 (s, 3H), 0.88 (s, 12H), 0.06 (s, 3H), 0.05 (s, 
3H); 13C NMR (CDCl3, 75 MHz) δ 141.4, 122.3, 95.7, 79.9, 72.3, 63.5, 57.2, 55.5, 34.3, 30.5, 
25.9, 24.9, 20.1, 18.3, -5.4; IR (neat) 2956, 2857, 1470, 1253, 1107 cm-1; HRMS (ES) m/z calcd. 
for C18H36O4NaSi (M + Na) 367.2281, found 367.2298; [α]25D -6.41° (c 1.06, CHCl3). 
 
6-(3-tert-Butyl-dimethyl-silanyloxy-2-methoxypropyl)-4-methoxy-
5,5-dimethyl-2-vinyltetrahydropyran-3-ol 96:  Preparation
OTBS
OMe
O
HO
OMe
OMe
OTBS
vinylmagnesium bromid 1 M in THF, 100 mL) over a period of 1 hour.  The reaction mixture 
e bath when necessary throughout the addition to prevent reflux.  
Following the addition the reaction mixture was stirred at rt for 4 hours at which point 
trivinylalane formation is complete. 
Synthesis of 96:  To a solution of 93 (1.21 g, 3.48 mmol) in CH2Cl2 (10 mL) at 0 °C was added 
dimethyldioxirane3 (0.2 M, 26 mL, 5.22) and the reaction mixture was stirred at 0 °C for 45 
minutes.  The reaction mixture was 
mL) and added drop wise to a solution of trivinylalane (0.10 M, 104 mL, 10.4 mmol) at -72 °C.  
The resulting reaction mixture was stirred at -72 °C for 1 hour, warmed to rt and stirred for 8 
95 
 hours.  The reaction mixture was carefully quenched with the addition of H2O (20 mL).  
Saturated aqueous sodium potassium tartrate (100 mL) was added and the reaction mixture was 
stirred at rt for 8 hours.  The reaction mixture was extracted with CH2Cl2 (3 x 20 mL).  The 
organic layers were combined, washed with brine (2 x 10 mL), dried with Na2SO4, filtered, 
concentrated under reduced pressure and purified by flash chromatography (20% EtOAc in 
hexanes) to provide the desired product (1.15 g, 85%):  1H NMR (CDCl3, 300 MHz) δ 6.17 (ddd, 
J =  17.2, 10.7, 6.2 Hz, 1H), 5.44 (ddd, J = 14.3, 1.7, 1.7 Hz, 1H), 5.42 (ddd, J = 7.5, 1.7, 1.7 Hz, 
1H), 4.51-4.45 (m, 1H), 3.87 (ddd, J = 10.2, 6.6, 4.0 Hz, 1H), 3.68-3.59 (m, 1H), 3.63 (dd, J = 
6.4, 3.7 Hz, 1H), 3.58 (s, 3H), 3.43 (dd, J = 10.1, 1.5 Hz, 1H), 3.36 (s, 3H), 3.36-3.31 (m, 1H), 
2.81 (d, J = 10.0 Hz, 1H), 2.37 (d, J = 4.1 Hz, 1H), 1.72 (ddd, J = 14.1, 8.4, 1.8 Hz, 1H), 1.52 
(ddd, J = 14.1, 10.2, 4.0 Hz, 1H), 0.91 (s, 3H), 0.88 (s, 9H), 0.87 (s, 3H), 0.05 (s, 6H); 13C NMR 
(CDCl3, 75 MHz) δ 132.4, 120.2, 87.6, 79.8, 76.1, 74.1, 69.7, 64.0, 62.5, 57.2, 41.5, 30.3, 25.9, 
23.5, 18.3, 13.8, -5.4; IR (neat) 3448, 2930, 1471, 1109 cm-1; HRMS (ES) m/z calcd. for 
C20H40O5Si (M + Na) 411.2543, found 411.2574; [α]25D +84.33° (c 1.02, CHCl3). 
 
3,5-(4-Benzyloxybutoxymethoxy)-4-methoxy-6-
vinyltetrahydropyran-2-yl-2-methoxypropoxy-tert-
butyldimethylsilane (97):  To a solution of 96 (2.42 g, 6.23 mmol) in CH2Cl2 (4 mL) at rt was 
).  Benzylo
added and the reaction mixture was warm
O
OMe
OTBS
OMe
OO
BnO
added diisopropylethylamine (4 mL xybutoxymethyl chloride (1.71 g, 7.47 mmol) was 
ed to 40 °C and stirred for 8 hours.  The reaction 
mixture was cooled to rt, H2O (5 mL) was added and the reaction mixture was extracted with 
CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with 10% HCl (10 mL) and 
brine (2 x 10 mL), dried with Na2SO4, filtered and concentrated.  The resulting oil was purified 
96 
 by flash chromatography (10 % EtOAc in hexanes) to provide the desired product (3.2 g, 89 %): 
1H NMR (CDCl3, 300 MHz) δ 7.61-7.27 (m, 5H), 6.19 (ddd, J = 17.0, 10.8, 5.8 Hz, 1H), 5.47-
5.38 (m, 2H), 4.79 (d, J = 6.7 Hz, 1H), 4.71 (d, J = 6.7 Hz, 1H), 4.62-4.45 (m, 1H) 4.51 (s, 3H), 
3.81 (dd, J = 10.0, 6.5 Hz, 1H), 3.66-3.57 (m, 3H), 3.52 (s, 3H), 3.52-3.43 (m, 2H), 3.41-3.31 
(m, 2H), 3.38 (s, 3H), 2.86 (d, J = 10.1 Hz, 1H), 1.75-1.66 (m, 5H), 1.57-1.52 (m, 1H), 0.90 (s, 
12H), 0.85 (s, 3H), 0.06 (s, 6H);  13C NMR (CDCl3, 75 MHz) δ 138.9, 133.9, 128.6, 127.9, 
127.8, 119.9, 96.1, 86.1, 77.5, 76.7, 75.6, 74.1, 73.2, 70.4, 68.2, 64.5, 62.3, 57.5, 42.0, 30.7, 26.8, 
26.7, 26.2, 23.4, 18.6, 14.0, -5.0; IR (neat) 2930, 1471, 1361, 1112 cm-1; HRMS (ES) m/z calcd. 
for C32H56O7NaSi (M + Na) 603.3693, found 603.3718; [α]25D +31.40° (c 1.07, CHCl3). 
 
2-Methylpropane-2-sulfinic acid 3-
benzyloxybutoxymethoxy-6,3-tert-
utyldimethylsilanyloxy-2-methoxypropyl-4-methoxy-5,5-
e
97 (0.20 g, 0.34 mmol) in CH2Cl2 (10 mL) at -78 °C unti
color.  Triphenylphosphine (0.18 g,
O
b
dimethyltetrahydropyran-2-ylm thyleneamide 98:  Ozone was bubbled through a solution of 
l the solution sustained a deep blue 
 0.69 mmol) was added and the reaction mixture was warmed 
to rt and stirred for 3 hours.  The reaction mixture was concentrated under vacuum and the 
resulting oil was dissolved in THF (4.5 mL) and Ti(OiPr)4 (0.49 g, 1.72 mmol) was added at rt 
followed by (R)-tert-butanesulfinamide5 (0.06 g, 0.52 mmol).  The reaction mixture was stirred 
for 8 hours, poured into an equal volume of brine and the resulting mixture was filtered through a 
plug of celite.  The celite was washed thoroughly with EtOAc and the eluent was combined.  The 
eluent was washed with brine (10 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The resulting oil was purified by flash chromatography (20% EtOAc in 
OMe
O
N
S
O
O
BnO
OTBS
OMe
H
97 
 hexanes) to provide the desired product (0.13 g, 62%).  1H NMR (CDCl3, 300 MHz) δ 8.38 (d, J 
= 2.6 Hz, 1H), 7.37-7.26 (m, 5H), 4.84 (d, J = 6.8 Hz, 1H), 4.78-4.74 (m, 1H), 4.77 (d, J = 6.8 
Hz, 1H), 4.50 (s, 2H), 4.01 (dd, J = 10.2, 7.1 Hz, 1H), 3.69-3.63 (m, 3H), 3.53-3.42 (m, 5H), 
3.51 (s, 3H), 3.35 (s, 3H), 2.78 (d, J = 10.3 Hz, 1H), 1.84-1.76 (m, 1H), 1.67-1.66 (m, 4H), 1.55-
1.52 (m, 1H), 1.22 (s, 9H), 0.89 (s, 15H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (CDCl3, 300 
MHz) δ 166.6, 138.4, 128.1, 127.4, 127.3, 96.0, 86.2, 79.2, 76.4, 76.1, 75.9, 72.6, 69.8, 68.0, 
63.0, 61.9, 56.9, 56.7, 41.5, 29.9, 26.3, 26.3, 25.8, 22.8, 18.1, 13.4, -5.5; IR (neat) 2929, 1619, 
1471, 1362, 1091 cm-1; HRMS (ES) m/z calcd for C35H63NO8NaSiS 708.3941, found 708.3926; 
[α]25D +0.36° (c 1.10, CH3Cl). 
98 
 2.5  References 
 
1. Perry, N. B.; Blunt, J. W.; Munro, M. G. H.; Pannell, L. K. “Mycalamide A, an Antiviral 
Compound from a New Zealand Sponge of the Genus Mycale” J. Am. Chem. Soc. 1988, 
110, 4850-4851. 
2. Perry, N. B.; Blunt, J. W.; Munro, M. G. H.; Pannell, L. K.; Thompson, A. M. “Antiviral 
and Antitumor Agents from a New Zealand Sponge, Mycale sp.  2. Structures and 
Solution Conformations of Mycalamides A and B” J. Org. Chem. 1990, 55, 223-227. 
3. Simpson, S.; Garson, M. J.; Blunt J. W.; Munro, M. H. G.; Hooper, J. N. A. 
“Mycalamides C and D, Cytotoxic Compounds from the Marine Sponge Stylinos n. 
Species” J. Nat. Prod. 2000, 63, 704-706. 
4. West, L. M.; Northcote, P. T.; Hood, K. A.; Miller, J. H.; Page. M. J. “Mycalamide D, a 
New Cytotoxic Amide from the New Zealand Marine Sponge Mycale Species” J. Nat. 
Prod. 2000, 707-709. 
5. Sakemi, S.; Ichiba, T.; Kohmoto, S.; Saucy G.; Higa, T. “Isolation and Structural 
Elucidation of Onnamide A, a New Bioactive Metabolite of a Marine Sponge, Theonella 
sp” J. Am. Chem. Soc. 1988, 110, 4851-4852. 
6. Matsunaga, S.; Fusetani, N.; Nakao, Y. “Eight New Cytotoxic Metabolites Related to 
Onnamide A from Two Marine Sponges of the Genus Theonella” Tetrahedron 1992, 48, 
8369-8376. 
7. Kobayashi, J.; Itagaki, H.; Shigemori, T.; Sasaki, J. “3 New Onnamide Congeners from 
the Okinawan Marine Sponge Theonella sp.” J. Nat. Prod. 1993, 56, 976. 
99 
 8. Vuong, D.; Capon, R. J.; Lacey, E.; Gill, J. H.; Heiland, K.; Friedel, T. “Onnamide F: A 
New Nematocide from a Southern Australian Marine Sponge, Trachycladus 
laevispirulifer” J. Nat. Prod. 2001, 64, 640-642. 
9. Fusetani, N.; Sugawara, T.; Matsunaga, S. “Theopederins A-E, Potent Antitumor 
Metabolites from a Marine Sponge Theonella sp.” J. Org. Chem. 1992, 57, 3828-3832. 
10. Tsukamoto, S.; Matsunaga, S.; Fusetani, N.; Toh-e, A. “Theopederins F-J: Five New 
Antifungal and Cytotoxic Metabolites from the Marine Sponge, Theonella swinhoei” 
Tetrahedron, 1999, 55, 13697-13702. 
11. Paul, G. K.; Dunasekera, S. P.; Longley, R. E.; Pomponi, S. A. “Theopederins K and L 
Highly Potent Cytotoxic Metabolites from a Marine Sponge Discodermia Species” J. 
Nat. Prod. 2002, 65, 59-61. 
12. Petit, G. R.; Xu, J-P.; Chapuis, J-C.; Petit, R. K.; Tackett, L. P.; Doubek, D. L. Hooper, J. 
N. A.; Schmidt, J. M. “Antineoplastic Agents. 520. Isolation and Structure of 
Irciniastatins A and B from the Indo-Pacific Marine Sponge Ircinia ramose” J. Med. 
Chem. 2004, 47, 1149-1152. 
13. Cichewicz, R. H.; Valeriote, F. A.; Crews, P. “Psymberin, a Potent Sponge-Derived 
Cytotoxin from Psammocinia Distantly Related to the Pederin Family” Org. Lett. 2004, 
6, 1951-1954. 
14. Cardani, C.; Ghiringhelli, D.; Mondelli, R.; Quilico. A. “The Structure of Pederin” 
Tetrahedron Lett. 1965, 6, 2537–2545. 
15. Mitsutoshi, Y.; Matsuda, F.; Hadegewa, K.; Matsumoto, T. “Total Synthesis of (+)-
Pedamide” Tetrahedron Lett. 1982, 23, 4039-4042. 
100 
 16. Matsuda, F.; Yanagiya, M.; Matsumoto, T. “Total Synthesis of (+)-Pederine.  A Simple 
Synthetic Method for N-(1-Methoxylalkyl) Amides” Tetrahedron Lett. 1982, 23, 4043-
4046. 
17. Matsuda, F.; Tomiyoshi, N.; Yanagiya, M.; Matsumoto, T. “A New Stereocontrolled 
Synthesis of (+)-Pederine. Unusual Conformation Around C-10-C-11 Bond in Pederine 
Derivatives” Tetrahedron Lett. 1983, 24, 1277-1280. 
18. Matsuda, F.; Nobuya, T.; Mitsutoshi, N.; Matsumoto, T. “Stereocontrolled Total 
Synthesis of (+)-Pederine” Tetrahedron Lett. 1988, 44, 7063-7080. 
19. Mienwald, J. “An Approach to the Synthesis of Pederin” Pure Appl. Chem. 1977, 49, 
1275-1290. 
20. Meinwald, J.; Adams, M.; Duggan, A. J. “An Adventurous Synthesis of Pederinolactone” 
Heterocycles 1977, 7, 989-995. 
21. Adams, M. A.; Duggan, A. J.; Smolanoff, J.; Meinwald, J. “Total Synthesis of (±)-
Pederamide” J. Am. Chem. Soc. 1979, 101, 5364-5370. 
22. Wratten, S. J.; Meinwald, J. “An Investigation of the Mechanism of the Pederenal 
Transformation” Tetrahedron Lett. 1980, 21, 3164-3166. 
23. Hong, C. Y.; Kishi, Y. “Total Synthesis of Mycalamides A and B” J. Org. Chem. 1990, 
55, 4242-4245. 
24. Hong, C. Y.; Kishi, Y. “Total Synthesis of Onnamide A” J. Am. Chem. Soc. 1991, 113, 
9693-9694. 
25. Isaac, K.; Kocienski, P.; Cambell, S. “Synthetic Approaches to Pederin.  A Synthesis of 
Ethyl Pederate” J. Chem. Soc., Chem. Commun. 1983, 249-250. 
101 
 26. Kocienski, P.; Wilson, T. M. “Synthetic Approaches to Pederin. A Synthesis of (±)-
Benzoylpedamide” J. Chem. Soc., Chem. Commun. 1984, 1011-1012. 
27. Wilson, T.; Kocienski, P.; Faller, A.; Campbell, S. “The Total Synthesis of (±)-Pederin” 
J. Chem. Soc., Chem. Commun. 1987, 106-108. 
28. Jorowicki, K.; Kocienski, P.; Marczak, S.; Willson, T. “A Synthesis of (+)-Pederin. The 
Metallated Dihydropyran Approach” Tetrahedron Lett. 1990, 31, 3433-3436. 
29. Wilson, T. M.; Kocienski, P.; Jarowicki, K.; Isaac, K.; Faller, A.; Cambell, S. F.; 
Bordner, J. “Studies Related to the Synthesis of (±)-Pederin.  Part 1. Synthesis of Ethyl 
Pederate and Benzoylselenopederic Acid” Tetrahedron, 1990, 46, 1757-1766. 
30. Wilson, T. M.; Kocienski, P.; Jarowski, K.; Isaac, K.; Hitchcock, P. M.; Faller, A.; 
Cambell, S. F. “Studies Related to the Synthesis of Pederin. Part 2. Synthesis of Pederol 
Dibenzoate and Benzoylpedamide.” Tetrahedron 1990, 46, 1767-1782. 
31. Kocienski, P.; Jarowicki, K.; Marczak, S. “Pederin: The Metallated Dihydropyran 
Approach.  Stereoselective Reduction of N-Acylimidates via Rhodium-Catalyzed 
Hydroboration” Synthesis, 1991, 1191-1200. 
32. Jarowicki, K.; Kocienski, P.; Marczak, S.; Willson, T.  “A Synthesis of (+)-Pederin, the 
Metalated Dihydropyran Approach.” Tetrahedron Letters  1990,  31,  3433-3436 
33. Willson, T. M.; Kocienski, P.; Jarowicki, K.; Isaac, K.; Hitchcock, P. M.; Faller, A.; 
Campbell, S. F.  “Studies Related to the Synthesis of Pederin.  Part 2.  Synthesis of 
Pederol Dibenzoate and Benzoylpedamide.” Tetrahedron 1990, 46, 1767-1782. 
34. Willson, T. M.; Kocienski, P.; Jarowicki, K.; Isaac, K.; Faller, A.; Campbell, S. F.; 
Bordner, J. “Studies Related to the Synthesis of (+)-Pederin.  Part 1.  Synthesis of Ethyl 
Pederate and Benzoylselenopederic Acid.” Tetrahedron 1990, 46, 1757-1766. 
102 
 35. Kocienski, P.; Raubo, P.; Davis, J. K.; Boyle, F. T.; Davies, D. E.; Richter, A. “A 
Synthesis of 18-O-Methyl Mycalamide B” J. Chem. Soc., Perkin Trans. 1  1996, 1797-
1808. 
36. Kocienski, P.; Narquizian, R.; Raubo, P.; Smith, C.; Boyle, F. T. “A Synthesis of 
Mycalamide B” Synlett. 1998, 869-872.  
37. Kocienski, P.; Narquizian, R.; Raubo, P.; Smith, C.; Boyle, F. T. “A Synthesis of 
Theopederin D and a Formal Synthesis of Pederin” Synlett. 1998, 1432-1434. 
38. Kocienski, P.; Narquizian, R.; Raubo, P.; Smith, C.; Farrugia L. J.; Muir, K.; Boyle F. T. 
“Synthetic Studies on the Pederin Family of Antitumor Agents. Syntheses of Mycalamide 
B, Theopederin D, and Pederin” J. Chem. Soc., Perkin Trans. 1 2000, 2357-2384. 
39. Roush, W. R.; Marron, T. G. “Toward the Synthesis of Mycalamides A, B and Onnamide 
A: A Highly Stereoselective Synthesis of the Trioxadecalin Ring System” Tetrahedron 
Lett. 1993, 34, 5421-5424. 
40. Marron, T. G.; Roush, W. R. “Diastereoselective Synthesis of N-Benzoyl Mycalamide, 
the Fully Elaborated Trioxadecalin Nucleus of Mycalamide A.  Control of the Key N-
Acyl Aminal Stereocenter via Carbamate Acylation” Tetrahedron Lett. 1995, 36, 1581-
1584. 
41. Roush, W. R.; Pfeifer, L. A. “Stereoselective N-Acylation Reactions of α-Alkoxy 
Carbamates” J. Org. Chem. 1998, 63, 2062-2063. 
42. Roush, W. R.; Pfeifer, L. A. “Total Synthesis of Mycalamide A and 7-epi-Mycalamide 
A” Org. Lett. 2000, 2, 859-862. 
103 
 43. Nakata, T.; Nagao, S.; Mori, N.; Oishi, T. “Total Synthesis of (+)-Pederin. 1. 
Stereocontrolled Synthesis of (+)-Benzoylpedamide” Tetrahedron Lett. 1985, 26, 6461-
6464. 
44. Nakata, T.; Fukui, H.; Nakagawa, T.; Matsukura, H. “Total Synthesis of Mycalamide A. 
Further Synthetic Study of the Right Half” Heterocycles, 1996, 42, 159-164. 
45. Trotter, N. S.; Takahashi, S.; Nakata, T. “Simple and Efficient Synthesis of (+)-Methyl 7-
Benzoylpederate, a Key Intermediate Toward the Mycalamides” Org. Lett. 1999, 1, 957-
959. 
46. Takahiro, T.; Nishi, Y.; Takahashi S.; Kobayashi, J.; Nakata, T. “Total synthesis of 
Pederin, a Potent Insect Toxin: the Efficient Synthesis of the Right Half, (+)-
Benzoylpedamide” Tetrahedron 2002, 58, 6359-6365. 
47. Toyota, M.; Hirota, M.; Hirano, H.; Ihara, M. “A Stereoselective Synthesis of the C-10 to 
C-18 (Right Half) Fragment of Mycalamides Employing Lewis Acid Promoted 
Intermolecular Aldol Reaction” Org. Lett. 2000, 2, 2031-2034. 
48. Toyota, M.; Hirota, M.; Nishikawa, Y.; Fukumoto, K.; Ihara, M. “Palladium-Catalyzed 
Intramolecular Allylic Alkylation Reaction in Marine Natural Product Synthesis:  
Enantioselective Synthesis of (+)-Methyl Pederate, a Key Intermediate in Synthesis of 
Mycalamides.” J. Org. Chem. 1998, 63, 5895-5902. 
49. Hoffman, R. W.; Schlapbach, A. “Synthesis of the Trioxadecalin-Part of Mycalamide B” 
Tetrahedron Lett. 1993, 34¸7903-7906. 
50. Trost, B. M.: Yang, H.; Probst, G. D. “A Formal Synthesis of (–)-Mycalamide A” J. Am. 
Chem. Soc. 2004, 126, 48-49. 
104 
 51. Sohn, J-H.; Waizumi, N.; Zhong, M.; Rawal, V. H. “Total Synthesis of Mycalamide A” 
J. Am. Chem. Soc. 2005, 127, 7290-7291. 
52. Jiang, X; Garcia-Fortanet, J.; De Brabander J. K. “Synthesis and Complete 
Stereochemical Assignment of Psymberin/Irciniastatin A” J. Am. Chem. Soc. 2005, 127, 
11254-11255. 
53. Piel, J.; Burtzke, D.; Fusetani, N.; Hui, D.; Platzer, M.; Wen, G.; Matsunaga, S.  
“Exploring the Chemistry of Uncultivated Bacterial Symbionts: Antitumor Polyketides of 
the Pederin Family” J. Nat. Prod. 2005, 68, 472-479. 
54. Burres, N. S. and Clement, J. J. “Antitumor Activity and Mechanism of Action of the 
Novel Marine Natural Products Mycalamides A and B and Onnamide” Cancer Res. 1989, 
49, 2935-2940. 
55. Galvin, F.; Freeman, G. J.; Razi-Wolf, Z.; Benacerraf, B.; Naler, L.; Reiser, H.; “Effects 
of Cyclosporine, F506, and Mycalamide A on the Activation of Murine CD4+ T Cells by 
the Murine B7 Antigen” Eur. J. Immunol. 1993, 23, 283. 
56. Ogawara, H.; Higashi, K.; Uchino, K.; Perry, N. B. “Change of ras-Transformed NRK-
Cells Back to Normal Morphology by Mycalamides A and B, Antitumor Agents from a 
Marine Sponge” Chem. Pharm. Bull. 1991, 39, 2152-2154. 
57. Han, Z.; Wei, W.; Dunaway, S.; Darnowski, J. W.; Calabresi, P.; Sedivy, J.; 
Hendrickson, E. A.; Balan, K. V.; Pantazis, P.; Wyche, J. “Role of p21 in Apoptosis and 
Senescence of Human Colon Cancer Cells Treated with Camptothecin” J. Biol. Chem. 
2002, 277, 17154-17160. 
105 
 58. Nishimura, S.; Matsunaga, S.; Yoshida, M.; Hirota, H.; Yokoyama, S.; Fusetani, N. “13-
Deoxytedanolide, a Marine Sponge-Derived Antitimor Macrolide, Binds to the 60S 
Ribosomal Subunit” Bioorganic and Medicinal Chem. 2005, 13, 449-454. 
59. Thompson, A. M.; Blunt, J. W.; Munro M. H. G.; Perry, N. B.; Pannell, L. K.; 
“Chemistry of the Mycalamides, Antiviral and Antitumor Compounds from a Marine 
Sponge. Part 3. Acyl, Alkyl and Silyl Derivatives” J. Chem. Soc., Perkin Trans. 1 1992, 
1335-1342. 
60. Thompson, A. M.; Blunt, J. W.; Murray, H. G.; Munro, H. G.; Clark, B. M. “Chemistry 
of the Mycalamides. Part 4. Reactions of Mycalamide A and Alkyl Derivatives with 
Basic Nucleophiles” J. Chem. Soc., Perkin Trans. 1 1994, 1025-1031. 
61. Thompson, A. M.; Blunt, J. W.; Munro M. H. G.; Perry, N. B. “Chemistry of the 
Mycalamides, Antiviral and Antitumor Compounds from a Marine Sponge. Part 5. Acid-
Catalyzed Hydrolysis and Acetal Exchange, Double Bond Additions and Oxidation 
Reactions” J. Chem. Soc., Perkin Trans. 1 1995, 1233-1241. 
62. Abell, A. D.; Blunt, J. W.; Founds, G. J.; Munro, M. H. G. “Chemistry of the 
Mycalamides, Antiviral and Antitumor Compounds from a Marine Sponge. Part 6.  The 
Synthesis and Testing of Analogues of the C(7)-C(10) Fragment” J. Chem. Soc., Perkin 
Trans. 1 1997, 1647-1654. 
63. Dinkerton, L. V.; Adair, N. K.; Euske, J. M.; Brady, K. T.; Robinson, P. D. 
“Regioselective Synthesis of Substituted 1-Thiohex-2-enopyransoides” J. Org. Chem.  
1988, 53, 845-850. 
106 
 64. Halcomb, R. L.; Danishefsky, S. J. “On the Direct Epoxidation of Glycals:  Application 
of a Reiterative Strategy for the Synthesis of β-Linked Oligosaccharides” J. Am. Chem. 
Soc. 1989, 111, 6661-6666. 
65. Adam, W.; Bialas, J.; Hadjiarapoglou, L. “A Convenient Preparation of Acetone 
Solutions of Dimethyldioxirane” Chem. Ber. 1991, 124, 2377. 
66. Gilbert, M.; Ferrer, G.; Sanchez-Baeza, F.; Messeguer, A. “Easy Availability Of More 
Concentrated and Versatile Dimethyldioxirane Solutions” Tetrahedron Lett. 1996, 37, 
3585-3586. 
67. Gilbert, M.; Ferrer, G.; Sanchez-Baeza, F.; Messeguer, A. “Availability and Reactivity of 
Concentrated Dimethyldioxirane Solutions in Solvents other than Acetone” Tetrahedron  
1997, 53, 8643-8650. 
68. Rainier, J. D.; Cox, J. M. “Aluminium- and Boron-Mediated C-Glycoside Synthesis from 
1,2-Anhydroglycosides” Org. Lett. 2000, 2, 2707-2709. 
69. Ellman, J. A.; Owens, T. D.; Tang, T. P. “N-tert-Butanesulfinyl Imines: Versatile 
Intermediates for the Asymmetric Synthesis of Amines” Acc. Chem. Res. 2002, 35, 984-
995. 
70. Evans, J. W.; Ellman, J. A. “Stereoselective Synthesis of 1,2-Disubstituted β-Amino 
Alcohols by Nucleophilic Addition to N-tert-Butanesulfinyl α-Alkoxyaldimines” J. Org. 
Chem. 2003, 68, 9948-9957. 
71. Bedford, C. D.; Harris, R. N.; Howd R. A.; Goff, D. A.; Koolpe G. A.; Petesch, M.; 
Koplovitz, I.; Sultan, W. E.; Musallam, H. A. “Quaternary Salt of 2-
[(Hydroxyimino)methyl]imidazole.  3. Synthesis and Evaluation of (Alkenyloxy)-, 
(Alkynyloxy)-, and (Aralkyloxy)methyl Quaternarized 2-[(Hydroxyimino)methyl]-1-
107 
 Alkylimidalolium Halides as Reactivators and Therapy for Soman Intoxication” J. Med. 
Chem. 1989, 32, 504-516. 
72. De Armas, P.; Concepcion, J. I.; Francisco, C. G.; Hernandez, R.; Salazar, J. A.; Suarez, 
E. “Intramolecular Hydrogen Abstraction. Hypervalent Organoiodine Compounds, 
Convenient Reagents for Alkoxy Radical Generation” J. Chem. Soc. Perkin. Trans. I  
1998, 405-411. 
73. Philips, R. S.; Heiss, C. H. “Asymmetric Reduction of Ethynyl Ketones and 
Ethynylketoesters by Secondary Alcohol Dehydrogenase from Thermoanaerobacter 
ethanolicus” J. Chem. Soc., Perkin Trans. 1 2000, 2821-2825. 
74. Bromidge, S. M.; Entwistle, D. A.; Goldstein, J.; Orlek, B. S. “A Convenient Synthesis of 
Masked β-Ketoaldehydes by the Controlled Addition of Nucleophiles to 
(Trimethylsilyl)ethynyl Ketones” Synth. Commun. 1993, 23, 487-494. 
75. Danishefsky, S. D.; Larson, E.; Askin D.; Kato, N. “On The Scope, Mechanism, and 
Stereochemistry of the Lewis Acid Catalyzed Cyclocondensation of Activated Dienes 
with Aldehydes:  An Application to the Erythronolide Problem” J. Am. Chem. Soc. 1985, 
107, 1246-1255. 
76. Luche, J. L. “Lanthanoids in Organic Synthesis. 1. Selective 1,2-Reductions of 
Conjugated Ketones” J. Am. Chem. Soc. 1978, 100, 2226-2227. 
77. Golender, L.; Senderowitz, H.; Fuches, B. “Relative Stabilities and Conformational Ring 
Inversion Potentials in Heterocyclic Decalin Systems and Stereoelectronic Implications” 
J. Mol. Struct. (Theochem) 1996, 370, 221-236. 
78. Inukai, T.; Yoshizawa, R. “Preparation of β-Ketoaldehydes by Acylation of Aldehyde 
Enamines” J. Org. Chem. 1967, 32, 404-407. 
108 
 79. Kinnaird, J. W. A.; Ng, P. Y., Kubota, K.; Wang, X; Leighton, J. A. “Strained Silacycles 
in Organic Synthesis: A New Reagent for the Enantioselective Allylation of Aldehydes” 
J. Am. Chem. Soc. 2002, 124, 7920-7921. 
80. Lou, S.; Westbrook, J. A.; Schaus, S. E. “Decarboxylative Aldol Reactions of Allyl β-
Keto Esters via Heterobimetallic Catalysis” J. Am. Chem. Soc. 2004, 126, 11440-11441. 
81. Blanchette, M. A.; Malamas, M. S.; Nantz, M. H.; Roberts, J. C.; Somfai, P.; Whritenour, 
D. C.; Masamune, S. “Synthesis of Bryostatins. 1. Construction of the C(1)-C(16) 
Fragment” J. Org. Chem. 1989, 54, 2817-2825. 
82. Paterson, I.; Gibson, K. R.; Oballa, R. M. “Remote, 1,5-Anti Stereoinduction in the 
Boron-Mediated Aldol Reactions of β-Oxygenated Methyl Ketones” Tetrahedron Lett. 
1996, 37, 8585-8588. 
83. Evans, D. A.; Cote, B.; Coleman, P. J.; Connell, B. “1,5-Asymmetric Induction in Boron-
Mediated β-Alkoxy Methyl Ketone Aldol Addition Reactions” J. Am. Chem. Soc. 2003, 
125, 10893-1089. 
84. Chen, K.; Hardmann, G. E.; Prasad, K.; Repic, O.; Shapiro, M. J. “1,3-Syn 
Diastereoselective Reduction of β-Hydroxyketones Utilizing Alkoxydialkylboranes” 
Tetrahedron Lett. 1987, 28, 155-158. 
85. Rychnovsky, S. D.; Rogers, B. N.; Richardson, T. I. “Configurational Assignment of 
Polyene Mactolide Antibiotics Using the [C13]Acetonide Analysis” Acc. Chem. Res. 
1998, 31, 9-17. 
86. Ferrier, R. J. “Unsaturatured Carbohydrates. Part 21. A Carbocyclic Ring Closure of a 
Hex-5-enopyranoside Derivative” J. Chem. Soc. Perkin Trans. 1 1979, 1455. 
109 
 87. Rech, J. C.; Floreancig, P. E. “An Oxidative Entry into the Amido Trioxadecalin Ring 
System” Org. Lett. 2003, 5, 1495-1498. 
88. Aubele, D. L.; Rech, J. C.; Floreancig, P. E. “Catalytic Aerobic Generation of 
Acyliminium Ions through Electron-Transfer-Mediated Carbon-Carbon Bond Activation” 
Adv. Synth. Catal. 2004, 346, 359-366. 
89. Ma, B.; Lii, J.; Allinger, N. L. “Molecular Polarizabilities and Induced Dipole Moments 
in Molecular Mechanics” J. Comput. Chem. 2000, 21, 825. 
90. Still, W. C.; Tempczyk, A.; Hendrickson, T. J. “Semianalytical Treatment of Solvation of 
Molecular Mechanics and Dynamics” J. Am. Chem. Soc. 1990, 112, 6127-6129. 
110 
 3.   Synthesis of the N7-C25 Fragment of Psymberin 
 
3.1  Introduction 
 
 The natural product psymberin1/irciniastatin A2 was isolated independently from two 
marine sponges of the same family (Ircinidae family).  The geminal dimethyl tetrahydropyran 
and the N-acylaminal functionalities suggest that psymberin/irciniastatin A is related to the 
pederin family of natural products, though psymberin/irciniastatin A would be the first member 
of this family that does not contain the highly conserved pederic acid tetrahydropyran ring 
system (A, Figure 36). 
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Figure 36: Psymberin/Irciniastatin A and Related Compounds 
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I. Isolation and Structural Determination 
 
 In 2004 Pettit and coworkers2 reported the isolation of irciniastatin A from the marine 
sponge Ircinia ramose native to the Indo-Pacific region.  Irciniastatin A was isolated from the 
methanol-CH2Cl2 extract of Ircinia ramose sponge by gel permeation and reverse phase HPLC.  
The extraction and purification of 1 kilogram (wet) of sponge resulted in the isolation of 34.7 mg 
of irciniastatin A.   
 The structure of irciniastatin A was assigned through the use of mass spectrometry and 
NMR spectroscopy (Figure 37).   The high-resolution FAB mass spectrum showed a 
pseudomolecular ion peak at m/z 610.3228 [M + H] indicating a molecular formula of 
C31H48NO11.2  The use of 2D-COSY, TOCSY and HMBC experiments provided the necessary 
information to establish the connectivity of the natural product.  Interpretation of the HMBC 
spectrum was particularly useful allowing for the identification of the amide linkage from a 
correlation of the amide proton (N-H) to the C6 carbonyl carbon (Figure 37).  Additionally, 
correlations from the C29 proton to the carbons of the aromatic ring (C18-C21 and C23) were 
integral for determining the connectivity of the dihydroisocourmarin.  The nOe enhancements, 
shown in Figure 37, led to the assignment of the relative stereochemistry of the N-acylaminal and 
the geminal dimethyl tetrahydropyran subunits reported by Pettit.2  While Pettit and coworkers 
were able to establish the carbon skeleton of the irciniastatin A, their reported structure was 
largely devoid of stereochemical information. 
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 Crews and coworkers1 reported the isolation of psymberin in 2004 (shortly following the 
report from Pettit and coworkers2) from the marine sponge Psammocinia collected from the 
waters of Papau, New Guinea  (Figure 38, the numbering schemes of Pettie and Crews differ 
slightly, the Crews scheme will be used for the remainder).  The structural determination of 
psymberin was accomplished by Crews and coworkers by employing techniques and analyses 
similar to those used by Pettit and coworkers in their structural determination of irciniastatin A.2  
Crews assigned the relative and absolute stereochemistry for most of the chiral centers in 
psymberin by analyzing 1H NMR coupling constants,  nOeSy and COSY correlation data and by 
comparing the chemical shifts and coupling constants of the 1H NMR of psymberin to the 
spectral data reported for pederin.1  The C16 stereocenter was assigned based on the circular 
dichroism spectrum that displayed a positive Cotton effect at 280 nm generated by the chiral 
dihydroisocourmarin.  Crews and coworkers were unable to assign the configuration of the freely 
rotating C4 center.1  
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Figure 38: Psymberin Reported by Crews 
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 The structures of irciniastatin A and psymberin proposed by Petit and Crews, 
respectively, share an identical carbon skeleton and relative stereochemistry of the dihydropyran 
ring but differ in their assignment of the relative stereochemistry of the N-acylaminal center.1,2  
The similarities in the structures reported by Petit and Crews led to the speculation that 
irciniastatin A and psymberin were identical compounds.1  A direct comparison of the NMR 
spectrum of irciniastatin A and psymberin was not possible because the NMR spectrum were 
recorded in CDCl3 and CD3OD, respectively.1,2   
 The incomplete stereochemical assignment of the C1-C6 side chain has resulted in two 
studies that have defined the relative and absolute stereochemistry of the C4 position.  Kiren and 
Williams4 employed the use of a 1H and 13C NMR chemical shift homology analysis to postulate 
that the stereocenters of the C4 and C5 positions of psymberin have an anti-relationship.  This 
analysis was performed by comparing the 1H and 13C NMR spectrum of the syn and anti model 
compounds (Figure 39), generated in 11 steps from D-glyceraldehyde acetonide, to the spectral 
data reported by Crews.1  The coupling constants and chemical shifts for the anti-model 
compound were consistent with the reported values for the natural product.4  While significant 
deviation from the reported values was observed in the chemical shifts of the 1H and 13C NMR 
spectrum of the syn-model compound, with the largest differences occurring for data 
corresponding to the C3-C5 positions.   
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Figure 39: Structure of Psymberin Proposed by Williams 
 
 The absolute and relative stereochemistry of the C4 and C5 positions of psymberin were 
confirmed by Floreancig and coworkers5 through the examination of the acidic methanolysis 
products of psymberin.  To conduct this study the four possible stereoisomers of the methyl ester 
derivatives of the psymberic acid fragment (C1-C6 side chain of psymberin) were generated from 
D- and L-serine in 8 steps (the 4S,5S derivative is shown in Figure 40).  Each methyl ester was 
individually subjected to acidic methanolysis conditions (H2SO4, MeOH, 40 °C, 24 h) resulting 
in the cationic cyclization to generate the corresponding furan.   The furans were analyzed by gas 
chromatography employing a chiral stationary phase and compared to the products resulting 
from the acidic methanolysis of psymberin.  The furan resulting from the methanolysis of 
psymberin was consistent in mass and retention time with the anti-4S,5S furan generated from 
the corresponding methyl ester (Figure 40).  The 4S,5S configuration of psymberin determined 
through the acidic methanolysis study is consistent with the configuration predicted by the 
chemical shift homology study of Kiren and Williams.4 
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Figure 40: Structure of Psymberin Proposed by Floreancig 
 
II. Biological Activity 
 
 The biological activity of psymberin makes it an unusual member of the pederin family 
of natural products.  Unlike the other members of the pederin family that exhibit equipotent 
cytotoxicity over a broad spectrum of cancer cell models, psymberin has displayed selective 
cytotoxicity for a number of cancer cell lines (Table 1).  Psymberin has shown a >104 fold 
activity difference for select melanoma, breast and colon cancer cell lines.2  The differential 
cytotoxicity observed for psymberin, as compared to the pederin family of natural products, has 
led to speculation that the dihydroisocourmarin and/or the vinylic methyl terminus may be 
responsible for the selective activity.2   
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 breast cancer.
   MCF7
   HS 578T
   MDA-MB-435
   NCI/ADR-RES
   T-47D
melanoma
   LOX IMVI.
   MALME-3M
   SK-MEL-2
   SK-MEL-5
   SK-MEL-28
   UACC-257
   UACC-62 colon cancer.
   HCC-2998
   HCT-116
   HT29
   SW-620
>2.5 x 10-5
>2.5 x 10-9
>2.5 x 10-5
>2.5 x 10-9
1.41 x 10-5
>2.5 x 10-5
>2.5 x 10-9
>2.5 x 10-5
>2.5 x 10-5
>2.5 x 10-9
  1.9 x 10-5
  1.4 x 10-5
  3.8 x 10-7
>2.5 x 10-9
>2.5 x 10-5
>2.5 x 10-5
cell line LC50 (M) cell line LC50 (M)
 
Table 1: Activity of Psymberin against Various Cancer Cell Lines 
 
III. The First Total Synthesis of Psymberin   
 
 Recently, De Brabander and coworkers3 reported the first total synthesis of 
psymberin/irciniastatin A wherein they demonstrated the compounds isolated by Pettit1 and 
Crews2 were identical.  For the remainder of this chapter this natural product will be referred to 
as psymberin.  The approach taken by De Brabander was highly convergent and divided 
psymberin into three fragments (Figure 41).  The synthesis of fragment 1 will not be discussed as 
it is not directly related to the research described herein.   
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Figure 41: De Brabander’s Retrosynthetic Analysis 
 
117 
  De Brabander and coworkers3 generated fragment 3 (Figure 41) from a 7 step sequence 
with a 43% overall yield starting from the previously reported aldehyde 4, generated in one step 
from 2,4-dimethoxytoluene (Scheme 18).  The allyl group of 5 was installed in good yield from 
the oxidation and amidation of aldehyde 4 followed by ortho-metallation and subsequent 
allylation.  A four step sequence that included methyl ether deprotection, methyl ester formation, 
phenol protection and oxidative olefin cleavage completed the synthesis of fragment 3 from 
amide 5. 
 
MeO
OMe
CHO
MeO
OMe
CONEt2
PMBO
OPMB
CO2Me
CHO
Reagents: (a) NaH2PO4, NaClO2, 2-methyl-2-butene, t-BuOH/H2O; (b) SOCl2, benzene; Et2NH; (c) sec-BuLi,
CuBr•SMe2, allylBr, THF, -78 °C, 69% over 3 steps; (d) BBr3, CH2Cl2, -78 °C to 25 °C; (e) Me3OBF4, CH2Cl2; Na2CO3, 
MeOH; (f) PMBCl, Bu4NI, K2CO3, DMF, -15 °C; (g) cat. OsO4, NMO, THF/H2O; NaIO4, aq MeOH, 77% over 4 steps.
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Scheme 18: De Brabander’s Psymberin Synthesis: Fragment 3 
 
 The C11 and C13 stereocenters of fragment 2 (Figure 41) were established with good 
enatantio- and diastereoselectivity, respectively, through a sequence of asymmetric Leighton 
allylations beginning with monoprotected aldehyde 6 (Scheme 19).3  Monosilylation of the 
resulting diol generated 9 in good yield.  Oxidative olefin cleavage of 9 and subsequent acylation 
of the resulting lactol generated acyl lactol 10.  The configuration of the C9 center was 
established by the diastereoselective Lewis acid catalyzed acetate displacement of the acyl lactol 
by TMSCN, as part of a 3 step sequence to complete the synthesis of fragment 2. 
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Scheme 19: De Brabander’s Psymberin Synthesis: Fragment 2 
 
 Fragments 2 and 3 were joined by a boron-mediated aldol addition resulting in aldol 
adduct 11, where the resulting C16 and C17 stereocenters were effectively controlled by the β-
alkoxy substituent of the boron enolate (Scheme 20).3   The C15 stereocenter was generated by a 
1,3-syn reduction of aldol adduct 11 followed by silyl ether cleavage generating 12 in excellent 
yield.  The hydration of the nitrile was accomplished by employing the Ghaffar and Parkin 
catalyst.  Subsequent protecting group manipulation of the resulting amide provided 13 in good 
yield.  Coupling of the imidate generated from 13 with the acid chloride derivative of fragment 1 
(14, also generated by Da Brabander and coworkers) and subsequent borohydride reduction 
generated the N-acylaminal at the C8 center with modest selectivity in favor of the natural 
configuration.  Removal of the acetate protecting groups generated 15, which was determined to 
be identical to psymberin and irciniastatin A by a comparison of spectral and optical rotation 
data.3  Note, this synthesis does not resolve the issue of the C8 N-acylaminal stereochemistry. 
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Scheme 20: De Brabander’s Psymberin Synthesis: Completion 
 
IV. Retrosynthesis 
 
 We have initiated synthetic studies directed toward the generation of psymberin as part of 
our interest in the pederin family of natural products.  The following is an account of our 
synthesis of the N7-C25 fragment of psymberin.  The majority of this chapter has been published 
as a communication.19 
 The retrosynthesis of psymberin outlined in Figure 42 focuses on the generation of the 
N7-C25 fragment of this natural product, which was the focus of our research effort.  The 
cleavage of the C-N bond of the N-acylaminal generated amide 16 and a psymberic acid 
derivative (not shown).  This disconnection was employed by De Brabander and coworkers and 
was developed for use in the synthesis of pederin and related natural products.  A 2 step 
sequence that included the selective cyanide displacement and subsequent nitrile hydrolysis was 
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 expected to generate amide 16 from acyl lactol 17.  The acyl lactol 17 was expected to arise from 
the oxidative olefin cleavage of 18 followed by acylation of the resulting lactol.  Disconnection 
of the C15-C14 bond generates ketone 19 and aldehyde 20.  The joining of these fragments is 
expected to occur through a selective aldol addition establishing the C15 stereocenter that will be 
subsequently used to control the C12 stereocenter during a 1,3-syn-reduction.  The stereocenter in 
ketone 19 can be generated from an asymmetric allyation (as described in Chapter 2) and the 
stereochemistry of aldehyde 20 can be generated from the asymmetric crotylation of an aldehyde 
derived from arene 21.  Arene 21 can be generated from allene 22 and diene 23. 
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Figure 42: Retrosynthetic Scheme for Psymberin 
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 3.2  Results and Discussion 
 
 The synthesis of the N7-C25 fragment of psymberin commenced with the generation of 
arene 24 (Scheme 21).  The cycloaddition6 of allene 22,7 available in one step from 
commercially available 1,3-acetonedicarboxylate, with silylketene acetal 238 followed by 
fluoride mediated aromatization generated arene 24 in a 70% yield.  The cycloaddition 
proceeded at ambient temperature in the absence of solvent and can be used to generate 
multigram quantities of arene 24.  Protection of the phenolic functional groups under standard 
conditions (TBSOTf, 2,6-lutidine) provided bis-silyl ether 25 in nearly quantitative yield.   
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Scheme 21: Synthesis of the Psymberin Arene 
 
 The aliphatic methyl ester of arene 25 was selectively reduced with a single equivalent of 
di-iso-butylaluminum hydride (DIBAL), generating aldehyde 26 in sufficient purity to eliminate 
the need for purification (Scheme 22).  The C16 and C17 stereocenters were established through a 
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 Brown crotylation reaction9 that generated 27 as a single diastereomer in a 65% yield over 2 
steps with a 90% ee determined by HPLC analysis (Chiralcel OD-H column).  Silyl ether 
protection of the resulting alcohol proceeded in nearly quantitative yield generating 28 upon 
treatment of 27 with TBSOTf in the presence of 2,6-lutidine.  Oxidative olefin cleavage of 28 
under standard ozonolysis conditions proceeded smoothly to generate aldehyde 29 in a 93% 
yield.  Aldehyde 29 constitutes the aldehyde partner for a subsequent Mukaiyama aldol reaction. 
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Scheme 22: Generation of C14-C25 Fragment of Pysmberin 
 
 The silyl enol ether Mukaiyama aldol partner (34, Scheme 23) was generated in 3 steps 
from ketoaldehyde 31.10  The stereoselective Leighton11 allylation of ketoaldehyde 3110 
generated β-hydroxyketone 32 in 90% yield and 94% ee determined by GC analysis (Chiraldex 
G-TA column) (Scheme 23).  Treatment of β-hydroxyketone 32 with triethylsilyl chloride 
(TESCl) in the presence of imidizole resulted in the formation of silyl ether 33 in quantitative 
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 yield.  Treatment of 33 with TMSOTf in the presence of Et3N generated silyl enol ether 34 with 
sufficient purity that it was used without purification in the subsequent Mukaiyama aldol.   
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Scheme 23: Synthesis of the C7-C13 Fragment of Psymberin 
 
 The Mukaiyama aldol addition12 of silyl enol ether 34 into aldehyde 29 proceeded in 95% 
yield generating the C15 stereocenter as a 6:1 mixture of inseparable diastereomers (Figure 43).  
The generation of the syn,syn-stereotriad, observed in aldol adduct 35, is the result of the Felkin-
Ahn13 addition of the silyl enol ether 34 into aldehyde 29.  The syn,syn-stereochemical 
relationship resulting from the Mukaiyama aldol addition was tentatively assigned by analyzing 
the chemical shifts and coupling constants in the 1H NMR spectrum of aldol adduct 35.  The 1H 
NMR patterns generated by aldol adduct 35 were consistent with the patterns reported by 
Roush16 for syn,syn-aldol adducts.  This assignment was further verified in subsequent 
intermediates. 
 The 1,2-asymmertic induction generated from the α-position (C16) of aldehyde 29 
conflicts with the 1,3-asymmertic induction generated from the β-position (C17).15  The 
generation of the syn,syn-stereotriad is expected to occur from the Felkin-Ahn approach of the 
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 nucleophile, whereby the α-substituent controls the stereochemistry generated from the 
addition.13   The generation of the anti,syn-stereotriad would be expected arise if the approach of 
the nucleophile was controlled by the β-siloxy substituent (1,3-asymmertic induction).14  Evans 
and coworkers have demonstrated that in similar systems α-control overrides β-control when 
sterically encumbered nucleophiles are employed.  In these cases the steric interactions that 
generally dictate 1,2-asymmertic induction have a more pronounced influence than the 
electrostatic effects that are invoked to explain the asymmetric induction generated by the β-
alkoxy stereocenter.15  Based on this reasoning the transition state for the Mukaiyama aldol is 
shown in Figure 43.    
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Figure 43:  Mukaiyama Aldol to Generate the C15 Stereocenter of Psymberin 
 
 The reduction of aldol adduct 35 under chelation-control conditions with Et2BOMe as the 
chelating agent generated the syn-diol 36 with excellent selectivity (Scheme 24).17  The 
inseparable mixture of aldol diastereomers was now separable as the diol intermediate.  The 
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 acetonide of 36 was generated and the syn-diol relationship was confirmed through 13C NMR 
acetonide analysis.  The observed 13C NMR chemical shifts of acetonide 37 were consistent with 
values reported by Rychnovsky18 and coworkers for related syn-acetonides.   
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Scheme 24: Syn-Reduction of Psymberin Aldol Adduct 
 
 The generation of the requisite geminal dimethyl tetrahydropyran commenced with the 
oxidative olefin cleavage of diol 36 generating lactol 38 in a 76% yield (Scheme 25).  The 
unstable lactol was directly subjected to acetic anhydride in the presence of DMAP resulting in 
acylation at both the C9 and C15 centers in a 76% yield.  Treating acyl lactol 39 with BF3•OEt2 
resulted in the formation of an oxocarbenium ion that was selectively trapped with TMSCN to 
generate nitrile 41 in a 98% yield as a single diastereomer.  The selectivity observed in the nitrile 
formation arises from the axial addition of TMSCN into oxocarbenium ion 40. 
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Scheme 25: Tetrahydropyran Formation 
 
 Hydration of nitrile 41 under the commonly employed basic peroxide conditions resulted 
in partial nitrile hydration accompanied by varying degrees of silyl ether cleavage.  To avoid 
silyl group loss in the nitrile hydration the platinum catalyst 42, reported by Ghaffar and 
Parkin,19 was employed (Figure 44).  Heating nitrile 41 to 80 °C in ethanol and water in the 
presence of 42 resulted in the generation of amide 43 in 96% yield with no detectable silyl group 
loss.  Catalyst 42 facilitates nitrile hydration by coordinating to the N-terminus of the nitrile 
allowing for the intermolecular addition of dimethylphosphine oxide ligand generating an 
imidate intermediate.  Subsequent water addition into the imidate followed and collapse of the 
tetrahedral intermediate generates the amide and regenerates catalyst 42.  The generation of 
amide 43 completes our synthesis of the N7-C25 fragment of psymberin.   
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Figure 44: Nitrile Hydration and Completion of the N7-C25 Fragment of Psymberin 
  
 During the optimization of the workup conditions for the TMSCN displacement of the 
acyl lactol 39 (Scheme 25) varying amounts of partially deprotected nitrile were isolated (44, 
Figure 45).  To explore our deprotection strategy and the generation of the dihydroisocourmarin, 
nitrile 44 was subjected to tetrabutylammonium fluoride (TBAF) in THF resulting in cleavage of 
the silyl ethers and closure of the dihydroisocoumarin ring.  The removal of the acetate group 
was accomplished by treatment with basic methanol generating dihydroisocourmarin 44.  The 1H 
NMR of dihydroisocourmarin 44 was recorded in CD3OD and matched remarkably well with the 
C10-C25 fragment of psymberin.  The chemical shifts and coupling constants observed from the 
1H NMR of dihydroisocoumarin 45 are shown in red and the reported values for the 
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 corresponding protons in psymberin are shown in blue (Figure 45).  The strong correlation in the 
1H NMR of 45 and psymberin provided convincing evidence that the structure reported by Crews 
and coworkers is accurate. 
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Figure 45: Chemical Shift and Coupling Constant Analysis of the Synthetic Fragment 
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 3.3  Conclusions 
 
 We have developed an efficient and stereoselective synthesis of the N7-C25 fragment of 
psymberin.  The synthesis is highlighted by the de novo generation of the C25-C17 
pentasubstituted arene that allows for the expedient generation of multigram quantities of this 
intermediate.  The C16 and C17 stereocenters were generated with good yield and selectivity by a 
Brown crotylation and the C11 stereocenter was generated with excellent yield and selectivity 
from an asymmetric Leighton allylation. The C9, C13, and C15 stereocenters were established by a 
selective Lewis acid mediated lactol displacement, syn-reduction and Mukaiyama aldol reaction, 
respectively, where the stereochemistry resulting from these transformations was controlled by 
the substrate.  The flexibility of this synthesis allows for easy access to derivatives that can be 
use to explore the origins of the selective cytotoxicity of psymberin. 
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 3.4  Experimentals 
 
General Procedures:  Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature as follows: [ά]λ (c, g/100mL).  Infrared 
spectra were recorded on a Nicoler Avatar 360 FT-IR spectrometer.  NMR spectra were recorded 
on a Bruker Avance-300, 500, or 600 spectrometer with chemical shifts reported relative to 
residual CHCl3 (7.27 ppm) for 1H and CDCl3 (77.0 ppm) for 13C spectra.  Unless otherwise 
stated, all reactions were performed in dry glassware under a nitrogen atmosphere using standard 
inert atmosphere techniques for the manipulation of solvents and reagents.  Anhydrous 
methylene chloride (CH2Cl2) was obtained by distillation over calcium hydride and THF and 
diethyl ether were obtained by passage through an alumina packed column on a solvent 
purification system.  Flash chromatography was performed on EM silica gel 60 (230-240 mish). 
 
4,6-Dihydroxy-2-methoxycarbonylmethyl-3-methyl benzoic acid methyl 
ester, 24:6  To neat dimethyl allenedicarboxylate7 22 (12.0 g, 76.9 mmol) at 
0 °C was added 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene4 23 
(92.3 mmol, 26.6 g) and the reaction mixture was warmed to rt and stirred for 6 hours.  The 
reaction mixture was cooled to 0 °C and treated with NEt3•HF (1 M in ethanol, 120 mL)(see 
below for preparation of this reagent).  The resulting solution was stirred at rt for 15 minutes, 
diluted with H2O (200 mL) and extracted with EtOAc (6 x 50 mL).  The organic layers were 
combined, washed with brine (50 mL), dried with Na2SO4, filtered, and concentrated under 
reduced pressure.  The desired product appeared as a white precipitate and was isolated by 
filtration.  Product remaining in the crude oil was purified by flash column chromatography 
HO
OH
CO2Me
CO2Me
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 (20% EtOAc in hexane).  The solids were combined providing the desired product as a white 
powder (13.1 g, 70%):  1H NMR (d6-DMSO, 300 MHz) δ 10.06 (s, 1H), 9.98 (s, 1H), 6.37 (s, 
1H), 3.72 (s, 3H), 3.69 (s, 2H), 3.59 (s, 3H), 1.95 (s, 3H);  13C NMR (d6-DMSO, 75 MHz) δ 
170.9, 169.3, 158.8, 156.8, 134.2, 116.1, 109.7, 101.4, 51.6, 51.5, 36.1, 11.1; IR (dry film) 3303, 
1701, 1647, 1596, 1328, 1225 cm-1;  HRMS(EI) m/z calcd for C12H14O6 (M+) 254.0790, found 
254.0799;  m.p. 188-189 °C. 
Preparation of 1.0 M Et3N•HF in ethanol:  To a solution of commercially available Et3N•3HF 
(12.3 g, 76.3 mmol) in absolute ethanol (42.8 mL) at rt was added freshly distilled Et3N (152.6 
mmol, 15.4 g) and the resulting solution was stored in a Nalgene® polyethylene bottle at rt. 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2-methoxycarbonylmethyl-3-
methyl benzoic acid methyl ester (25):  To a solution of 24 (3.20 g, 13.3 
mmol) in CH2Cl2 (50 mL) at 0 °C was added 2,6-lutidine (5.71 g, 53.3 
mmol) followed by the dropwise addition tert-butyldimethylsilyl trifluoromethanesulfonate 
(TBSOTf) (7.75 g, 29.3 mmol).  The reaction mixture was warmed to rt and stirred for 6 hours.  
H2O (50 mL) was added and the reaction mixture was extracted with CH2Cl2 (2 x 25 mL).  The 
organic layers were combined, washed with 10% aq. HCl (20 mL) and brine (50 mL), dried with 
Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil was purified by 
flash chromatography (10% EtOAc in hexanes) to provide the desired product (6.40 g, 99%):  1H 
NMR (CDCl3, 300 MHz) δ 6.28 (s, 1H), 3.83 (s, 3H), 3.67 (s, 3H), 3.66 (s, 2H), 2.09 (s, 3H), 
1.01 (s, 9H), 0.96 (s, 9H), 0.22 (s, 6H), 0.20 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 171.0, 168.8, 
155.3, 151.2, 132.7, 121.7, 120.2, 109.0, 51.9, 51.8, 36.2, 25.7, 25.5, 18.3, 18.0, 12.2, -4.2, -4.4; 
TBSO
OTBS
CO2Me
CO2Me
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 (IR neat) 2953, 2859, 1737, 1594, 1472, 1435, 1419, 1261, 1163, 863, 840, 781 cm-1; 
HRMS(ES) m/z calcd for C24H42O6NaSi2 (M + Na) 505.2418, found 505.2395. 
 
 4,6-Bis-tert-butyldimethylsilanyloxy-3-methyl-2,2-oxoethyl benzoic 
acid methyl ester (26):  To a solution of 25 (6.10 g, 12.6 mmol) in CH2Cl2 
(80 mL) at -78 °C was added DIBAL (in hexanes)(12.7 mL, 12.7 mmol) 
and the reaction mixture was stirred at -78 °C for 2 hours.  EtOAc (5 mL) was added and the 
reaction mixture was poured into saturated aqueous sodium potassium tartrate (100 mL) at 0 °C.  
The resulting reaction mixture was warmed to rt, stirred for 4 hours, and extracted with CH2Cl2 
(3 x 10 mL).  The organic layers were combined, washed with brine (2 x 10 mL), dried with 
Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil was used without 
purification. 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2-2-hydroxy-3-methylpent-4-
enyl-3-methyl benzoic acid methyl ester, 27: To a suspension of 
predried KOtBu (1.70 g, 15.1 mmol) in THF (5 mL) at -78 °C was added 
cis-2-butene (1.70 g, 30.2 mmol).  At -78 °C 1.6 M n-butyl lithium in hexane (9.45 mL, 15.1 
mmol) was added slowly over a period of 15 minutes.  The resulting yellow reaction mixture was 
warmed to -45 °C for 10 minutes then cooled to -78 °C and (-)-methoxydiisopinocamphenyl 
borane (5.58 g, 17.6 mmol) in ether (17 mL) was added dropwise.  The reaction mixture was 
stirred for 30 minutes at -78 °C.  Freshly distilled BF3•OEt2 (2.86 g, 20.2 mmol) was added to 
the reaction mixture at -78 °C followed by the dropwise addition of 26 (12.7 mmol, crude) in 
THF (5 mL).  The reaction mixture was stirred at -78 °C for 2.5 hours and saturated aqueous 
CO2Me
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O
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 NH4Cl (5 mL) was added.  The reaction mixture was poured into 20 mL of pH 7 buffer at 0 °C, 
30% hydrogen peroxide (5 mL) was added and the reaction mixture was warmed to rt and stirred 
for 10 hours.  The reaction mixture was extracted with EtOAc (3 x 15 mL).  The organic layers 
were combined, washed with saturated aqueous NaSO3 (10 mL) and brine (2 x 10 mL), dried 
with Na2SO4, filtered and concentrated under reduced pressure. The resulting crude oil was 
purified by flash chromatography (2% EtOAc in hexane) to provide the desired product as a 
single diastereomer by NMR (5.03 g, 65%, 90% ee).  Enantioselectivity was determined by 
HPLC using a Diacel ChiralcelTM OD-H column with 1% isopropanol in hexane as the mobile 
phase and a flow rate of 1ml/min at 700 psi.  The retentions times were Tr (min.)  3.43 (S,S) and 
3.68 (R,R)):  1H NMR (CDCl3, 500 MHz) δ 6.24 (s, 1H), 5.89 (ddd, J = 17.7, 10.4, 7.7 Hz, 1H), 
5.12 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 11.1 Hz, 1H), 3.86 (s, 3H), 3.63-3.58 (m, 1H), 3.24 (d, J = 
6.1 Hz, 1H), 2.94 (dd, J = 14.3, 2.6 Hz, 1H), 2.46 (dd, J = 14.3, 10.8 Hz, 1H), 2.36-2.30 (m, 1H), 
2.09 (s, 3H), 1.13 (d, J = 6.8, 3H), 1.01 (s, 9H), 0.96 (s, 9H), 0.23 (s, 3H), 0.22 (s, 3H), 0.21 (s, 
3H), 0.18 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 170.8, 155.5, 151.0, 140.9, 137.6, 120.8, 
120.2, 114.8, 108.0, 74.2, 52.2, 45.1, 35.8, 25.6, 25.5, 18.2, 17.9, 15.4, 12.2, -4.3, -4.3, -4.4, -4.5; 
(IR neat) 3465, 2956, 2930, 2888, 2859, 1729, 1701, 1590, 1471, 1258 cm-1; HRMS(ES) m/z 
calcd for C27H48O5Si2 (M+) 508.3038, found 508.3040; [α]20D +36.3° (c 1.50, CHCl3). 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2-2-tert-
butyldimethylsilanyloxy- 3-methylpent-4-enyl-3-methyl benzoic acid 
methyl ester 28:  To a solution of 27 (4.57 g, 8.98 mmol) in CH2Cl2 (60 
mL) at 0 °C was added 2,6-lutidine (1.92 g, 18.0 mmol) followed by the dropwise addition of 
TBSOTf (2.61 g, 9.88 mmol) and the reaction mixture was stirred at 0 °C for 15 minutes.  H2O 
CO2Me
TBSO
OTBS
OTBS
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 (20 mL) was added and the reaction mixture was extracted with CH2Cl2 (3 x 10 mL).  The 
organic layers were combined, washed with 10% HCl (10 mL) and brine (2 x 10 mL), dried with 
Na2SO4, filtered and concentrated under reduced pressure.  The resulting oil was purified by 
flash chromatography (5% EtOAc in hexane) to provide the desired product (5.51 g, 99%):  1H 
NMR (CDCl3, 500 MHz) δ 6.19 (s, 1H), 6.05 (ddd, J = 16.9, 10.6, 5.9 Hz, 1H), 5.09 (dd, J = 
10.6, 1.2 Hz, 1H), 5.04 (dd, J = 17.5, 1.2 Hz, 1H), 3.87 (ddd, J = 10.2, 3.5, 3.5 Hz, 1H), 3.82 (s, 
3H), 2.73 (dd, J = 14.0, 10.4 Hz, 1H), 2.59 (dd, J = 14.0, 3.3 Hz, 1H), 2.34-2.41 (m, 1H), 2.12 (s, 
3H), 1.03 (d, J = 6.8 Hz, 3H), 1.01 (s, 9H), 0.97 (s, 9H), 0.79 (s, 9H), 0.21 (s, 6H), 0.20 (s, 3H), 
0.19 (s, 3H), -0.02 (s, 3H), -0.50 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 169.5, 154.8, 150.6, 
140.1, 137.8, 122.4, 120.7, 114.3, 107.6, 76.7, 51.6, 43.5, 32.9, 26.0, 25.7, 25.6, 18.3, 18.1, 18.0, 
14.6, 12.8, -4.1, -4.2, -4.4, -5.2; IR (neat) 2956, 2930, 2858, 1729, 1590, 1417, 1256, 1162 cm-1; 
HRMS (ES) m/z calcd for C33H62O5NaSi3 (M + Na) 645.3803, found 645.3828; [α]20D +52.0° (c 
1.00, CHCl3). 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2-2-tert-
butyldimethylsilanyloxy-3-methyl-4-oxobutyl-3-methyl benzoic acid 
methyl ester, 29:  Ozone was gently bubbled through a solution of 28 
(0.9 g, 1.5 mmol) in CH2Cl2 (15 mL) at -78 °C until the reaction mixture sustained a deep blue 
color.  Triphenylphosphine (1.2 g, 4.5 mmol) was added, the cold bath was removed and the 
reaction mixture was stirred at rt for 2 hours.  The reaction mixture was concentrated under 
reduced pressure and purified by flash chromatography (2% EtOAc ? 10% EtOAc in hexanes) 
to provide the desired product (0.83 g, 93%):  1H NMR (CDCl3, 500 MHz) δ 9.86 (s, 1 H), 6.23 
(s, 1 H), 4.37 (ddd, J = 9.1, 5.0, 3.7 Hz, 1H), 3.84 (s, 3H), 2.84 (dd, J = 14.0, 9.1 Hz, 1H), 2.74 
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 (dd, J = 5.0 Hz, 1H), 2.40-2.51 (qd, J = 7.0, 3.4 1H), 2.14 (s, 3H), 1.09 (d, J = 7.0 Hz, 3H), 1.02 
(s, 9H), 0.97 (s, 9H), 0.81 (s, 9H), 0.22 (s, 6H), 0.20 (s, 3H), 0.19 (s, 3H), -0.05 (s, 3H), -0.34 (s, 
3H); 13C NMR (CDCl3, 125 MHz) δ 204.8, 169.3, 155.1, 150.8, 136.2, 122.0, 120.4, 108.0, 72.9, 
52.1, 51.8, 34.8, 25.8, 25.6, 25.5, 18.2, 18.0, 17.8, 12.7, 8.5, -4.3, -4.5, -5.1, -5.3; IR (neat) 2954, 
2858, 1727, 1591, 1163, 863 cm-1; HRMS(ES) m/z calcd for C32H60O6NaSi3 (M + Na) 647.3595, 
found 647.3566; [α]20D +51.0° (c 1.24, CHCl3). 
 
4-Hydroxy-3,3-dimethylhept-6-en-2-one, 32:  To a solution of 3010 (24.0 g, 
89.6 mmol) in toluene (450 mL) at -15 °C was added 3111 (8.20 g, 72.0 mmol) 
dropwise and the reaction mixture was stirred at -15 °C for 24 hours.  10% aqueous HCl (200 
mL) was added at -15 °C and the reaction mixture was warmed to rt and stirred for 10 minutes.  
The organic layer was collected and the aqueous layer was extracted with toluene (3 X 10 mL).  
The organic layers were combined, washed with 10% aqueous HCl (20 mL) and brine (20 mL), 
dried with Na2SO4, filtered and applied directly to a silica gel flash column packed in pentane.  
The toluene was eluted from the column with pentane and the product was eluted with 20% ether 
in pentane to provide the desired product (10.1 g, 90%, 94% ee)  The enantioselectivity was 
determined by GC with a chiral stationary phase.  The chira CG column emplyed was a 
ChiraldexTM G-TA column (Advanced Separation Technologies, Inc.) using a flow rate 0.5 
mL/min, method: 100 °C for 20 minutes, Tr (min.) (R) 21.361, (S) 23.013):  1H NMR (CDCl3, 
300 MHz): δ 5.94-5.80 (m, 1H), 5.18-5.11 (m, 2H), 3.77 (ddd, J = 10.3, 4.2, 2.4 Hz, 1H), 2.36 
(d, J = 10.3 Hz, 1H), 2.32-2.23 (m, 1H), 2.19 (s, 3H), 2.09-1.96 (m, 1H), 1.17 (s, 3H), 1.14 (s, 
3H); 13C NMR (CDCl3, 75 MHz) δ 214.5, 135.8, 117.9, 75.3, 51.6, 36.4, 26.3, 21.7, 19.4: IR 
OOH
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 (neat) 3462, 3076, 2977, 1701, 1641, 1469, 1356, 1129, 1070, 915 cm-1; HRMS(EI) m/z calcd for 
C9H17O2 (M + H) 157.122855, found 157.122995; [α]20D +12.0° (c 1.10, CHCl3).  
 
 4-Triethylsilanyloxy-3,3-dimethylhept-6-en-2-one (33):  To a solution of 32 
(2.00, 12.8 mmol) in DMF (2 mL) at rt was added imidazole (2.60, 38.4 
mmol).  The reaction mixture was stirred for 30 minutes at rt and cooled to 0 °C.  
Chlorotriethylsilane (2.74, 19.2 mmol) was added at 0 °C and the reaction mixture was warmed 
to rt and stirred for 8 hours.  H2O (10 mL) was added and the reaction mixture was extracted 
with hexanes (5 x 10 mL). The organic layers were combined, washed with brine (2 x 10 mL), 
dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil was 
purified by flash chromatography (5% EtOAc in hexanes) to provide the desired product (3.47, 
100%): 1H NMR (CDCl3, 500 MHz) δ 5.86-5.78 (dddd, J = 17.2, 10.1, 7.1, 7.1 Hz, 1H), 5.10-
5.05 (m, 2H), 3.98 (dd, J = 7.2, 4.3 Hz, 1H), 2.24-2.20 (m, 1H), 2.18 (s, 3H), 2.17-2.13 (m, 1H), 
1.15 (s, 3H), 1.13 (s, 3H), 0.99 (t, J = 8.0 Hz, 9H), 0.64 (q, J = 8.0, 6H); 13C NMR (CDCl3, 125 
MHz) δ 213.3, 136.0, 116.8, 77.0, 53.0, 38.7, 27.0, 21.7, 20.4, 6.9, 5.3; IR (neat) 2956, 2877, 
1704, 1467, 1094, 739 cm-1; HRMS(EI) m/z calcd for C13H25O2Si (M - C2H5) 241.1624, found 
241.1622; [α]20D +9.14° (c 1.17, CHCl3). 
 
4-Triethylsilanyloxy-3,3-dimethyl-2-trimethylsilanyloxyhepta-1,6-diene 
(34):  To a solution of 33 (0.20 g, 0.8 mmol) in diethyl ether (4 mL) at 0 °C 
was added triethylamine (0.24 g, 2.4 mmol) followed by the drop-wise addition of trimethylsilyl 
triflate (TMSOTf) (0.26 g, 1.2 mmol).  The reaction mixture was warmed to rt and stirred for 4 
hours.  The reaction mixture was diluted with pentane (10 mL) and washed with saturated 
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 aqueous NaHCO3 (2 x 10 mL), dried with Na2SO4, filtered, and concentrated under reduced 
pressure to provide the desired product (0.27 g, 100%).  The product was used without further 
purification: 1H NMR (CDCl3, 300 MHz) δ 5.91-5.77 (m, 1H), 5.04-4.97 (m, 2H), 4.11 (d, J = 
1.4 Hz, 1H), 3.96 (d, J = 1.4 Hz, 1H), 3.85 (dd, J = 8.4, 2.7 Hz, 1H), 2.29-2.22 (m, 1H), 2.07-
1.97 (m, 1H), 1.05 (s, 3H), 0.96 (s, 3H), 0.95 (t, J = 7.9 Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H), 0.21 
(s, 9H); 13C NMR (CHCl3, 125 MHz) δ 164.8, 137.7, 115.6, 87.5, 76.5, 45.3, 38.0, 24.4, 19.1, 
7.0, 5.5, -0.1. 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2,2-tert-
butyldimethylsilanyloxy-4-hydroxy-3-methyl-6-oxo-8-
triethylsilanyloxyundec-10-enyl-3-methyl benzoic acid 
methyl ester (35):  To a solution of 29 (0.650 g, 1.04 mmol) in CH2Cl2 (10 mL) was added 34 
(0.544 g, 1.56 mmol).  The reaction mixture was cooled to -78 °C and freshly distilled BF3•OEt2 
(0.174 g, 1.25 mmol) was added dropwise.  The reaction mixture was stirred at -78 °C for 10 
hours.  Saturated aqueous NH4Cl (5 mL) was added and the reaction was warmed to rt and 
extracted with CH2Cl2 (2 x 10 mL).  The organic layers were combined, washed with brine (2 x 
10 mL), dried with Na2SO4, filtered, and concentrated under reduced pressure.  The resulting oil 
was purified by flash chromatography (3% EtOAc in hexane) to provide the desired product 
(0.88, 95%, ~6:1 dr by NMR):  1H NMR (CDCl3, 600 MHz) δ 6.20 (s, 1H), 5.79-5.74 (m, 1H), 
5.08-5.02 (m, 2H), 4.33-4.27 (m, 1H), 4.02 (dd, J = 7.2, 4.5 Hz, 0.85H), 3.99 (dd, J = 7.2, 4.5 
Hz, 0.15H), 3.94 (ddd, J = 10.2, 3.3, 3.3 Hz, 1H), 3.82 (s, 3H), 3.27 (d, J = 2.6 Hz, 0.85H), 3.24 
(d, J = 2.6 Hz, 0.15H), 2.93 (dd, J = 14.2, 10.4 Hz, 1H), 2.85 (dd, J = 17.7, 1.2 Hz, 0.15 H), 2.79 
(dd, J = 18.3, 1.8 Hz, 0.86H),  2.73 (dd, J = 14.2, 3.4 Hz, 1H), 2.66 (dd, J = 18.3, 10.1 Hz, 
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 0.85H), 2.57 (dd, J = 18.3, 10.1 Hz, 0.15H), 2.19-2.00 (m, 2H), 2.15 (s, 3H), 1.60-1.55 (m, 1H), 
1.13 (s, 3H), 1.11 (s, 3H), 1.02 (s, 9H), 1.01 (d, J = 7.0 Hz, 3H), 0.96 (s, 9H), 0.97 (t, J = 7.9 Hz, 
9H) 0.80 (s, 9H), 0.61 (q, J = 7.9 Hz, 6H), 0.22 (s, 6H), 0.20 (s, 3H), 0.19 (s, 3H), -0.13 (s, 3H), -
0.44 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 217.4, 169.5, 154.8, 150.6, 137.7, 135.9, 122.3, 
120.5, 117.0, 107.6, 77.0, 74.0, 67.1, 53.3, 51.8, 44.7, 44.4, 38.9, 33.0, 26.0, 25.7, 25.5, 22.3, 
19.6, 18.2, 18.0, 17.9, 12.9, 11.2, 7.0, 5.4, -4.1, -4.2, -4.2, -4.4, -5.1,-5.3; IR (neat) 3540, 2955, 
2858, 1729, 1590, 1434, 1191 cm-1; HRMS(ES) m/z calcd for C47H90O8NaSi4 (M + Na) 
917.5611, found 917.5706; [α]20D +12.87° (c 1.27, CHCl3). 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2,2-tert-
butyldimethylsilanyloxy-4,6-dihydroxy-3,7,7-trimethyl-8-
triethylsilanyloxyundec-10-enyl-3-methyl benzoic acid 
methyl ester (36):  To a solution of 35 (0.83 g, 0.93 mmol) in THF (10 mL) and methanol (1 
mL) at -78 °C was added diethylmethoxyborane (0.10 g, 1.01 mmol) and the reaction mixture 
was stirred at -78 °C for 1 hour.  Sodium borohydride (0.11, 2.78 mmol) was added and the 
reaction mixture was stirred for 8 hours at -78 °C. The temperature was slowly increased to -35 
°C over a period of 5 hours.  The reaction mixture was poured into ice cooled pH 7 buffer (50 
mL) and diluted with EtOAc (25 mL).  At 0 °C hydrogen peroxide (30%, 10 mL) was added and 
the reaction mixture was warmed to rt and stirred for 12 hours.  The reaction mixture was 
extracted with EtOAc (3 x 20 mL) and the organic layers were combined, washed with saturated 
aqueous NaSO3 (2 x 10 mL) and brine (20 mL), dried with Na2SO4, filtered, and concentrated 
under reduced pressure.  The resulting oil was purified by flash chromatography (4% EtOAc in 
hexane) to provide the desired product (0.62 g, 74%).  At this point the it was possible to 
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 separate the undesired aldol adduct:  1H NMR (CDCl3, 300 MHz) δ 6.19 (s, 1H), 5.94-8.80 (m, 
1H), 5.14-5.06 (m, 2H), 4.80 (bs, 1H), 4.09 (bs, 1H), 4.08-4.03 (m, 2H), 3.91 (ddd, J = 10.0, 3.4 
Hz, 1H), 3.82 (s, 3H), 3.61 (dd, J = 7.2, 3.7 Hz, 1H), 2.93 (dd, J = 14.0, 10.2 Hz, 1H), 2.73 (dd, J 
= 14.0, 6.3 Hz, 1H), 2.55-2.40 (m, 1H), 2.38-2.28 (m, 1H), 2.15 (s, 3H), 1.66-1.48 (m, 3H), 1.01 
(s, 9H), 0.96 (s, 9H), 1.02-0.94 (m, 18H), 0.80 (s, 9H), 0.67 (q, J = 8.0 Hz, 6H), 0.22 (s, 3H), 
0.21 (s, 3H), 0.20 (s, 3H), 0.19 (s, 3H), -0.11 (s, 3H), -0.46 (s, 3H); 13C NMR (CDCl3, 75 MHz) 
δ 169.5, 154.8, 150.6, 138.1, 136.3, 122.4, 120.7, 117.0, 107.5, 83.7, 77.8, 76.7, 72.5, 51.8, 45.7, 
40.9, 37.5, 36.8, 33.3, 29.7, 26.0, 25.7, 25.6, 23.1, 20.6, 18.3, 18.1, 17.9, 12.9, 11.2, 6.9, 5.5, 5.3, 
-4.1, -4.2, -4.4, -5.1, -5.2; IR (thin film) 3390, 2955, 2858, 1728, 1590, 1191 cm-1; HRMS(ES) 
m/z calcd for C47H92O8NaSi4 (M + Na) 919.5767, found 919.5847; [α]25D +27.17° (c 0.72, 
CHCl3).  
 
4,6-Bis-(tert-butyldimethylsilanyloxy)-2-[2-(tert-
butyldimethylsilanyloxy)-4,6-dihydroxy-3,7,7-trimethyl-8-
triethylsilanyloxyundec-10-enyl]-3-methyl benzoic acid 
methyl ester (37):  To a solution of 17 (50 mg, 0.06 mmol) in 2,2-dimethoxypropane (2 mL) at 
rt was added catalytic amounts of para-toluenesulfonic acid and the reaction mixture was stirred 
for 2 hours.  Triethylamine (0.1 mL) was added followed by H2O (2 mL).  The reaction mixture 
was extracted with EtOAc (2 x 5 mL).  The organic layers were combined, washed with brine, 
dried with Na2SO4, filtered and concentrated under reduced pressure.  The resulting oil was 
purified by flash chromatography (2% EtOAc in hexane) to provide the desired product (49 mg, 
98%): 1H NMR (CDCl3, 300 MHz) δ 6.18 (s, 1H), 5.92-5.83 (m, 1H), 5.06-4.98 (m, 2H), 4.15-
4.09 (m, 1H), 3.94-3.87 (m, 1H), 3.85-3.77 (m, 1H), 3.81 (s, 3H), 3.47 (dd, J = 9.6, 3.8 Hz, 1H), 
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 2.93-2.89 (m, 1H), 2.68-2.63 (m, 1H), 2.33-2.29 (m, 1H), 2.15-2.11 (m, 1H), 2.13 (s, 3H), 1.57-
1.45 (m, 1H), 1.33-1.25 (m, 2H), 1.27-0.82 (m, 24H), 1.01 (s, 9H), 0.96 (s, 9H), 0.80 (s, 9H), 
0.61 (q, J = 7.9 Hz, 6H), 0.22 (s, 3H), 0.21 (s, 3H), 0.19 (s, 3H), 0.18 (s, 3H), -0.12 (s, 3H), -0.49 
(s, 3H); 13C NMR (CDCl3, 75 MHz) δ 169.6, 154.8, 150.6, 138.1, 137.6, 122.3, 120.6, 115.8, 
107.5, 98.0, 75.9, 75.8, 72.4, 67.6, 51.7, 44.6, 42.3, 38.1, 33.0, 30.4, 29.8, 25.9, 25.7, 25.6, 20.3, 
18.6, 18.3, 18.2, 18.1, 17.9, 12.9, 10.7, 7.1, 5.8, -4.1, -4.2, -4.4, -5.1,-5.3. 
 
4,6-Bis-tert-butyldimethylsilanyloxy-2,2-tert-
butyldimethylsilanyloxy-4-hydroxy-5,6-hydroxy-3,3-
dimethyl-4-triethylsilanyloxytetrahydropyran-2-yl-3-
methylpentyl-3-methyl benzoic acid methyl ester (38): Ozone was gently bubbled through a 
solution of 36 (0.59 g, 0.66 mmol) in CH2Cl2 (50 mL) at -78 °C until the reaction mixture 
sustained a deep blue color.  Triphenylphosphine (0.69, 2.6 mmol) was added and the reaction 
mixture was warmed to rt and stirred for 3 hours.  The reaction mixture was concentrated under 
reduced pressure and purified by flash chromatography (10% EtOAc in hexanes) to provide the 
desired product containing minimal amounts of inseparable impurities (0.45 g, 76%).  The 
resulting material was used without further purification. 1H NMR (CDCl3, 300 MHz) δ 6.21 (s, 
0.4H), 6.20 (s, 0.6H), 5.30 (bs, 0.6H), 4.67-4.62 (m, 0.4H), 3.98-3.92 (m, 4H), 3.87-3.81 (m, 
1H), 3.84 (s, 1.2H), 3.83 (s, 1.8H), 3.81-3.78 (m, 0.6H), 2.60 (bs, 0.4H), 3.50-3.48 (m, 0.6H), 
3.37-3.35 (m, 0.4H), 3.14 (bs, 0.4H), 3.11 (bs, 0.6H), 2.96-2.87 (m, 1H), 2.75 (dd, J = 14.0, 4.4 
Hz, 1H), 2.16 (s, 1.2H), 2.15 (s, 1.8H), 1.80-1.49 (m, 5H), 1.02 (s, 9H), 1.02-0.92 (m, 11H), 0.96 
(s, 9H), 0.85-0.82 (m, 6H), 0.83 (s, 9H), 0.61-0.58 (m, 6H), 0.22 (s, 3H), 0.20 (s, 3H), 0.19 (s, 
3H), -0.06 (bs, 3H), -0.33 (s, 1.2H), 0.38 (s, 1.8H). 
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2,4-Acetoxy-5,6-acetoxy-3,3-dimethyl-4-
triethylsilanyloxytetrahydropyran-2-yl-2-tert-
butyldimethylsilanyloxy-3-methylpentyl-4,6-bis-tert-
butyldimethylsilanyloxy-3-methyl benzoic acid methyl ester (39): To a solution of 38 (0.43 g, 
0.47 mmol) in pyridine (2 mL) and CH2Cl2 (1 mL) at 0 °C was added acetic anhydride (0.49 g, 
4.70 mmol) followed by a catalytic amount of DMAP.  The reaction mixture was warmed to rt 
and stirred for 10 hours.  H2O (5 mL) was added and the reaction mixture was extracted with 
CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with brine (10 mL), dried with 
Na2SO4, filtered and concentrated under reduced pressure.  The resulting oil was quickly purified 
by flash chromatography (10 % EtOAc in hexane) to provide the desired product (0.35 g, 76%) 
containing minor impurities.  Note: extended exposure to silica gel resulted decomposition of 39; 
1H (CDCl3, 300 HMz) δ 6.19 (bs, 1H), 5.54 (dd, J = 10.1, 2.4 Hz, 0.5H), 5.34-5.28 (m, 1.5H), 
3.92-3.87 (m, 1H), 3.82 (s, 1.5H), 3.81 (s, 1.5H), 3.75-3.70 (m, 1H), 3.45-3.43 (m, 0.5H), 3.32 
(bd, 0.5H), 2.78-2.57 (m, 2H), 2.12 (s, 3H), 2.12 (s, 3H), 2.00 (s, 1.5H), 1.98 (s, 1.5H), 1.89-1.62 
(m, 5H), 1.01 (s, 9H), 1.01-0.96 (m, 3H), 0.96 (s, 9H), 0.96-0.92 (m, 9H), 0.86-0.79 (m, 6H), 
0.81 (s, 9H), 0.59 (q, J = 7.7 Hz, 6H), 0.21 (s, 6H), 0.19 (s, 3H), 0.19 (s, 3H), -0.11 (s, 2H), -0.12 
(s, 1H), -0.45 (s, 2H), -0.50 (s, 1H); 13C NMR (CDCl3, 75 MHz) δ 170.7, 170.6, 169.8, 169.3, 
168.6, 154.7, 150.6, 150.5, 137.2, 122.2, 120.5, 107.5, 92.7, 91.5, 80.0, 77.5, 75.6, 74.0. 72.4, 
72.2, 70.8, 51.7, 43.6, 43.3, 39.6, 39.0, 36.2, 34.5, 33.9, 33.4, 32.9, 25.9, 25.6, 25.5, 22.7, 22.5, 
21.3, 21.2, 21.2, 21.0, 18.2, 18.0, 17.8, 12.8, 12.8, 12.2, 11.6, 11.5, 11.3, 12.8, 12.2, 11.6, 11.5, 
11.3, 6.8, 5.0, -4.2, -4.3, -4.5, -5.2, -5.3; IR (thin film) 2956, 2883, 1732, 1590 1251 cm-1; HRMS 
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 (ES) m/z calcd for C50H94O11NaSi4 (M + Na) 1005.5771, found 1005.5771; [α]25D +60.48° (1.28, 
CHCl3). 
 
2,4-Acetoxy-2-tert-butyldimethylsilanyloxy-5,6-cyano-3,3-
dimethyl-4-triethylsilanyloxytetrahydropyran-2-yl-3-
methylpentyl-4,6-bis-tert-butyldimethylsilanyloxy-3-
methyl benzoic acid methyl ester 41:  To a solution of 39 (0.10 g, 0.10 mmol) in CH2Cl2 (5 
mL) at -78 °C was added TMSCN (27 mg, 0.30 mmol) followed by a dropwise addition of 
BF3•OEt2 (17 mg, 0.12 mmol).  The reaction mixture was stirred at -78 °C for 10 minutes then 
warmed to -42 °C and stirred for 1.5 hours.  The reaction mixture was poured into a stirred 
mixture of pH 7 buffer (10 mL) and CH2Cl2 (10 mL) at 0 °C.  The resulting mixture was warmed 
to rt and extracted with CH2Cl2 (3 x 10 mL).  The organic layers were combined, washed with 
brine (10 mL), dried with Na2SO4, filtered and concentrated under reduced pressure. The 
resulting oil was purified by flash chromatography (10 % EtOAc in hexanes) to provide the 
desired product (92 mg, 97%); 1H NMR (CDCl3, 300 MHz) δ 6.19 (s, 1H), 5.28 (app. q, 1H), 
4.79 (app. d, 1H), 3.96 (ddd, J = 9.3, 3.8, 3.8 Hz, 1H), 3.82 (s, 3H), 3.70 (dd, J = 11.5, 4.5 Hz, 
1H), 3.54 (app d, 1H), 2.81 (dd, J = 13.9, 9.8 Hz, 1H), 2.68 (dd, J = 13.9, 4.2 Hz, 1H), 2.12 (s, 
3H), 2.08 (s, 3H), 2.00-1.88 (m, 3H), 1.78-1.65 (m, 2H), 1.01 (s, 9H), 1.01-1.00 (m, 3H), 0.97-
0.91 (m, 12H), 0.96 (s, 9H), 0.83-0.80 (m, 3H), 0.82 (s, 9H), 0.60 (q, J = 7.9 Hz, 6H), 0.22 (s, 
6H), 0.19 (s, 6H), -0.06 (s, 3H), -0.50 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 170.3, 169.6, 154.8, 
150.6, 137.3, 122.4, 120.7, 117.4, 107.5, 79.1, 76.1, 74.4, 72.2, 72.1, 63.3, 51.8, 41.7, 39.9, 33.6. 
32.4, 26.0, 25.7, 25.6, 22.5, 21.4, 18.2, 18.0, 17.9, 12.9, 12.1, 11.4, 6.8, 5.0, -4.2, -4.2, -4.2, -4.4, 
CO2Me
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 -5.0, -5.1; IR(thin film) 2956, 2858, 1735, 1690, 1162 cm-1; HRMS(ES) m/z calcd for 
C49H91NO9NaSi4 (M + Na) 972.5669, found 972.5681; [α]25D +39.90° (c 0.99, CHCl3). 
 
2,4-Acetoxy-2-tert-butyldimethylsilanyloxy-5,6-
carbamoyl-3,3-dimethyl-4-
triethylsilanyloxytetrahydropyran-2-yl-3-methylpentyl-
4,6-bis-tert-butyldimethylsilanyloxy-3-methyl benzoic acid 
methyl ester 43:  To a solution of 41 (93 mg, 0.10 mmol) in ethanol (4 mL) and H2O (0.6 mL) 
was added (Me2PO)2HPt(Me2POH)18 (2.1 mg, 5.0 µmol) and the reaction mixture was placed 
into an oil bath preheated to 80 °C.  The reaction mixture was stirred at 80 °C for 8 hours, cooled 
to rt, filtered through a short silica gel column with a Na2SO4 plug on top of the silica gel and 
washed with adequate amounts of EtOAc (50 mL).  The eluent was collected, concentrated and 
purified by flash chromatography (20% EtOAc in hexanes) to provide the desired product (92 
mg, 96%); 1H NMR (300 MHz, CDCl3) δ 7.49 (bs, 1H), 6.20 (s, 1H), 5.41 (bs, 1H), 5.21-5.18 
(m, 1H), 5.26 (dd, J = 5.8, 2.4 Hz, 1H), 3.94-3.85 (m, 1H), 3.83 (s, 3H), 3.39 (dd, J = 10.6, 4.2 
Hz, 1H), 3.27 (dd, J = 10.2, 2.7 Hz, 1H), 2.69 (m, 2H), 2.31-2.26 (m, 1H), 2.10 (s, 3H), 2.02 (s, 
3H), 1.85-1.60 (m, 4H), 1.00 (s, 9H), 1.00-0.89 (m, 24H), 0.83 (s, 12H), 0.81-0.83 (m, 6H), 0.22 
(s, 3H),  0.21 (s, 3H), 0.19 (s, 3H), 0.18 (s, 3H), -0.08 (s, 3H), -0.32 (s, 3H); 13C NMR (CDCl3, 
125 MHz) δ 174.1, 171.7, 169.4, 155.0, 150.8, 136.9, 121.9, 120.6, 107.7, 80.4, 74.6, 73.2, 73.0, 
72.5, 51.9, 43.7, 38.8, 33.7, 33.4, 29.8, 25.9, 25.7, 25.6, 23.4, 21.7, 18.2, 18.0, 18.0, 14.4, 12.9, 
11.0, 6.9, 5.0, -4.2, -4.2, -4.3, -4.7, -5.1; IR (neat) 2955, 2858, 1727, 1692, 1591, 1471 cm-1; 
HRMS (ES) m/z calcd for C49H93NO10NaSi4 (M + Na) 990.5774, found 990.5798; [α]25D +23.26° 
(c 0.89, CHCl3). 
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6,3-(6,8-Dihydroxy-5-methyl-1-oxoisochroman-3-yl)-2-
hydroxybutyl-4-hydroxy-5,5-dimethyltetrahydropyran-2-
carbonitrile 45:  To a solution of 44 (10 mg 14 
µmol))(obtained from unoptimized TMSCN addition into 39) in THF (2 mL) was added TBAF 
(74 mg, 0.28 mmol) and the reaction mixture was stirred for 5 hours.  H2O (2 mL) was added and 
teh reaction mixture was extracted with EtOAc (3 x 5 mL).  The organic layers were combined, 
washed with brine, dried with Na2SO4, filtered and concentrated under reduced pressure.  The 
resulting residue was taken up in MeOH (2 mL) and K2CO3 (10 mg) and the reaction mixture 
was stirred at rt for 3 hours.  H2O was added to stop the reaction at partial conversion and the 
reaction mixture was extracted with EtOAc (3 x 5 mL).  The organic layers were combined, 
dried with Na2SO4, concentrated under reduced pressure and purified by preparatory TLC (100% 
EtOAc) to provide the desired product (~1 mg, 17%).   1H NMR (CD3OD, 300 MHz) δ 6.19 (s, 
1H), 4.95 (dd, J = 6.0, 1.0 Hz, 1H), 4.44 (ddd, J = 11.3, 7.1, 3.3 Hz, 1H), 3.98-3.93 (ddd, J = 7.7, 
5.2, 2.5 Hz, 1H), 3.53 (dd, J = 11.8, 4.7 Hz, 1H), 3.42 (dd, J = 10.1, 2.0 Hz, 1H), 3.07 (dd, J = 
16.6, 3.4 Hz, 1H), 2.79 (dd, J = 16.6, 11.2 Hz, 1H), 2.00 (s, 3H), 1.96-1.88 (m, 2H), 1.80-1.74 
(m, 2H), 1.69-1.61 (m, 1H), 1.06 (d, J = 6.9 Hz, 3H), 0.92 (s, 3H), 0.81 (s, 3H); IR (dry film) 
3438, 2926, 1650, 1467, 1376, 1252, 1173, 1101 cm-1; HRMS (EI) m/z calcd. for C22H29NO7Na 
(M + Na) 442.1842, found 442.1818. 
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 APPENDIX A 
 
 
 
The Development of the Electron Transfer Initiated Cyclization for Application in the 
Synthesis of Amido Trioxadecalin Systems 
(Supporting Information) 
(1H and 13C NMR spectra) 
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 APPENDIX B 
 
 
Efforts Toward the Total Synthesis of Mycalamide B  
(Supporting Information) 
(1H and 13C NMR Spectra) 
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 APPENDIX C 
 
 
 
Synthesis of the N7-C25 Fragment of Psymberin 
(Supporting Information) 
(1H and 13C NMR Spectra) 
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